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ABSTRACT 
Bisphenol A (BPA) is a chemical incorporated in plastics and resins used for food 
and beverage containers that has been shown to have estrogenic activity. The 
fact that BPA possess this activity should not be surprising as it was originally 
explored for use as a pharmaceutical estrogen. Exposure to BPA has been 
associated with adverse reproductive and developmental effects in wildlife and 
laboratory animal models. There are also associations between exposure in 
humans and adverse health effects, although some of these findings are 
controversial. The mechanism(s) of action of BPA are well researched, however 
there is no definitive explanation for the frequently reported discrepancies 
between in vitro and in vivo studies. Metabolic activation of BPA in vivo has been 
suggested as a possible reason for this discrepancy in estrogenic potency. As 
public awareness of the possible health effects of BPA increases manufacturers 
have increasingly started to use replacement chemicals as monomers in 
materials that can be labelled as BPA-free. However there is still little information 
on the estrogenic potency of these structurally similar bisphenol chemicals or how 
they may affect health outcomes, as observed with BPA. The studies conducted 
in this thesis therefore aimed to investigate the tissue targets, molecular 
mechanisms and health effects of BPA, its related chemicals Bisphenol S (BPS), 
Bisphenol F (BPF) and Bisphenol AF (BPAF) and the BPA metabolite 4-methyl-
2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP). For this work, a novel ERE 
transgenic (ERE-TG) zebrafish, that expresses green fluorescent protein (GFP) 
in response to activation of ERE was employed. These fish can be applied to 
identify body targets of environmental estrogens in real time with high sensitivity 
and specificity. 
BPA, BPF, BPS and BPAF were shown to all preferentially target the heart in 
ERE-TG zebrafish and GFP induction occurred first in the heart out of the 
different responding body tissues. The response to BPA was shown to be 
dependent on the classical estrogen receptor (ER) signalling pathway. However 
concentrations necessary to induce this response varied for the different 
bisphenols, with the rank order of potency of BPAF>BPA=BPF>BPS. 
Bioconcentration factors of the bisphenols were 4.5, 17.8, 5.3 and 0.067 for 
exposures to 1000 µg BPA/l, 1000 µg BPF/l, 100 µg BPAF/l and 50000 µg BPS/l 
respectively. These data indicate bioavailability is an important consideration in 
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the differing estrogenic potencies of the different bisphenols. The toxicities of the 
different bisphenols on early life stage zebrafish followed a similar rank potency 
order as for the estrogenic activity (BPAF>BPA>BPF>BPS). Specific 
morphological abnormalities were observed for the different bisphenolic chemical 
treatments in the toxicity assessments, possibly suggesting that they may act 
through different ways in inducing their toxic effects. It is recognised that the 
toxicities for the bisphenolic chemicals were observed at concentrations several 
orders of magnitude higher than those measured in most aquatic environments 
and thus the threat they pose to wildlife health might be considered as relatively 
low, except in circumstances where short but high exposures may occur from 
accidental release into the environment. 
The BPA metabolite MBP was found to be up to 1000-fold more potent than the 
parent compound as an estrogen in ERE-TG fish. The heart was a key target 
tissue for MBP, as observed for the other bisphenolic compounds. The 
atrioventricular valves and bulbus arteriosus were identified as the primary 
targets within the heart. MBP was not measured in zebrafish embryos exposed 
to BPA and whether this is produced as a metabolite in zebrafish is still not known. 
Morpholino knockdown of specific ER subtypes indicated that esr1 is a major 
pathway for the estrogenic response to BPA in the heart during early life stages 
of zebrafish. Video capture and analysis was used to assess the cardiovascular 
health of zebrafish exposed to BPA and it was found that at very high exposure 
concentrations (2500 µg/l) BPA could induce an unstable atrial:ventricular beat 
ration in 5 dpf larvae and reduced heart beat rate in 14 dpf. 
In the final study of this thesis transcriptomic profiling was conducted on hearts 
extracted from 96 hpf ERE-TG zebrafish larvae exposed to BPA. The findings 
demonstrated that BPA, at an exposure concentration of 150 µg/l caused a down-
regulation of a number of genes associated with ion transport and cell-to-cell 
communication, functions that are essential in maintaining a regular and 
consistent heart rate. These effect mechanisms may help to explain the effects 
on the heart seen at the higher BPA exposure concentrations in the previous 
chapter, although this would need more extensive work to draw any such 
associations with good confidence 
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Overall, the findings presented in this thesis have provided a body of evidence to 
show that all of the bisphenolic chemicals tested possess estrogenic activity and 
as such have the potential for health effects in wildlife and also to humans. It is 
also the case however that currently in most ambient environments 
concentrations of these bisphenolic chemicals are far below those that could 
induce adverse health outcomes.  The work in this thesis re-enforces the 
importance of understanding metabolic activation of chemicals in vivo. It 
furthermore illustrates the power of transgenic fish and an integrated approach 
for gaining greater insight into potential health effects of chemicals. 
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CHAPTER 1: General Introduction 
1.1 The endocrine system and estrogens 
The endocrine system is a major signalling system in biological organisms that 
employs hormones to regulate and control the physiological processes of 
reproduction, growth, development and metabolism. In vertebrates the major 
tissues of the endocrine system include the various glands including the 
hypothalamus, pituitary, thyroid and adrenal glands and the gonads. The 
hormones produced by cells in these tissues are chemical messengers carried 
through the body via the circulatory system at very low concentrations, yet have 
the potential to elicit dramatic responses in target tissues. These effects are 
mediated through the binding of receptors in target cells, which may be present 
in the cell membrane or cytosol and these ligand receptor interactions in turn may 
induce changes by regulation of gene transcription. Nuclear receptors are a 
family of receptors that include the estrogen receptor (ER), and are ligand-
activated regulators that directly interact with and control the expression of 
genomic DNA via specific response elements upstream of their target genes. In 
the case of steroid hormones, which are relatively small and lipid soluble allowing 
free diffusion into cells, hormone-receptor complexes form in the cytosol, 
dimerise with a second complex and other expressed co-factors and move into 
the nucleus. Here they bind DNA and stimulate the transcription of specific genes. 
In other cases, estrogens trigger their actions after binding to membrane estrogen 
receptors such as GPR30 (Revankar et al. 2005), or to ion channels (Valverde et 
al. 1999) capable of linking to intracellular signal transduction pathways that can 
generate rapid tissue responses (Hall et al. 2001). 
Sex steroids are a group of steroid hormones that have traditionally been well 
documented for their effects on early sexual differentiation, regulation of 
gametogenesis and development of secondary sexual characteristics, and a 
wider range of pleiotropic effects. Traditionally the main sex steroids, estrogens 
and androgens, have been thought of as female and male respectively. However, 
it has been demonstrated that both play a role in growth, differentiation and 
homeostasis of reproductive organs in both sexes. Additional processes that 
depend on the actions of estrogens are varied and widespread, including 
functioning of the cardiovascular, central nervous, skeletal and immunological 
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systems. The three major natural occurring estrogens are estrone (E1), 17β-
estradiol (E2) and estriol (E3), with E2 being the most prominent estrogen in 
terms of both levels detected and estrogenic activity. 
1.2 Estrogen receptors 
There are currently two ERs described in mammals, ERα and ERβ encoded by 
the genes esr1 and esr2 respectively. ERs can be found widely expressed in 
different tissue types, however distinct expression patterns have been shown in 
a range of vertebrate animals. High expression of ERα has been found in the 
uterus, mammary gland, placenta, central nervous system, cardiovascular 
system, bone and efferent ducts (Nilsson et al. 2001, Hess 2003). Whereas ERβ 
has been shown to be expressed at higher levels in the prostate, testis, ovary, 
pineal gland, thyroid gland, adrenals, gallbladder, skin, urinary tract, lymphoid 
tissues and muscle (Ciocca and Roig 1995, Taylor and Al-Azzawi 2000). ERs 
may bind as either homodimers or heterodimers to estrogen response elements 
(EREs) in the promoter region of responsive genes.  
Both ERs are highly conserved (97% similarity) in their DNA-binding domains 
(DBDs), in mammals which is reflected in the similar affinities in binding to EREs 
(Klinge 2001). Although ligand binding domain (LBD) is less conserved (55% 
similarity) (Kuiper et al. 1998a) in mammals, E2 binds both ERs with similar 
affinity. However, this difference may account for observed differences in 
transcriptional responses to ligands in a promoter- and cell-dependent manner, 
indicating functional differences between the receptor subtypes. 
In contrast with mammals there have been three receptor subtypes identified in 
many teleost fish (in some cases four have been identified), known as ERα, ERβ1 
and ERβ2 encoded by the genes esr1, esr2b and esr2a respectively (Hawkins et 
al. 2000). Several studies have looked at the tissue distribution of ERs in different 
fish species, although results differ, common tissues expressing ERα and ERβ1 
include the gonads and liver (Ma et al. 2000, Socorro et al. 2000, Menuet et al. 
2002, Filby and Tyler 2005, Chandrasekar et al. 2010). Consistent with the role 
of the gonads in sexual development and the vital role the liver plays in the 
production of the proteins necessary for oocyte synthesis and maturation 
(including vitellogenin (VTG) and zona radiata protein (ZRP)). Other tissues that 
have been determined to express ERs in fish include the brain, heart, muscle, 
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neuromasts and pituitary, however frequency and subtype preference appears to 
differ between species (Socorro et al. 2000, Menuet et al. 2002, Choi and Habibi 
2003, Tingaud-Sequeira et al. 2004, Filby and Tyler 2005). The ligand binding 
traits of different species appear to differ, which may help to explain the 
differences observed. Even within commonly used laboratory species both ER 
activation assays and VTG induction in vivo were found to differ considerably in 
responsiveness (Lange et al. 2012). Cloning of LBD into different ERs indicated 
the LBD plays a significant role in accounting for ligand sensitivity in different 
species (Miyagawa et al. 2014). Whole-mount in situ hybridization of ER genes 
in zebrafish found high levels of esr2a and esr2b mRNAs detected in the 
epidermis, pectoral fin buds, hatching gland and, to a lesser extent, the 
developing brain at 24 hours post fertilization (hpf), low levels of esr1 were also 
detected (Tingaud-Sequeira et al. 2004). By 72 hpf all mature primary 
neuromasts in both the anterior and posterior lateral line systems express 
significant levels of esr2a and esr2b transcripts, whereas esr1 remains weaker. 
In contrast (Gorelick et al. 2014) did not find ERs to be distributed in a similar 
pattern using in situ hybridization. At 120 hpf esr2a (reported as esr2b) is found 
expressed strongly in the liver whilst esr1 is expressed specifically in the heart 
valves, esr2b (reported as esr2a) was not detected. The reasons for these 
differences are unclear as both studies were conducted at a similar life stage and 
found distinct expression patterns. It is unlikely that differences in methods or in 
situ probe synthesis would produce such differing results. 
1.3 Disruption of Estrogen signalling 
Exposure to both natural and anthropogenically derived chemicals is unavoidable 
for both humans and wildlife. A vast array of chemicals are produced and 
released into the environment and have been determined to have deleterious 
effects (reviewed in Kumar and Holt (2014) and Mathieu-Denoncourt et al. (2015). 
Due to the nature of the endocrine system, which relies on relatively small 
changes in expression of endogenous hormones to bring about sometimes large 
changes in physiology, it is possible that these chemicals, even at low 
concentrations may produce adverse developmental, reproductive and 
neurological effects. The chemicals capable of eliciting these changes are known 
as endocrine disrupting chemicals (EDCs), defined by the International 
Programme on Chemical Safety as “…an exogenous substance or mixture that 
18 
 
alters function(s) of the endocrine system and consequently causes adverse 
health effects in an intact organism, or its progeny, or (sub)populations”. 
A number of different chemicals have been described as endocrine disruptors 
including (anti)estrogens, (anti)androgens and thyroid disruptors. Chemicals now 
known to act as EDCs include natural steroidal estrogens (E2 and E1), phyto and 
myco estrogens (particularly genistein), synthetic steroidal estrogens (EE2 and 
DES), plasticisers (BPA and phalates), polyaromatic hydrocarbons (PAHs), 
androgens, surfactants (alkyl phenol ethoxylates, which break down into 
nonylphenol), dioxins and brominated flame retardants (reviewed in (Mills and 
Chichester 2005) and (Diamanti-Kandarakis et al. 2009)). These chemicals are 
diverse in structure and function and therefore can interact differently with the 
environment. For example, some have high bioconcentration factors and may 
result in high burdens even when exposure concentration is low, or others, such 
as BPA may have such ubiquitous exposure that effects may be evident despite 
having a low bioconcentration potential. Humans may be exposed to these 
chemicals through dietary or dermal absorption and inhalation from many 
everyday sources including medicines, detergents, flame retardants, plastic 
bottles, metal cans, pesticides and cosmetics. All of these substances may 
also enter the environment via waste water treatment works (WWTW) into rivers 
and estuaries or from agricultural runoff or landfill leachates. Our water bodies in 
particular tend to act as a sink for our chemical discharges.  
A growing body of evidence from recent decades has provided a number of 
examples of reproductive and developmental abnormalities in a number of taxa 
as a result of exposure to EDCs (Tyler et al. 1998, Vos et al. 2000, Bernanke and 
Kohler 2009). Although the potency of different EDCs varies greatly, most tend 
to be weaker than natural hormones. Potency is directly related to both the affinity 
and efficacy of a typical ligand, where affinity refers to the interaction of the ligand 
and receptor and efficacy is measured by the relative ability to produce a 
downstream response. Whereas natural hormones tend to possess a high affinity 
and efficacy, some EDCs may have a high affinity but a low efficacy. Various 
other factors in cells, including receptor abundance and type can also have 
effects on efficacy complicating measurements. Nevertheless, many EDCs are 
found at high concentrations, are persistent or exist as complex mixtures which 
may have undescribed interactive effects, in regards to both affinity and efficacy. 
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It is generally accepted that these chemicals do pose some risk to humans and 
wildlife, though debate still exists over the potential to cause population level 
disruption at current exposure levels. 
1.4 Mechanisms of disruption 
Although it is possible for various EDCs to affect a number of cellular hormonal 
pathways, most research has investigated the interference of EDCs with nuclear 
receptors. Chemicals that bind receptors may do so in an agonistic way, 
stimulating a hormonal response. Others, though they may be structurally similar 
may not activate receptors when binding occurs, preventing the actions of 
endogenous hormones, therefore acting as an antagonist. Antagonists may 
appear to produce a similar phenotype as agonists, for example anti-androgenic 
chemicals and estrogenic chemicals have different modes of action but both 
result in apparent feminisation of fish (Filby et al. 2007). Chemicals that act as 
receptor agonists can have an additive effect, whereby low concentrations of 
various chemicals may elicit a larger effect than would be expect by individual 
chemical exposure (Rajapakse et al. 2001). EDCs can also act synergistically, 
increasing beyond an additive response, although it is unlikely that chemicals with 
the same mode of action will act this way (reviewed in Cedergreen (2014). Some 
EDCs have the ability to affect the metabolism or production of natural hormones 
either increasing or reducing existing levels, for example imidazole fungicides or 
organotins may modulate CYP19 activity post-transcriptionally disrupting 
estrogen biosynthesis and subsequently reproductive function (Cheshenko et al. 
2008). These chemicals may exert their effects by interfering in other signalling 
systems, such as the thyroid, immune or nervous systems. Some chemicals may 
act through several different mechanisms, for example, BPA has been 
demonstrated to bind and activate ERs and estrogen related receptors (ERRs), 
act through non-genomic pathways, antagonise ARs and interact with thyroid 
receptors (Welshons et al. 2006). EDCs can also function more indirectly by 
interfering with receptor protein synthesis or degradation, modulating 
coactivators, affecting transport or excretion of hormones, interfering with 
feedback mechanisms or by disrupting endocrine tissues directly (Tabb and 
Blumberg 2006). 
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Of the vast array of EDCs, the most widely documented, due to effects and levels 
found in the environment are estrogenic. Chemicals that can mimic the effects of 
estrogen were identified more than 80 years ago (Dodds and Lawson 1936), 
however it wasn’t for many decades that it was realised these chemicals could 
have widespread effects at the concentrations found in the environment. First 
alerted due to the observation of intersex (the presence of both male and female 
sex cells within the same gonad) in feminized male fish, this phenomenon has 
now been reported in various species. In more severely affected males a reduced 
capacity for fertilisation has been observed and adverse effects at the level of fish 
populations have also been suggested (Tyler and Jobling 2008, Hamilton et al. 
2014). Although the effects of estrogens on the gonads in fish are well 
documented there is less research into the potential effects in other target tissues. 
As ERs are widely distributed and estrogens are known to have developmental 
and modulatory effects on many targets it is possible that these tissues are also 
targets for disruption. 
This thesis largely concerns the effects and mechanisms of the environmental 
estrogen BPA and closely related chemicals, and the next sections of text provide 
a detailed background on these chemicals only, rather than on the wider known 
body of estrogenic chemicals.  
1.5 Bisphenol A 
BPA is a well-documented environmental estrogen. Largely employed in the 
production of plastics and epoxy resins, BPA based materials are versatile and 
widely used in a vast array of products. Originally synthesised in 1891 by Russian 
scientist A.P. Dianin by the condensation of acetone with two equivalents of 
phenol, BPA was not utilised until estrogenic activity was detected in 1936 by 
(Dodds and Lawson 1936). Dodds attempted to further develop BPA as a 
synthetic estrogen before abandoning it in favour of DES (Vogel 2009). It wasn’t 
until the 1950s that the first epoxy resins were produced, shortly after US and 
Swiss scientists filed patents based on the production of a hard, clear plastic 
formed from the polymerisation of BPA called polycarbonate (Vogel 2009). 
Production of BPA has increased dramatically since the introduction of 
polycarbonate; world production capacity was approximately 1.1 million tonnes in 
the 1980s and more than 2.4 million tonnes in 2009. Over this period annual 
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production increased over five times. This occurred despite the fact that research 
in the 1990s identified BPA to be an endocrine disrupting chemical (EDC) 
(Krishnan et al. 1993, Steinmetz et al. 1997). Latest estimates (2012) on global 
production of BPA stands at 4.6 million tonnes with 70% being used in 
polycarbonates, 26% in epoxy resins and 4% in other applications (Ltd 2013). 
Levels of BPA detected in media that has been in contact with polycarbonate 
plastics varies greatly, with differences often attributable to treatment conditions, 
including temperature and contact time. BPA may leach from plastics not only by 
diffusion of residual, unbound BPA remaining from the manufacturing process, 
but also by hydrolysis of the polymer (Geens et al. 2012). This causes 
observations in contrast to typical migration behaviour, whereby repeated use 
may see a reduction in leachate present; due to hydrolysis of the polycarbonate 
BPA migration has actually been observed to increase over time (Brede et al. 
2003, Torres et al. 2014). 
BPA leachate measured from polycarbonate baby bottles - a source of concern 
due to the vulnerability to EDCs during development – has been measured to be 
low under conditions which are most likely to occur under normal use 
(Biedermann-Brem et al. 2008, Simoneau et al. 2011). However after performing 
certain treatments based on changes in temperature pH, hardness and duration, 
levels of BPA were found to be much higher: (Biedermann-Brem and Grob 2009) 
detected BPA at 137µg/l in baby bottles that had only been sterilised for twice the 
recommended time, whilst (Cao and Corriveau 2008) found migration levels to 
range between 228 and 521 µg/l after being heated at 70 oC for 6 days (an 
unlikely scenario under normal use, however). BPA has also been detected in 
plastic bottles labelled as BPA free. In one study BPA was detected in 77% of 
polyamide bottles labelled BPA-free with levels measured ranging from 0.5 – 
1005 µg/kg, much higher than some values found for polycarbonate plastic and 
over the European Union migration limit of 600 µg/kg (Simoneau et al. 2012). 
Although BPA has been banned by the European Union for use as an additive, 
or as a monomer in polycarbonate plastics, it is still possible that BPA can be 
used as a monomer in other materials such as polyamide. The authors carried 
out several confirmation studies including external testing which supported their 
previously observed results, concluding that the presence of BPA in this polymer 
is not only abnormal but illicit.  
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BPA Epoxy resins are the second most common use of BPA by weight. Although 
used in a variety of applications, it is their use in food contact materials that line 
food and drink cans or metal lids that is likely to be of most concern due to the 
potential dietary exposure to leached BPA; Goodson et al. (2004) determined that 
80-100% of BPA present in the can coating migrated into the contents during the 
sterilisation process. The concentrations of BPA in the contents also remained 
stable across various temperature treatments for up to 9 months (Goodson et al. 
2004). 
Studies detecting the concentration of BPA in food from epoxy lined containers 
vary greatly. Even within the same study investigating the same contents, 
variation in internal concentration can be highly variable with an approximate 100-
fold difference between peas (2.6-310 ng/g), refried beans (6.3-790 ng/g) 
(Noonan et al. 2011) and corn (1.2-8.2 ng/g) (Geens et al. 2010) . It is possible 
that some variation can be attributed to the handling of containers after 
processing. BPA concentration has been shown to be increased by can damage 
across several brands of tomato (Errico et al. 2014). However, it is possible that 
these inconsistencies are a result of different can styles or coatings which may 
differ by supplier. These differences are poorly investigated and not currently 
subject to regulation. There is evidence that indicates BPA has an affinity to 
partition into the solid portion of the contents, with concentrations in the solid 
phase measured to be 10-fold higher than the liquid phase (Yoshida et al. 2001, 
Geens et al. 2010, Noonan et al. 2011). It was suggested these results are due 
to surface adsorption or migration due to fat content and the lipophilic nature of 
BPA.  
Although polycarbonate plastics are the most common use of BPA by weight the 
importance of epoxy lined food cans has been demonstrated as the dominant 
route of dietary exposure (Christensen and Lorber 2014, Lorber et al. 2015). 
Using data from Canada and the USA (Cao and Corriveau 2008, Noonan et al. 
2011) (Christensen and Lorber 2014) estimates that average daily exposure to 
BPA via canned food in individuals under the age of 20 is 92.3 ng/kg-day, 
whereas exposure via non-canned food items is predicted to be just 0.3 ng/kg-
day. A study investigating the effect of eating canned or fresh soup once a day 
for five days without restricting any other lifestyle factors found urinary BPA 
concentrations to be on average 22.5 µg/l higher when consuming canned food 
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(representing a 12-fold increase) (Carwile et al. 2011). However, it should be 
noted that in this study there was no attempt to measure the BPA concentration 
of the food consumed. Furthermore, with only one time point, it is likely to be a 
transient peak of unknown duration. 
BPA is commonly found in the monomers used for resins in dental sealants. 
Although these resins do not strictly incorporate BPA itself as a component, it 
may be present as an impurity or through degradation of the resins themselves 
(Rathee et al. 2012). BPA has been detected in saliva of specimens collected an 
hour and three hours after sealant placement between 5.8 and 105.6 µg/l; 
however there was no measured increase of BPA serum concentrations up to 
five days after placement (Fung et al. 2000). Another study investigating salivary 
BPA in Korean children fitted with dental sealants found lower concentrations of 
salivary BPA (0.002 to 8.305 µg/l), though concentrations in treated individuals 
were still significantly higher than those without any sealant (Han et al. 2012). 
(Joskow et al. 2006) determined that the amount of BPA leached from dental 
sealant may depend on the sealant type, with one brand increasing salivary BPA 
significantly more than another. Although there do not appear to be any findings 
where BPA has been significantly elevated in the blood serum following sealant 
placement, one study observed an increase in urinary BPA in children with a 
number of sealants from the NHANES cohort. However upon adjusted analysis, 
this increase was not found to be significant (McKinney et al. 2014). Although it 
is possible that dental sealants may increase the load of BPA exposure, 
especially in the short term, it appears unlikely that it contributes significantly 
when compared to other sources. 
BPA has also been detected in paper and paper products, particularly thermal 
papers where it is used as a colour developer. The ubiquitous use of thermal 
paper, for example in till receipts and card printers often results in daily contact 
where BPA may be absorbed dermally. Studies have reported high 
concentrations of BPA in thermal paper from cash registers, between 3 and 17 
mg/g (Biedermann et al. 2010, Mendum et al. 2010). However, it is thought that 
actual dermal transfer may be relatively low, with one study estimating daily 
intake values of BPA through dermal absorption being 17.5 and 1300 ng/kg 
bw/day for the general population and occupationally exposed individuals 
respectively (Liao and Kannan 2011). Although much higher levels were 
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calculated by (Biedermann et al. 2010) they also concluded low levels of 
absorption, where even with exaggerated contact (repeated contact for 
10hrs/day) estimated concentrations were still 42 times lower than the present 
recommended tolerable daily intake (71µg/day). 
Although absorption may be argued to be low from thermal paper, the large 
amount produced may result in the release of BPA into other products or the 
environment. It has been estimated that approximately 30% of thermal paper 
enters recycling facilities, where it may potentially end up in other paper products, 
toilet roll in particular (Liao and Kannan 2011). (Fukazawa et al. 2001) 
investigated the presence of BPA in the final effluent of eight plants 
manufacturing paper from recycled sources and BPA was detected in all samples 
ranging at concentrations between 8 and 370 µg/l. Any paper products not 
recycled can be assumed to end up being released into the environment either 
via landfill or loose disposal. Using conservative estimates (Liao and Kannan 
2011) calculated up to 30.4 tonnes of BPA could be released into the environment 
through discharge of thermal paper alone in the USA and Canada every year. 
Despite the fact the BPA does not occur naturally its widespread and varied use 
and continuous release have led to it being ubiquitous in the environment. 
Release of the raw chemical can furthermore occur during the manufacture and 
subsequent transport and processing. Release from BPA containing products 
may then commonly occur via effluent discharge, landfill leachates, combustion 
and the environmental degradation of materials. In 2012 in the United States 
alone, total release of BPA was reported to be 745 metric tonnes (an increase of 
238 tonnes from 2007). Total transfers off site or for further waste management, 
including incineration or wastewater treatment accounted for an additional 1129 
metric tonnes (USEPA 2014). Similar release information is not available for 
Europe and Asia which hold larger market shares in overall production volume 
(North America accounts for 18% of the world BPA production volume (Ltd 2013), 
therefore global release is likely to be many times higher. Although there is limited 
information on the specific amounts of BPA released from production sites, 
several studies have attempted to quantify the levels of BPA in environmental 
samples. Due to the ubiquitous nature of BPA and its methods of release/disposal 
it has been commonly detected in aqueous, sediment and aerial samples. 
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BPA concentrations measured in surface waters vary greatly with regards to 
location, time of year and sampling method. In a review by (Flint et al. 2012) of 
22 studies investing BPA concentrations in surface waters, 17 found maximum 
BPA concentrations to be 1µg/l or less, with minimum measurements at low ng/l 
concentrations, or not detected. However some studies have determined 
concentrations of BPA in environmental waters to be very high including 
measurements at 21, 19 and 12µg/l in the Netherlands, Japan and USA 
respectively (Flint et al. 2012). However, the Netherlands river where 21µg/l was 
detected was measured to be <0.011µg/l several months later (Belfroid et al. 
2002). If there were no unreported errors in the methodology these values may 
be from single high discharges. Short term high exposures to BPA, particularly 
during critical stages of development can have lasting alterations, therefore these 
brief but high measurements should not be overlooked (Saili et al. 2012, Tse et 
al. 2013). 
BPA detected in industrial or waste water treatment effluent displays a similar 
wide range of reported levels, with most measurements being lower than 1µg/l 
(Flint et al. 2012). However maximum concentrations have been found to be 
several orders of magnitude higher than those found in surface waters. A 
Japanese study found BPA present in paper-mill effluent at 370µg/l, with a mean 
of 59µg/l, and an Australian study found a mean concentration of 23µg/l in a 
waste water treatment effluent (Fukazawa et al. 2002, Al-Rifai et al. 2007). 
Similarly, BPA has been measured at very high concentrations in a small number 
of landfill leachates. In Japan, for example concentrations as high as 5,400 
(Yamada et al. 1999) and 17,200 µg/l (Yamamoto et al. 2001) have been 
reported. 
1.6 Observations on the effects of BPA in Mammals/humans 
1.6.1 Male fertility and reproductive function 
1.6.1.1 Mammalian models 
Exposure to BPA has been reported to decrease sperm production and fertility in 
male mice and rats, possibly through the disruption of meiotic progression during 
spermatogenesis. (Liu et al. 2013) found that adult male rats dosed orally with 
200μg/kg bodyweight (BW)/day had significantly reduced sperm counts, 
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associated with meiotic disruption. By using an estrogen receptor (ER) 
antagonist, it was also determined that ER signalling was responsible for 
mediating the BPA-induced reproductive impairment. However (Qiu et al. 2013) 
found that BPA induced spermatogenesis disorders in adult rats mainly through 
decreasing androgen receptor expression. This illustrates that the mechanisms 
by which BPA may be acting in the testis are likely complex and probably result 
from multi pathways effects. Estrogens can act to modulate androgen signalling 
without directly binding to androgen receptors (ARs). Another study also found 
that sperm production was reduced in rats orally exposed to BPA at 
concentrations of only 20μg/kg BW/day (Sakaue et al. 2001). (Tiwari and Vanage 
2013) found significant reductions in sperm production at 10 μg/kg BW/day and 
an increase in sperm DNA damage and decreased motility, but only at a very high 
dose of 5.0 mg/kg BW/day. Studies in mice have resulted in similar findings, with 
oral exposure to BPA as low as 25 μg/kg BW/day causing a significant reduction 
in sperm counts and sperm production efficiency, which in turn was associated 
with a significant reduction in pregnancy rates (Al-Hiyasat et al. 2002). Quality 
and quantity of spermatozoa were decreased in mice orally exposed for 5 weeks, 
and this was associated with a slowing of meiotic progression of germ cells. 
Offspring of these mice were classed as abnormal as they were smaller at 35 
days compared with controls (Zhang et al. 2013). Subcutaneous injection of 20 
μg/kg BW/day BPA into adult rats and mice has been shown to cause 
abnormalities in spermatids, including deformations of acrosomes and nuclei 
after 6 days. 2 months after dosing cessation adverse effects were shown to be 
reversed (Toyama et al. 2004). (Chitra et al. 2003) Also found that orally dosing 
rats at between 0.2 and 20 μg/kg BW/day caused a reduction in epididymal sperm 
motility and sperm count in a dose-dependent manner. 
Alterations in male reproductive tissue weights have also been recorded, notably 
reduction in prostate and seminal vesicle weights in mice and rats exposed to a 
high dose of BPA (20 mg/kg BW/day) (Takao et al. 1999, Takahashi and Oishi 
2003). In contrast with these findings however in rats exposed to 20μg/kg BW/day 
BPA orally reductions in the testis and epididymis weights were observed, but 
there was no significant change in the weight of the seminal vesicles, prostate 
weight was reported to increase (Sakaue et al. 2001, Chitra et al. 2003). The 
concentration needed in this study to produce detectable effects was below the 
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current EPA exposure limit of 50 µg/kg BW/day, it was however above estimates 
of human exposure in the NHANES cohort, as estimated by urinary BPA 
concentrations (0.017-0.274 µg/kg BW/day) (Lakind & Naiman 2008, 2011). The 
differences observed between the different studies (decreasing/increasing 
prostate weights etc.) may be due to the very high dose inhibiting prostate growth. 
However, the lower dose (which reflects more accurately environmental 
exposures) is possibly more likely to indicate a hormonal response, which 
typically only requires concentrations at ppt. 
1.6.1.2 Humans 
There have been few human studies that have made associations between 
urinary BPA concentrations and sperm concentration/quality. Notably (Li et al. 
2011) studied the effect of occupational exposure to BPA from males across four 
regions in China. Comparisons between these men and men who had not been 
exposed to BPA showed increasing urine BPA level was associated with many 
factors pertaining to sperm quality, namely decreased sperm concentration, 
decreased total sperm count, decreased sperm vitality, and decreased sperm 
motility. There was no significant change in semen volume or abnormal sperm 
morphology. Males, who were not occupationally exposed to BPA were still found 
to have measurable concentrations of urinary BPA, but at lower levels, and these 
males also demonstrated a significant negative correlation between BPA and 
sperm concentration. Adjustments were also made for potential confounders, for 
example, exposure to other chemicals/metals. A study recruiting US males 
through an infertility clinic found that urinary BPA concentrations measured in 
spot urine samples collected on the same day as a semen sample were 
associated with declines in semen quality, including concentration, motility and 
morphology and increased sperm DNA damage (comet assay)(Meeker et al. 
2010). However, some cohort studies have reported finding no significant 
association between male fertility and urinary BPA action (Mendiola et al. 2010). 
Embryo quality, in particular reduced embryo cell number and increased embryo 
fragmentation score, were associated with increased serum BPA concentration 
in men (Bloom et al. 2011a). 
In addition to looking at semen quality, Li et al published two further studies 
investigating associations between urinary BPA concentrations and sexual 
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function in Chinese male populations, exposed through factory work where BPA 
or epoxy resin is manufactured (Li et al. 2010a, Li et al. 2010b). Again potential 
confounders, such as chemical/metal exposure were statistically controlled for. 
Increased urinary BPA concentrations was found to be associated with a number 
of factors pertaining to sexual function including decreased libido, erectile 
dysfunction, ejaculation strength and satisfaction with sex life (Li et al. 2010a). 
Similar results were found in both studies for different populations. BPA-exposed 
workers also reported significantly reduced sexual function within 1 year of 
employment within the exposed environment (Li et al. 2010b). 
1.6.2 Female fertility and reproductive function 
1.6.2.1 Mammalian models 
Few studies have reported direct links between BPA exposure in mammals and 
reduced female fertility; those that do exist do not provide definitive conclusions. 
A decline in the reproductive capacity of female mice perinatally exposed to BPA 
has been observed and in a dose dependant manner. A decline in fertility and 
fecundity has been observed over time for concentrations as low as 25ng/kg 
bodyweight (BW)/day (Cabaton et al. 2011). (Markey et al. 2005) also report that 
female mice exposed in a similar way, in utero, had genital tract alterations during 
adulthood, though there was no attempt to observe the effect of these 
abnormalities on reproductive output. However mice exposed orally for 2 
generations to BPA at concentrations between 0.05-5 mg/kg BW/day found no 
adverse effects on female reproduction (Kobayashi et al. 2010). Exposure of 
female mice to 20-100 μg/kg BW/day of BPA resulted in a significant increase in 
meiotic abnormalities, including aneuploidy in the oocytes; this abnormality was 
initially observed in mice that were housed in polycarbonate cages and provided 
water in polycarbonate bottles that had been damaged by washing with a harsh 
detergent (Hunt et al. 2003). Oocytes of females exposed during foetal 
development displayed similar meiotic abnormalities, including synaptic defects 
and increased levels of recombination (Susiarjo et al. 2007). In the mature 
female, these aberrations were translated into an increase in aneuploid eggs and 
embryos. Neonatal subcutaneous injection of BPA at doses between 10-
1000μg/kg BW/day resulted in severe pathologies of the uterus including 
adenomyosis, leiomyomas, atypical hyperplasia, and stromal polyps and a 
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statistically significant increase in cystic ovaries (Newbold et al. 2007). There are 
a number of other studies that have found a link between BPA exposure and the 
occurrence of cystic ovaries (Kato et al. 2003, Signorile et al. 2010, Vo et al. 
2010). 
1.6.2.2 Humans 
There have been several cohort studies on individuals receiving in vitro 
fertilisation (IVF) treatment, where BPA concentrations have been measured in 
relation to multiple reproductive endpoints, such as ovarian response, fertilisation 
and implantation success and embryo quality. Ovarian response is measured by 
number of retrieved oocytes and peak E2 serum concentrations after 
hyperstimulation with human chorionic gonadotropin (hCG). Ovarian response 
has been observed to be reduced in US cohort studies in women found to 
possess higher total urinary BPA (Mok-Lin et al. 2010, Ehrlich et al. 2012). (Bloom 
et al. 2011b) also found BPA concentrations were associated with lower serum 
E2, however no reduction in the number of oocytes retried was observed. 
Fertilisation success of oocytes was also found to be lower in the study by Ehrlich 
et al. This finding was also observed in a separate cohort study by Fujimoto et al. 
2011 where a 55% decrease in the probability of fertilisation was found with 
increased female serum BPA. Women with higher urinary BPA were also found 
to have a higher chance of embryo implant failure in a separate study (Ehrlich et 
al. 2012). 
There have been several studies that relate BPA concentrations to the 
prevalence of Polycystic Ovarian Syndrome (PCOS), one of the leading causes 
of female sub-fertility (occurring in populations at an incidence of 4-
8%(Knochenhauer et al. 1998, Michelmore et al. 1999, Azziz et al. 2004). In a 
study by Takeuchi and Tsutsumi 2002, total serum BPA was found to be 
significantly higher in women with PCOS compared with those with no evidence 
of PCOS. These results were supported by further studies that investigated 
associations between serum BPA concentrations and the occurrence of PCOS in 
women (Takeuchi et al. 2004, Kandaraki et al. 2011, Tarantino et al. 2013). Other 
features commonly associated with PCOS include obesity, insulin resistance, 
type 2 diabetes and cardiovascular, symptoms also often linked to BPA exposure 
in human populations. (Takeuchi and Tsutsumi 2002) 
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1.6.3 Obesity/metabolism 
1.6.3.1 Mammalian models 
Reported over a decade ago, pregnant mice treated with 2.4 μg BPA/kg BW/day, 
during days 11-17 of gestation, produced male and female offspring that were 
significantly heavier than control females on postnatal day 22, despite having a 
similar body weight at birth (Howdeshell et al. 1999). Many subsequent studies 
in rats and mice have observed an association between increase in body weight 
and perinatal exposure to BPA in males and females (Rubin et al. 2001, Takai et 
al. 2001, Miyawaki et al. 2007), only in females (Markey et al. 2003, Nikaido et 
al. 2004, Somm et al. 2009) and in males alone (Akingbemi et al. 2004, Patisaul 
and Bateman 2008). However, significant differences appeared to vary between 
life stage, with some studies appearing to show statistically significant alterations 
in body weight almost immediately after birth (Rubin et al. 2001, Somm et al. 
2009), while others showing little difference until weeks or months after birth 
(Howdeshell et al. 1999, Takai et al. 2001, Akingbemi et al. 2004, Nikaido et al. 
2004, Markey et al. 2005). 
In contrast to these findings, a separate study found no difference in body weights 
between mice prenatally exposed to BPA at 10-1000 μg/kg BW/day and control 
mice (Newbold et al. 2007). A possible reason for this is that mice were only 
weighed at 18 months, a much more advanced age than adopted in most other 
studies. Although puberty was accelerated in female mice exposed prenatally to 
2 and 20 μg BPA/kg BW/day subcutaneously, body weight decreased in relation 
to unexposed females (Honma et al. 2002). A decrease in weight was suggested 
to be a result of the mice being raised by their own mothers, a factor not shared 
with studies that observed an increase in weight. Exposure to BPA during 
pregnancy and lactation may cause a detrimental effect on nursing behaviour and 
efficiency possibly leading to a reduction in weight (Palanza et al. 2002, Della 
Seta et al. 2005). 
Body weight is not necessarily an accurate measure of obesity in rodents and 
only a few studies have assessed the impact of BPA exposure on more accurate 
measurements of obesity such as fat mass, fat pad weight, and adipose tissue 
cell composition (Thayer et al. 2012). (Miyawaki et al. 2007) found dosing 
pregnant/lactating mice with 1 and 10 μg/ml and continuing with exposure 
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through to PND 31, resulted in a mean adipose tissue weight increase (132% at 
1μg/ml in females; 59% at 10 μg/ml in males) and the mean total cholesterol level 
also increased (33% at 1μg/ml, 17% at 10 μg/ml in females). (Ronn et al. 2013) 
dosing mice with 25-2500μg/l BPA, found no increase in fat pad, but the mice had 
a significantly higher liver fat content when compared to untreated individuals. 
Exposure of rat Fa hepatoma cells, a liver cell line, at both 30 and 300 ng BPA 
/ml significantly increased intracellular triglyceride content and lipid accumulation, 
without any effect on cell viability (Grasselli et al. 2013). 
Male and female mice express ERs in adipose tissue and there is evidence that 
E2 acts via ERα to have an inhibitory effect on adipocyte number and lipogenesis. 
Elimination of ERα via knockdown models also causes impaired glucose 
tolerance and insulin resistance in addition to increased fat mass, adipocyte area 
and number (Heine et al. 2000, Cooke et al. 2001). Bisphenol A has been shown 
to imitate the action of E2 in vivo to affect blood glucose homeostasis through 
genomic and non-genomic pathways. At the same concentrations and the action 
of both BPA and E2 on insulin content was blocked by the anti-estrogen 
fulvestrant (Alonso-Magdalena et al. 2006). The role of E2 on glucose 
homeostasis is not straightforward. High E2 levels have been noted to be 
associated with the development of insulin resistance since the 1960s (Wynn and 
Doar 1969), however, women with low estrogen levels post-menopause are also 
at risk of developing type 2 diabetes (Godsland 2005, Morimoto et al. 2011). ERα 
knockout models have demonstrated glucose intolerance and insulin sensitivity, 
suggesting estrogen signalling is necessary to prevent these symptoms (Heine 
et al. 2000). 
Male mice exposed to BPA at a dose of 100 μg/kg per day via injection for 4 days 
demonstrated elevated levels of circulating insulin, leading to insulin resistance 
and glucose intolerance (Alonso-Magdalena et al. 2006). In the same study 
Pancreatic β cells in primary culture exposed to low doses of BPA demonstrated 
rapid glucose-induced insulin secretion and increased insulin content, reflecting 
the in vivo observations. It is possible that the increased insulin production of the 
pancreas is in response to the developing insulin resistance, or a direct effect of 
action by BPA or E2 on the pancreatic β cells, or both. Isolated rat pancreatic 
islets exposed to 10 μg/l BPA demonstrated a significant increase in insulin 
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secretion after 24hrs incubation, via cytosolic/nuclear ER dependant pathway 
(Adachi et al. 2005). 
1.6.3.2 Human 
The idea that dramatic global rises in the incidence of obesity and associated 
metabolic factors may not be solely as a result of increased caloric intake and 
decreased physical activity, but may involve the interference of xenobiotic 
chemicals dubbed environmental obesogens, is a relatively new field. In this 
context the term obesogen was first adopted by Felix Grun and Bruce Blumberg 
in 2006 (Grun and Blumberg 2006). Since then obesity and metabolic disorders 
have been a frequently studied endpoint with regard to human health and BPA. 
Several studies using data obtained from the United States NHANES surveys 
found associations between the occurrence of BPA in urine samples and 
BMI/waist circumference in both adults (Carwile and Michels 2011, Shankar et al. 
2012a) and children/adolescents (Trasande et al. 2012, Bhandari et al. 2013, Eng 
et al. 2013). A further study included analysis of hypertension, elevated serum 
triglycerides, glucose intolerance and reduced high-density lipoprotein in addition 
to assessing obesity. Participants that measured positive for three of these 
endpoints were considered to have metabolic syndrome, and levels of BPA were 
positively associated with the metabolic syndrome, independent of additional 
factors including age, gender and ethnicity (Teppala et al. 2012). 
A study investigating the association between pre and postnatal BPA urinary 
concentrations and BMI found that BPA concentrations at 9 years were positively 
correlated with BMI, waist circumference and fat mass in both boys and girls 
(Harley et al. 2013). Prenatal urinary BPA concentrations from mothers were also 
measured and determined to be associated with a decreased BMI in girls at 9 
years old, but not boys (Harley et al. 2013). This study is unique in its 
measurements of prenatal urinary BPA and obesity in childhood. As observed in 
the rodent studies mentioned previously, results can vary depending on life-stage 
at sampling, the authors note it is possible that the association my change as the 
subjects enter adolescence and additional analyses at older ages will help clarify 
the role of puberty in these observations (Harley et al. 2013). Two further studies 
investigated the association between urinary BPA and BMI/weight in Chinese 
school children. Findings support the evidence that BPA exposure may contribute 
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to an increase in BMI of children, though one study only found the association in 
girls (Li et al. 2013), whilst the other also found older children had significantly 
higher levels of BPA than younger ones (Wang et al. 2012a). Increased urinary 
BPA in adults was also found to be significantly associated with increased weight 
factors in European (Galloway et al. 2010) and Chinese (Zhao et al. 2012, Wang 
et al. 2012b) cohorts. 
As with many epidemiological studies positive correlations between BPA 
concentration and BMI/obesity need to be treated with some caution. It appears 
that several factors may contribute to the observed effects and results vary across 
studies when comparing, age, sex, ethnicity etc. It is possible that BPA may not 
be leading to an increase in BMI, but is present at higher concentrations due to 
the larger amount of body fat present. It has been suggested that BPA 
accumulates in body tissues, fat in particular, therefore excess lipid-rich tissue 
may lead to storage and continuous release of BPA (Stahlhut et al. 2009). It is 
also possible that a diet high in packaged and processed foods may possess a 
higher concentration of BPA, whilst independently leading to an increased BMI. 
However, interestingly one of the studies investigating the NHANES cohort found 
that higher urinary BPA concentrations, but not concentrations of other 
environmental phenols, were associated with an increase in obesity arguing for 
specificity of the association (Trasande et al. 2012). 
One study investigated the effect of BPA on preadipocytes from donors with a 
healthy body mass index. Treatment of preadipocytes with 1-50 µM BPA induced 
a dose dependent increase in differentiation and lipid accumulation and induced 
expression of adipogenic markers (Boucher et al. 2014). Although co-treatment 
with ICI 182 780 inhibited the observed effects of BPA, treatment with 17β-
estradiol alone had no effect suggesting action may be mediated through a non-
classic ER pathway (Boucher et al. 2014). 
Several studies investigating association between BPA and various endpoints in 
cohort studies have reported that an increase in urinary BPA is associated with 
type 2 diabetes diagnosis and glucose concentrations (Lang et al. 2008, Melzer 
et al. 2010, Shankar and Teppala 2011, Silver et al. 2011). Although there are 
existing links between obesity and the onset of type 2 diabetes in the study by 
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(Shankar and Teppala 2011), the positive association between BPA and diabetes 
was present regardless of the weight group of the subject. 
However, there was no clear association between BPA levels and type 2 diabetes 
in a survey of Chinese adults, though it should be noted that occurrence of 
diabetes was based on serum glucose and insulin concentrations, whereas 
subjects with diagnosed diabetes with successful treatment may obscure 
apparent associations. A study on Korean subjects also found no association 
between urinary BPA and prevalence of type 2 diabetes, though results were 
based purely on participant survey, there is a possibility that non-professional 
diagnosis may lead to an under-representation of actual prevalence (Kim and 
Park 2013). 
1.6.4 Cardiovascular 
1.6.4.1 Mammalian models 
Estrogen has been considered to play a role in the cardiovascular system for 
some time, often linked to a possible protective effect due to pre-menopausal 
women experiencing less cases of coronary heart disease than men or post-
menopausal women (Stampfer et al. 1991, Pelzer et al. 1996, Mendelsohn and 
Karas 1999). Because of this it has been suggested that BPA and other 
xenoestrogens will likely exert some effects on the cardiovascular system, 
however there are still only a small number of studies that have tried to actively 
determine the role of BPA in relation to this vital system. 
BPA was found to rapidly (<7 min) induce arrhythmia in isolated ventricular 
myocytes from adult females, but not males at the same concentration as E2, 
with the effects of BPA being particularly pronounced when exposed in 
combination with E2 (Yan et al. 2011). In the same study there was little effect of 
BPA on arrhythmia in vivo under normal conditions, however with the addition of 
catecholamine-induced stress BPA promoted ventricular arrhythmias, again only 
in female rats. Exposure to E2 and/or BPA rapidly altered Ca2+ handling, in 
particular increasing sarcoplasmic reticulum Ca2+ leak; the rapid response of 
female myocytes to estrogens was not seen in ERβ knockout mice, suggesting 
the observed effects are mediated specifically by Erβ-signalling. A further study 
investigating the effect of BPA on contractility and arrhythmia in ventricular 
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myocytes found effects in the pM range, only in female myocytes, although this 
sensitivity was abolished in ovariectomised females (Belcher et al. 2012). Results 
suggested the rapid actions were induced by membrane-associated receptors, 
with Erα and Erβ having opposing actions in myocytes. Rat hearts subjected to 
ischemia followed by reperfusions were found to have a marked increase in 
sustained ventricular arrhythmia when exposed to BPA at 1nM, however 
infarction size was also reduced agreeing with data that suggests a possible 
protective effect against cardiac infarction (Yan et al. 2013) 
BPA effects on cardiac structure/function from gestation through to 16 weeks 
(dosing at 0.5 µg/kg/day and 5.0 µg/kg/day) were found to include male mice 
having increased relative heart wall thickness, that was not a result of a 
pathological increase in blood pressure (suggesting that BPA acts directly upon 
the cardiac tissue) (Patel et al. 2013). Results from this study also implied that 
the impact of BPA on heart structure was long lasting and unaffected by BPA 
removal, possibly due to the completion of cardiac structure prior to birth. This 
could be of particular concern as it has been suggested that BPA may accumulate 
in the placenta, increasing exposure to developing foetuses (Poidatz et al. 2012). 
Developmental exposure to BPA through to adulthood has also been found to 
induce a raised systolic blood pressure (Cagampang et al. 2012). 
It is apparent that BPA has an effect on the heart both during development and 
in adults, being capable of inducing rapid responses at very low concentrations. 
It would appear that sex in particular plays a role in determining the severity of 
the disruption. However, the number of studies investigating the specific effects 
on cardiac signalling and function are still severely lacking and more data is 
necessary before real conclusions may be drawn. It is also necessary to 
determine the specific gene pathways activated by BPA and E2 to better 
understand the mechanism of disruption. 
1.6.4.2 Human 
Data from several epidemiological studies indicates that BPA may be a key factor 
in cardiovascular risk. Using NHANES survey data (Lang et al. 2008) found that 
higher urinary BPA concentrations were associated with cardiovascular 
diagnoses (including coronary heart disease, heart attack, and angina) in models 
adjusted for factors such as age, sex etc. To corroborate these finding another 
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NHANES survey from 2005/06 found higher BPA concentrations were associated 
with coronary heart disease (Melzer et al. 2010). To strengthen the evidence for 
causal interference Melzer et al. 2012a conducted a longitudinal study using the 
European Prospective Investigation into Cancer and Nutrition –Norfolk cohort. 
Urinary BPA was measured from samples given at the study commencement and 
found to be lower than both previous NHANES studies at 1.3 ng/ml, however 
concentrations were still positively associated with the incident of coronary artery 
disease up to 10.8 years after the study commencement (Melzer et al. 2012a). 
Another study by Melzer et al. again compared urinary BPA with grades of 
severity of coronary artery disease from patients participating in a UK study, 
urinary BPA concentration was significantly higher in patients with severe 
coronary artery disease when compared to the controls and nearly significant for 
those with intermediate disease (Melzer et al. 2012b). 
In a study using a Korean cohort of participants over 60 years with multiple 
examinations of its subjects, a positive association was found between urinary 
BPA and high blood pressure (Bae et al. 2012).  There was a negative correlation 
between BPA concentration and heart rate viability (a measurement of the beat-
to-beat variation of heart rate) (Bae et al. 2012). Decreased heart rate variability 
and high blood pressure are risk factors for cardiovascular disease. A similar 
result was found in the NHANES group by (Shankar and Teppala 2012b), in that 
a positive association was observed between increasing levels of urinary BPA 
and high blood pressure independent of confounding factors.  
All the results in the above sections indicate that BPA does induced health effects 
in humans. In many cases there is strong experimental evidence to support this. 
However further experimental work is needed, particularly to determine the 
mechanisms of action of BPA in these different tissues/cell types. 
1.7 Effects of BPA on other model vertebrates 
Although mammalian models are often used in an attempt to determine the 
impact of chemicals on human health and development, there are a wide 
number of alternative model vertebrates that provide advantages over some 
mammalian models. For environmentally important pollutants such as BPA it is 
also essential to determine the impacts on key wildlife species necessitating the 
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need to determine possible effects across a wide range of taxa. The following 
sections describe the effects of BPA on key vertebrate wildlife taxa. 
1.7.1 Amphibians 
Bisphenol A has been investigated in amphibian studies and it appears to have 
effects on both estrogen and thyroid signalling. BPA has been shown to induce 
the egg precursor protein vitellogenin in vitro and in vivo, supporting its role as an 
estrogen. Examples of this include VTG production in cultured hepatocytes of X. 
laevis (Mitsui et al. 2007) and R. chensinensis (Bai et al. 2011). Intraperitoneal 
injection of adult Bombina orientalis with BPA at a concentration of 100 mg/kg 
BW also induced hepatic VTG mRNA in male frogs to levels similar to those found 
in female livers (Gye and Kim 2005). Similar results were found for X. laevis 
(Kloas et al. 1999). However, a study on Rana temporaria hepatocytes did not 
find any effect of BPA up to a concentration of 100µM on vitellogenin 
concentration (Rouhani Rankouhi et al. 2005) . 
Amphibian metamorphosis is controlled by thyroid hormones, therefore disruption 
of metamorphosis by BPA has been linked to its role as a thyroid disrupter. BPA 
supressed T3-induced tail regression in Rana rugosa and also inhibited Silurana 
tropicalis spontaneous metamorphosis (Goto et al. 2006). When using a 
transgenic X. laevis model capable of producing GFP in tissues with TH response 
element binding activity, t3 was found to produce a clear GFP signal in hind limbs. 
This expression was suppressed with the addition of BPA, suggesting BPA 
inhibits TR-mediated gene expression (Goto et al. 2006). However a study using 
X. laevis found that even up to a concentration of 497µg/l BPA had no effect on 
growth, sex ratio or metamorphosis (Pickford et al. 2003). Timing of exposure 
and species sensitivity may possibly contribute to differences in observed results, 
however for these studies no information is given on the state the larval stage at 
the time of exposure. 
X. laevis exposed to BPA (at concentrations of 20µM and above) were found to 
have marked developmental abnormalities of the head and abdomen (Oka et al. 
2003). In that study, apoptosis was also found to occur specifically in the central 
nervous tissue cells of the brain and spinal cord. When exposed to 10µM 17β-
estradiol abnormalities were also observed, however these differed from those 
seen for BPA suggesting the observed effects are a result of non-estrogenic 
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activity (Oka et al. 2003). Sone et al. also determined that exposure to 20µM BPA 
induced developmental abnormalities including short body length, microcephaly, 
oedema and abnormal gut coiling (Sone et al. 2004). Apoptosis of spermatogenic 
cells in Rana chensinensis has been observed with the apoptotic index increasing 
with increasing BPA concentration and treatment time (Lin et al. 2008). X. Laevis 
exposed to BPA at concentrations from 10-8 to 10-4 M from the first developmental 
day resulted in dose-dependent defects in otolith formation. Treatment with TH, 
17β-estradiol and ICI 182, 780 had no observed effect on otolith formation, 
suggesting the observed effects of BPA are independent of ERs or THRs (Gibert 
et al. 2011). BPA at 10-7 M has also been found to produce a dose dependant 
skew in sex ratio towards females in X. laevis(Levy et al. 2004).  
When fertilised R. rugosa eggs were exposed to BPA at a concentration of 500nM 
for two days to determine the accumulation and pharmacokinetics it was found to 
have concentrated in the embryo body with a bioconcentration factor of 382.3 
(Takase et al. 2012). Interestingly BPA had a higher bioconcentration factor than 
the other chemicals tested, 17β-estradiol, 17α-ethinylestradiol and nonylphenol 
(bioconcentration factors of 217.9, 170.2 and 289.1 respectively) (Takase et al. 
2012). It has been suggested that temperature could have an effect on BPA 
uptake in R. temporaria, with uptake increasing at higher temperatures 
(Honkanen and Kukkonen 2006). 
1.7.2 Fish 
BPA has been detected in samples from freshwater and marine environments, 
occasionally at high concentrations up to 12-21 μg/l, although most 
measurements are usually reported lower than this in the ng/l range (Crain et al. 
2007). This has led to a significant number of studies on the effect of BPA on 
aquatic organisms, fish in particular. 
BPA has been determined to be lethal to fish, however only at concentrations 
many times higher than typically found in the environment. 96hr LC50 for 
zebrafish and fathead minnows are 8.04 and 4.6 mg/l, respectively (Alexander et 
al. 1988, Chow et al. 2013). Various fish species have exhibited morphological 
deformities as a result of BPA exposure including zebrafish (Lam et al. 2011) 
salmon Salmo salar (Honkanen et al. 2004), Medaka Oryzias latipes (Pastva et 
al. 2001) and Fathead minnow Pimephales promelas (Warner and Jenkins 2007).  
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Developing zebrafish exposed to BPA above 1500 µg/l had a significant increase 
in incidence of cardiac oedema, and treated fish also exhibited cranio-facial 
abnormality, retarded swim bladder development and partial yolk-sac 
reabsorption (Lam et al. 2011). The authors note that these abnormalities have 
been described previously in studies investigating the effect of thyroid hormone 
on developing zebrafish. The effect of BPA on transgenic zebrafish line that 
allowed clearer visualisation of circulatory and developing neural systems found 
BPA caused deformities to neuromast cells, suppressed vascularisation in the 
abdominal region, and inhibited branching of axons from the spinal cord (from 
500 µg/l) (Lam et al. 2011). 
A variety of reproductive effects have been reported in various fish species 
resulting from BPA exposure. Most of these effects again occur for exposure to 
BPA concentrations much higher than those measured in the environment. 
Intersex has been found to occur in both medaka after three weeks and carp after 
two weeks for exposures to 837 and 1000 µg BPA/l respectively (Kang et al. 
2002, Mandich et al. 2007). At 274 µg BPA /l male guppies were found to have a 
reduced (40-75%) total sperm count, which was indicated to be due to 
interference with Sertoli-cell function (Haubruge et al. 2000). A diverse range of 
fish species have been shown to produce vitellogenin and/or zona radiata 
proteins in plasma upon exposure to various concentrations of BPA, some may 
be deemed to be environmentally relevant, Gobiocypris rarus – 5 µg/l, sea bass 
(Dicentrarchus labrax) – 10 µg/l; however, many are higher, cod – 50 µg/l (Larsen 
et al. 2006), fathead minnow – 64 µg/l (Mihaich et al. 2012), carp – 100 µg/l 
(Mandich et al. 2007), zebrafish – 500 µg/l (Song et al. 2014), and medaka – 
1000 µg/l (Ishibashi et al. 2005). BPA exposure at environmental concentrations 
has also been found to reduce several parameters relating to sperm and testis 
quality in several species (Lahnsteiner et al. 2005, Mandich et al. 2007, Hatef et 
al. 2012). These data indicate, that despite BPA being reported as weakly 
estrogenic in vitro it may have reproductive consequences at concentrations 
currently measured in the environment. BPA’s actions in vivo may differ due to 
reasons discussed later in this chapter. 
Estrogens are known to act in the brain and the central nervous system via a 
variety of signalling pathways, therefore if BPA is present in brain tissue it may 
disrupt signalling necessary for important brain functioning. Fish from BPA 
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contaminated waters in Pittsburgh were found to have BPA in their brain tissue 
(Renz et al. 2013). In fact, it was suggested that due to the high lipid content of 
brain tissue it is likely that lipophilic chemicals such as BPA are likely to 
bioconcentrate here, possibly increasing the risk of exposure (Renz et al. 2013). 
BPA has been found to induce a strong brain-specific overexpression of 
cyp19a1b RNA in fish, specifically in the same sub-regions of the developing 
brain (mediobasal hypothalamus, preoptic area and telencephalon) as 17β-
estradiol (Chung et al. 2011, Shanthanagouda et al. 2014). This is thought to be 
largely coordinated through nuclear ERs. Female Gobiocypris rarus exposed to 
15µg/l BPA for 35 days were found to have significantly unregulated levels of 
gonadotropin-releasing hormone (GnRH) and GnRH receptor in their brain (Qin 
et al. 2013).  
Some studies have determined BPA may have an effect on neurodevelopment 
and behaviour. Hyperactivity has been induced in zebrafish larvae when exposed 
to BPA (Selderslaghs et al. 2013). Saili et al. 2012 also found that a similar 
response was observed when exposed to E2 and an ERRγ agonist, indicating 
that it is possible this response could be mediated through either traditional ER 
or ERRγ signalling, or a combination of the two. In mature zebrafish BPA 
exposure was found to significantly increase the time to learn a maze compared 
with control fish (Saili et al. 2012). Behavioural effects seen in adults were sex 
specific, having no significant effect on females (Weber et al. 2014). 
There is limited evidence that BPA may also have an effect on the fish immune 
system, Perca flavescens and Carassius auratus exposed to BPA from 4 µg/l and 
5 µg/l respectively, showed leukocyte blood counts significantly higher than in the 
controls (Yin et al. 2007, Rogers and Mirza 2013). (Rogers and Mirza 2013) also 
noted that the immune response to BPA was comparable to that of a pathogen 
exposure. A significant increase in the expression of genes related to immune 
response was observed in 168 hpf zebrafish larvae, specifically cytokines 
interferon γ, interleukin-1β, interleukin 10, Myxovirus resistance, and tumour 
necrosis factor α and chemokines CC-chemokine and CXCL-clc (Xu et al. 2013). 
The proinflammatory mediator NO was also found to be increased by BPA from 
100 µg/l accompanied by increased NOS activity (Xu et al. 2013). 
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BPA has been noted to have some effect on steroid synthesis and metabolism in 
fish including for androgens and estrogens. BPA has been determined to alter E2 
and testosterone plasma levels in carp (Mandich et al. 2007). Disruption of sex 
steroid ratio has been reported in turbot (Psetta maxima) exposed to 59 µg/l BPA 
where a reduction in androgen to estrogen ratio was observed in male fish 
(Labadie and Budzinski 2006). Sex steroids govern a wide range of biological 
processes at very low concentrations; as a result even small alterations can result 
in disruption of multiple pathways. 
Species sensitivity to the effects of BPA is evidenced through the varying degrees 
of response or the concentration necessary to elicit a similar response. Although 
these differences may sometimes be attributed to differences in experimental 
setup in one case where a study (Larsen et al. 2006) directly compared the 
response of two fish species, Atlantic cod (Gadus morhua) and turbot (S. 
maximus). At 59 µg/l both VTG and ZRP levels were significantly higher in the 
cod, interestingly when exposed to the estogenic chemical nonylphenol, the two 
species did not exhibit any species sensitivity in their response (Larsen et al. 
2006). One suggestion for this sensitivity is the rate at which BPA may be 
metabolised and/or excreted, (Lindholst et al. 2003) compared the toxicokinetics 
between zebrafish and rainbow trout, data indicated zebrafish metabolised BPA 
more rapidly than the trout leading to weaker estrogenic sensitivity. A further 
explanation is the specific binding affinities of ERs across different species, in 
vitro assays have demonstrated that estrogenic chemicals can have different 
binding affinities depending on the specific species ER used; specifically with the 
construction of chimeras (swapping LBDs between species), it has been shown 
LBD plays a significant role in accounting for BPA sensitivity in different species 
(Miyagawa et al. 2014). 
Although several studies indicate that the concentrations of BPA needed to 
induce effects are often higher than those found in the environment, it is important 
to remember that wildlife and indeed humans, are seldom exposed to chemicals 
individually but as complex mixtures, that can often have interactive or possibly 
synergistic effects. Mixtures of estrogenic chemicals, including BPA, have been 
shown to induce estrogenic effects in vivo (Vtg production) and in vitro (YES 
assay), even when individual concentrations produced no detectable effect 
(Peterson et al 2013). Empirical data gained from single chemical exposures 
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remains important, as elucidating specific chemical effects and mechanisms is 
difficult when testing in combination. However when endpoints are not observed 
to be significantly altered at concentrations close to environmental levels 
mechanistically important pathways may be altered at higher concentrations. This 
could indicate that even at lower concentrations, especially when exposed as part 
of a complex mixture of chemicals effects could still occur. In addition to possible 
effects of mixtures, it should also be noted that timing of exposure plays a key 
role in the potential toxicity of a chemical. The endocrine system in adults largely 
serves the purpose of maintaining optimum cellular and organ function, whereas 
in developing embryos, and prematurity the endocrine system also serves the 
purpose of correct development. Therefore, even slight immeasurable changes 
in function during critical windows of development can lead to much wider effects 
later in life, in humans for example, pesticide exposure during gestation has been 
seen as an influencing factor in leukaemia development later in life (Brown 2005). 
These data indicate that BPA can have a large number of effects in fish, including 
at environmental concentrations. These effects appear to be pleiotrophic, 
targeting multiple mechanisms and signalling pathways. This is concerning for 
wildlife as fish are one of the most commonly exposed vertebrates due to the 
largely aquatic nature of chemical disposal, for example, through WWTW. 
However as vertebrates fish possess many conserved molecular pathways with 
humans, indicating this data should also be of concern to human health. 
1.7.3 Reptiles 
Reptiles rely on temperature for sexual determination, however endocrine 
disruptors may also affect sexual phenotype regardless of developmental 
temperature. The numbers of current studies investigating the disruptive effect of 
BPA on reptilian development or physiology are still sparse. When exposed to 
9mg BPA/egg in ovo the caiman Caiman latirostris exhibited complete male to 
female sex reversal when incubated at the male-determining temperature (33oC), 
however unlike control females, oocytes in different developmental stages were 
not observed, suggesting gonad development was delayed (Stoker et al. 
2003).The same study also exposed a lower concentration (90µg/egg), where no 
sex reversal was observed, however seminiferous tubule development was 
identified as abnormal (Stoker et al. 2003). 
43 
 
BPA could possibly act in ovo to disrupt estrogen metabolism in the turtle 
Trachemys scripta (Clairardin et al. 2013). When administered BPA at 40µg/egg, 
levels of both 17β-estradiol and estrone were elevated, whereas levels of estrone 
sulphate were lower, possibly indicating estrogen sulfotransferase activity is 
altered in the presence of BPA, though this was not specifically tested and several 
metabolic conversions needed to produce estrone sulphate from 17β-estradiol 
could be potential targets. This supports the suggestion that non-ER related 
mechanisms could be responsible for certain measured endpoints. 
1.7.4 Birds 
There have been a relatively small number of studies published investigating the 
impact of BPA on birds. In studies on Japanese Quail (Coturnix japonica) ERα 
and ERβ using a competitive binding assay, the relative binding affinities for BPA 
were found to be very low (0.0035 and 0.011 for ERα and ERβ respectively when 
compared to 17β-estradiol)(Hanafy et al. 2004, Hanafy et al. 2005). An earlier 
study comparing the relative binding affinities (RBAs) of estrogenic chemicals to 
ERs across species also found that BPA had a weak RBA to the chicken (Gallus 
gallus) ERα (0.044 when compared to 17β-estradiol), however this was stronger 
than both human and mouse ERα binding (0.0080 and 0.0086 respectively) 
(Matthews et al. 2000). 
Ovotestis has been reported to occur in both C. japonica (Oshima et al. 2012) 
and G. gallus (Berg et al. 2001) when exposed during development. However in 
a subsequent study on C. japonica by the same group no statistical differences 
in testis morphology between control groups and BPA treated animals were 
observed (Halldin et al. 2001). In a long term study where male C. japonica were 
fed 2mg BPA/day BPA treatment delayed time taken to perform sexual 
interactions and was associated with a decrease in cloacal gland size, there was 
also a significant decrease in seminiferous tubule diameter (El-Gawish et al. 
2008). It should be noted that only a single, particularly high dose of BPA was 
tested, so definitive conclusions are unclear. (Furuya et al. 2003) found that orally 
dosing male G. gallus chicks at a high dose of BPA (200mg/week) over a period 
of 16 weeks had no effect on body growth, however comb and testes weight were 
lower in BPA-treated birds. Histology of testes and seminiferous tubuli 
demonstrated an immature appearance with limited spermatogenesis in BPA-
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treated birds compared to controls. These results were supported by a further 
study with a more robust methodology (Furuya et al. 2006). 
A study investigating the effect of BPA on immune system development in G. 
gallus chicks found that at a concentration of 250ug administered via direct 
injection the weight index of the bursae of Fabricus (a specialised organ 
necessary for B cell development in birds), number of lymphatic follicles in the 
bursae of Fabricus and the thickness of the thymus cortex and medulla were all 
significantly reduced (Tian et al. 2014). Microscopic analysis also showed that 
lymphatic follicles and epithelial cells of the bursae of Fabricus had irregular 
development in BPA exposed chicks, suggesting an involvement of BPA on 
immune system disruption in developing chicks. However only one dose was 
tested, although this was described as a very low-dose level there is no indication 
as to its environmental relevance. A single injection does also not take into 
account how the chemical may be handled and metabolised in vivo. 
In chicken cerebellar granule neurons isolated from BPA injected eggs Pax6 level 
was increased following 6 days of in vitro culture, Pax6 is critical in the correct 
development of granule neurons in the developing cerebellum (Mathisen et al. 
2013). The authors suggest BPA may contribute to incorrect development of the 
cerebellum, which is essential for motor control, sensory discrimination and 
complex cognitive tasks (Mathisen et al. 2013). 
The uptake of radiolabelled BPA remained low in chick embryos in comparison 
to the yolk, however pronounced labelling was observed in the bile and allantoic 
fluid, indicating BPA is readily metabolised and excreted (Halldin et al. 2001). 
When administered to laying adults BPA was largely excreted via the bile, with 
only small amounts of BPA remaining within the body 9 days after dosing, 
maternal transfer of BPA to eggs was also low (Halldin et al. 2001). 
1.8 Mechanism of BPA action 
Although largely regarded as an estrogenic chemical research has shown that 
the mechanisms of action of BPA are diverse. In addition to the ability to bind to 
and activate ERs (though apparently weakly so compared to E2), BPA binds 
strongly to the estrogen related receptor ERRγ, it can antagonise androgen and 
thyroid signalling by binding to the relevant receptors and has other non-genomic 
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effects (Fig 1.1). It is also possible that differing potencies observed between in 
vitro and in vivo studies could be related to the possibility of metabolic activation 
of BPA into a more potent metabolite. Understanding on the mechanisms of BPA 
action is now discussed. 
1.8.1 BPA as an estrogen 
As BPA was originally designed to be used for its estrogenic properties it is not 
surprising that the majority of research concerning its action is based on its 
estrogenic activity. The classical view of estrogen signalling has been that an 
estrogenic ligand, typically 17β-estradiol, acts by binding to an estrogen receptor 
(ER) located in the cytosol triggering migration to the nucleus. Dimerisation with 
another ER then occurs subsequently functioning as a transcription factor by 
binding to specific DNA sequences known as estrogen response elements 
(EREs). In mammals there are two known ERs: ERα and ERβ, with a third distinct 
receptor being described in teleost fish (resulting in ERα, ERβ1 and ERβ2). This 
nuclear signalling of the ER is now known to include the indirect activation of 
other transcription factors such as activator protein-1 (AP-1) and Sp1 (Kushner 
et al. 2000, Levin 2005). In addition to their nuclear function, membrane bound 
ERs have been shown to exert effects outside the nucleus, resulting from 
interactions with specific kinase domains to create cascades both in the cytosol 
and at the plasma membrane, these effects are characterised by a rapid 
response and are not exerted through regulation of gene expression (Fu and 
Simoncini 2008). Secondary messengers such as cAMP, cGMP and intracellular 
Ca2+ can in incorporated into rapid estrogen signalling, which in turn can also 
regulate gene expression (Alonso-Magdalena et al. 2012). Estrogen has also 
been found to bind to and activate other membrane sites including the orphan 
receptor GPER (formally GPR30) (Thomas et al. 2005, Funakoshi et al. 2006, 
Filardo et al. 2007) and ion channels (Valverde et al. 1999), activity which has 
been attributed to be responsible for certain non-genomic actions. 
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Figure 1.1 Possible mechanisms of toxicity for Bisphenol A (BPA). A: Normal 
hormonal and cellular response, B: BPA elicits an agonistic response by binding 
and activating the estrogen receptor (ER), C: BPA can act through non-genomic 
pathways via membrane bound receptors which can trigger rapid intracellular 
signalling cascades, affecting calcium signalling and ligand independent 
transcription through the recruitment of co-factors and other transcription factors, 
D: BPA elicits an agonistic response by binding and activating the estrogen 
related receptor γ (ERRγ), E: BPA binds and inhibits the androgen receptor (AR) 
affecting the normal signalling of androgens (antagonistic response), F: BPA is 
metabolically activated into a more potent estrogen e.g. 4-Methyl-2,4-bis(4-
hydroxyphenyl)pent-1-ene (MBP) which may elicit an agonistic response by 
binding to and activating the ER.  
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1.8.1.1 BPA acting through nuclear receptor signalling 
Many effects of BPA have been discussed in context of its ability to induce 
responses by interacting with classic nuclear ERs. Indeed, it is well established 
that BPA has the ability to bind to the ERs and modify gene expression. However, 
it has long been considered a weak estrogen as binding affinities to these ERs 
have been estimated to be several orders of magnitude lower than those found 
for 17β-estradiol. BPA binds both mammalian receptor subtypes, ERα and ERβ, 
however studies differ concerning their estimated binding affinities. Some studies 
have found very little difference in the ability of BPA to bind to the different 
subtypes (Kuiper et al. 1998b, Paris et al. 2002, Takayanagi et al. 2006, Baker 
and Chandsawangbhuwana 2012). Whereas several other studies have reported 
that BPA has a higher affinity for ERβ (Kuiper et al. 1997, Matthews et al. 2001, 
Yoshihara et al. 2004, Takemura et al. 2005). 
It has also been suggested that BPA may interact with the ERs in a different 
manner compared with 17β-estradiol. In vitro activity of BPA has been shown to 
possess actions distinct from other ERα agonists/antagonists, possibly due to a 
unique conformation of the activated ERα (Gould et al. 1998). 3D modelling of 
BPA interacting with ERs has shown that BPA lacks some contacts with amino 
acids in the ER found with E2, possibly explaining its lower affinity (Baker and 
Chandsawangbhuwana 2012). However novel contacts may be made at other 
points in the ER resulting in a distinct mode of activity. BPA could therefore 
theoretically induce a unique set of ER responsive genes, resulting in a biological 
response which differs from the classic E2-ER interaction (Baker and 
Chandsawangbhuwana 2012). 
Transcriptional activation may also be affected by co-activator recruitment. EC50 
potencies for the transcriptional activation of ERα by BPA was 1.6x10-4 M in the 
yeast estrogen screen (YES), whereas in the Yeast Two-hybrid with rat ERα and 
the co-activator TIF2 EC50 was 1.4x10-5 M (Yoshihara et al. 2004). Thus, 
mimicking more the conditions in mammalian cells with the inclusion of co-
activators resulted in an approximately 10-fold increase in transcriptional 
activation. Recruitment of co-activators and the effects of BPA also differ with 
respect to ER subtype. When bound to ERβ, BPA has an enhanced ability to 
recruit the co-activator TIF2 but not SRC-1e, consistent with a greater ability of 
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ERβ to potentiate reporter gene activity in transfected HeLa cells expressing TIF2 
(Routledge et al. 2000). These results indicate that ligand-dependent differences 
in the ability of the ERs to recruit co-activators may alter, in part, the receptors’ 
ability to potentiate gene expression in whole cells. 
BPA has also been shown to bind to ERs in other non-mammalian vertebrates. 
In the amphibian Xenopus laevis, BPA has been shown to bind to the ER in 
hepatocytes in vitro (Lutz et al. 2005). BPA has also been found to cause the 
synthesis of VTG through ER up-regulation in Rana chensinensis, albeit weakly 
active in doing so compared with E2 (Bai et al. 2011). BPA has also been shown 
to bind to fish ERs and promote gene transcription of several different species, 
including in carp, trout, medaka and zebrafish (Segner et al. 2003, Terasaki et al. 
2005, Torres-Duarte et al. 2012). In contrast to many studies on mammals that 
report BPA has a greater affinity for ERβ, in a zebrafish luciferase induction 
assay, BPA was found to display a stronger relative estrogenic potency, 
compared to E2 when binding to ERα than either ERβ subtype (Cosnefroy et al. 
2012). In that work no significant estrogenic effect was produced by cells 
transfected with ERβ1. It should be noted that the binding affinity for a receptor 
is not always predicative of the magnitude of  
response and xenoestrogen action alone and this can lead to an underestimate 
of chemical potency (Routledge et al. 2000). Estrogen responsive transgenic 
organisms are a relatively new tool in assessing the effects of estrogenic 
chemicals, particularly in fish. In an Estrogen responsive element transgenic 
(ERE-TG) zebrafish (Lee et al. 2012) demonstrated that BPA promoted 
transcription in many previously unreported tissues, including the liver, heart, 
brain, somite muscle, neuromast and fin. Treatment with the estrogen inhibitor 
ICI 182 780 demonstrated that this transcription was dependant on the classic 
estrogen receptor pathway. 
1.8.1.2 BPA actions through non-genomic pathways 
Although studies that involve BPA promoting transcription through binding with 
ERs often describe BPA as a weak estrogen, there are studies that indicate that 
BPA may exert a response at very low concentrations and in some cases at a 
similar concentration to 17β-estradiol, though through rapid signalling pathways 
(Alonso-Magdalena et al. 2005, Bouskine et al. 2009, Yan et al. 2011).  
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Considering the non-genomic pathways of action, BPA was discovered to induce 
rapid Ca2+ signals in pancreatic beta cells at an equally potent dose to E2 (Nadal 
et al. 2000, Quesada et al. 2002). BPA and E2-induced calcium signals were 
initiated at the plasma membrane and activated the transcription factor cAMP-
responsive element binding protein (CREB). Phosphorylated CREB (the 
activated form of CREB) was then increased after just 5 minutes of exposure 
(Quesada et al. 2002). Molecular activation by both E2 and BPA was unaffected 
by the addition of the anti-estrogen ICI182, 780, indicating that the classical ERs 
do not play a role in this pathway. In alpha cells of the pancreas it has been 
demonstrated that 1 nM of BPA can suppress intracellular calcium ion oscillations 
induced by low-glucose, the signal that triggers glucagon secretion, through a 
membrane estrogen receptor using a cGMP/PKG-mediated pathway (Alonso-
Magdalena et al. 2005). However, data obtained from ERβ(-/-) mice indicates that 
removal of this ER subtype prevents the BPA induced rapid decrease in K-ATP 
channel activity, increased glucose-induced calcium signals and insulin release 
in beta cells, indicating receptor crosstalk may still play a pivotal role in raid signal 
responses (Soriano et al. 2012). In addition, in vivo exposure of adult mice to a 
single low dose of 10 µg/kg of E2 and BPA correlates with a rapid rise in plasma 
insulin, in a ER independent manner, whereas longer exposure to either 
chemical, at the same low dose induces an insulin increase in an ER dependant 
manner (Alonso-Magdalena et al. 2006). (Adachi et al. 2005) also determined 
that long term exposure of rats to the same dose of BPA promotes insulin 
secretion via nuclear estrogen receptors. 
Studies assessing the effects of estrogen on cerebellar signalling indicate the 
rapid effects on ERK1/2 signalling in cerebellar granular cells are induced through 
a G protein-coupled receptor, requiring PKA and Src-kinase activity (Belcher et 
al. 2005). Interestingly, short term and long term exposure of cerebellar neurons 
to 10 pM E2 induced differing results. In the short term, exposure induced 
mitogen-activated protein kinase (MAPK) dependent decreases in viable granule 
cell numbers, whereas in contrast continuous exposure significantly increased 
granule cell numbers (Wong et al. 2003). Exposure to BPA at the same dose as 
E2 has also been shown to result in mimicking of the neurotoxic response in 
granule cells (Zsarnovszky et al. 2005, Le and Belcher 2010). Additionally, the 
ability of DPN (an ERβ agonist), but not PPT (an ERα agonist), to selectively 
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induce estrogen-like affects in the cerebellum supports the notion that rapid 
signalling effects of estrogens are initiated through ERβ-like receptor systems (Le 
and Belcher 2010). Further, co-administration of E2 and BPA highlighted the 
complexity of the rapid signalling mechanism in developing neurons as BPA 
demonstrated the ability to inhibit rapid E2 induced ERK1/2 activation in 
developing cerebellar neurons (Zsarnovszky et al. 2005). These results highlight 
the ability of BPA to not only act as a potent E2 mimic at low doses, but to also 
disrupt the rapid actions of E2 during cerebellar development indicating a potential 
impact on the developing brain. 
1.8.2 Interactions with Estrogen Related Receptors 
Within the family of NRs there are orphan receptors, for which there is no known 
ligand. Despite the fact that Estrogen Related Receptors (ERRs) were the first 
orphan receptors to be identified there is still no known endogenous ligand 
(Horard and Vanacker 2003). ERRα and β were originally discovered in 1988 
(Giguere et al. 1988), with ERRγ being discovered later in 1999 (Hong et al. 
1999). ERRs share a similar structure to ERs, particularly in their DBD regions; 
ERRα and ERα, for example, share over 60% sequence identity within their DBD 
(Horard and Vanacker 2003). 17β-estradiol (E2), does not bind to any of the ERR 
family, despite similarities in LBDs, however ERRs can still functionally bind to 
EREs in ER target genes, inducing translational responses, and suggesting a 
possible overlap in the action of ERs and ERRs (Huppunen and Aarnisalo 2004). 
There is evidence that a possible mechanism of action for BPA may be mediated 
by ERRγ. BPA has been shown to bind to ERRγ with high specificity (binding 
affinity IC50 = 9.78-13.1 nM) whereas natural estrogens E2 and E3 were inactive, 
showing no binding affinity up to 10µM (Takayanagi et al. 2006, Okada et al. 
2008). Interestingly, BPA also completely prevented the inhibitory action of the 
selective estrogen receptor modulator 4-hydroxytamoxifen (4-OHT) on ERRγ 
(Takayanagi et al. 2006). Analysis of human tissues has found ERRγ to be 
preferentially expressed in the placenta; ERRγ mRNA was also detected at lower 
levels in other reproductive tissues, the ovary, uterus, prostate and testis (Takeda 
et al. 2009). The presence of ERRγ in reproductive and placental tissue indicates 
it may be responsible for some of BPA’s attributed actions during foetal 
development. It has also been suggested that since ERRγ is highly expressed in 
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the placenta, it may facilitate the accumulation of BPA, thus increasing exposure 
of the developing foetus (Poidatz et al. 2012). 
Zebrafish also have an ERRγ, that is structurally similar to its mammalian 
counterpart and is expressed in the brain during early development (Bardet et al. 
2004). The killifish Fundulus heteroclitus also possess an ERR gene, indicated 
to be a form of ERRγ. In adult killifish this was found to be largely expressed in 
the gill, heart and gut (Tarrant et al. 2006). Developmental exposure of zebrafish 
to either 0.1 µM BPA or 0.1 µM GSK4716 (a synthetic ERRγ ligand) resulted in 
an equally significant increase in aggressive behaviour in a behavioural assay in 
adults (Weber et al. 2014). The fact that exposure to a higher BPA concentration 
(1µM) or 0.1 µM E2, resulted in a decrease in this response possibly suggests 
that at the lower concentration BPA could be acting as an ERRγ agonist. 
1.8.3 Interactions with Androgen Receptor 
BPA has also been reported to act as an androgen receptor (AR) antagonist, and 
this could serve to increase ‘estrogenic effects’. However, compared with 
estrogen receptors there is substantially less data concerning BPA interactions 
with androgen receptors and the molecular mechanisms for this antagonism are 
unclear. Several in vitro ligand competition assays have demonstrated the ability 
of BPA to displace synthetic androgen from recombinant ARs (Paris et al. 2002, 
Fang et al. 2003, Kim et al. 2010). Using several different assays, including yeast 
two-hybrid system, ligand competition and transient transfection assays results 
suggest BPA affects multiple steps of the activation and function of AR. These 
effects include inhibiting the binding of native androgens to AR, inhibiting AR 
nuclear translocation, and inhibiting AR interaction with its co-regulator, and its 
subsequent transactivation (Lee et al. 2003, Sun et al. 2006, Teng et al. 2013). 
In vivo exposure of fathead minnows has demonstrated clear evidence through 
observation of changes in liver metabolite profiles for the ability of BPA to mitigate 
the effects of 17-β-trenbolone (a strong AR agonist) which is consistent with an 
anti-androgenic mechanism of action. AR antagonistic activity of BPA was 
confirmed in vitro (Ekman et al. 2012). 
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1.8.4 Interactions with Thyroid Receptors 
Thyroid hormones (THs) are responsible for regulating a number of processes in 
a large number of taxa. In vertebrates they are responsible for normal brain and 
somatic development and in adults play a key role in metabolism (Zoeller 2010). 
There is evidence that BPA binds to the TH receptor (TR), acting as an 
antagonist. Specifically, in vitro studies have demonstrated that BPA antagonises 
the activation of TR by triiodothyronine (T3) (Moriyama et al. 2002, Seiwa et al. 
2004, Zoeller et al. 2005). BPA has been shown to displace T3 from rat liver 
thyroid receptor TR (with an inhibition constant (Ki) of 200 μM, being described 
as a weak ligand(Moriyama et al. 2002). It was suggested that the ability of low 
levels of BPA to inhibit thyroid hormone receptor-mediated gene expression may 
be made possible by enhancing the recruitment of the co-repressor N-CoR to the 
TR. 
A small number of in vivo studies in rats have shown that pups exposed to BPA, 
from a concentration of 0.1 mg/l (in drinking water), during gestation and lactation 
had an increase in circulating levels of thyroxine (T4) (Zoeller et al. 2005, Xu et 
al. 2007). An increased expression of a thyroid responsive gene in the brain was 
also detected (Zoeller et al. 2005, Xu et al. 2007). The thyroid system is complex 
and mechanistic interactions are poorly understood, it is therefore currently 
difficult to determine how BPA and other thyroid disruptors exert their effects on 
circulating thyroid hormone. Contrary to previously mentioned studies it has also 
been indicated that in utero and lactational exposure of BPA to mice does not 
affect thyroid functions, with BPA groups demonstrating no significant change in 
plasma (T4) concentration and thyroid gland function (Kobayashi et al. 2005). 
The experimental design in these different studies was similar and it is possible 
therefore that these contrasting results may be due to different strains of mouse 
used; Sprague-Dawley were used in the former mentioned studies and 
Crl:CD(SD) in the latter. Additionally parental exposure of gestating pups found 
no effect on TR expression indicating that the possible observed effects on 
thyroid function (transient hypothyroidism and behaviour) may not be mediated 
by BPA directly targeting the TR, but instead may operate via an alternative 
mechanism (Xu et al. 2007). 
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The thyroid system is well conserved across vertebrates and it is possible 
therefore that BPA may interact with TRs from other taxa in a similar manner to 
mammals. In Xenopus laevis embryonic and larval exposure to BPA blocked the 
actions of T3 and suppressed TR gene expression both in vivo and in vitro 
(Iwamuro et al. 2003). Microarray analysis has revealed that BPA antagonises 
the regulation of 33% of T3-induced genes and 36% of T3-repressed genes, 
including the majority of the most dramatically T3-regulated genes, and this may 
explain the observed inhibitory effect on metamorphosis (Heimeier et al. 2009).  
In zebrafish, BPA at environmentally relevant exposure concentrations (as low as 
10(-9) M via the water) altered expression of genes involved in thyroid hormone 
synthesis and thyroid specific transcription factors in a concentration and time 
dependant manner (Gentilcore et al. 2013). A study investigating the effect of 
BPA on T3 binding in the Japanese quail found that BPA was more likely to 
disrupt TH signalling by targeting transthyretin, a major TH-binding protein in 
plasma rather than the TR directly (Ishihara et al. 2003). 
1.8.5 Activity of Bisphenol A metabolites 
There have been multiple studies carried out on the metabolism and 
toxicokenetics of BPA, largely in mammalian systems, and these have shown a 
large number of possible metabolites produced in vitro (Nakagawa and Tayama 
2000, Nakagawa and Suzuki 2001, Pritchett et al. 2002, Inoue et al. 2003, Jaeg 
et al. 2004)and in vivo (Knaak and Sullivan 1966, Snyder et al. 2000, Volkel et al. 
2002). The majority of BPA is rapidly metabolised through glucuronidation to BPA 
glucuronide and subsequently excreted in the faeces and urine. In vitro studies 
on BPA glucuronide have found that it does not exhibit any estrogenic activity 
(Matthews et al. 2001). Although some metabolites have been found to possess 
estrogenic activity, for example BPA catechol and BPA o-quinone, this is largely 
weaker than the activity exhibited by the parent compound (Yoshihara et al. 
2001). As BPA is largely metabolised to BPA glucuronide it is also likely that the 
concentrations of these metabolites would be very low in vivo. Their weak activity 
and low concentration therefore mean it is unlikely their activity should be a 
concern. However there is increasing evidence that in mammalian livers, BPA 
may be metabolised to the much more potent estrogenic chemical 4-methyl-2,4-
bis(4-hydroxyphenyl)pent-1-ene (MBP) (Yoshihara et al. 2004). 
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The possibility of a potent metabolite was originally discovered when the 
estrogenic activity of BPA was increased after incubation with rat S9 liver fraction 
proportionately to the time of incubation (Yoshihara et al. 2001). In contrast 
incubation of rat S9 liver fraction with other estrogenic chemicals including 17β-
estradiol resulted in their inactivation (Yoshihara et al. 2001). Further 
investigation discovered two potent metabolites from S9 incubation of BPA, one 
being MBP the other was designated 4-methyl-2,4-bis(4-hydroxyphenyl)pent-2-
ene. Despite the much lower concentration of MBP compared with BPA the 
estrogenic activity of MBP, determined using the YES assay was higher 
(Yoshihara et al. 2004). S9 fractions from mouse, monkey and humans also 
produced similar metabolism profiles (Yoshihara et al. 2004). In vivo studies in 
rats and medaka (Oryzias latipes) have found that MBP exerts a strong 
estrogenic effect up to 400-1000 times stronger than that of its parent compound 
(Ishibashi et al. 2005, Nagae et al. 2005, Yamaguchi et al. 2005, Okuda et al. 
2010). 3D modelling of human ERs, BPA, MBP and 17β-estradiol suggest that 
the increased spacing between the phenolic rings in MBP from BPA allows key 
amino acid contacts with the ERs that are important in receptor binding of E2 
(Baker and Chandsawangbhuwana 2012). 
Discrepancies seen between the estrogenic potency of BPA in vitro and in vivo 
suggest a complex mechanism of action that may involve multiple pathways. In 
vitro studies demonstrating the estrogenic activity of BPA in cell lines and yeast 
screens will likely not include interactions chemicals may experience in vivo, in 
particular metabolic transformation. However, it should be noted that under 
normal circumstances metabolic activation of BPA may not be significant as the 
predominant metabolite is BPA glucuronide, and MBP is likely to be present at 
very low concentrations. In fact, MBP has not yet been measured as an in vivo 
metabolite. Nevertheless, under certain circumstances glucuronidation activity 
may be reduced. For example the developing livers of rats and humans, have 
been found to lack the necessary enzymes for glucuronidation, developing this 
capability only postnatally (Coughtrie et al. 1988). Additionally, rat foetuses 
exposed via parental exposure were found to contain BPA but not BPA 
glucuronide (which does not easily pass through the placental barrier), supporting 
the poor capacity for glucuronide conjugation in the foetus (Takahashi and Oishi 
2000). The developing foetus is identified as a key target of EDCs and research 
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on BPA in particular has often focused on the effects exerted at this crucial life 
stage. It is possible that combined with a poor ability to glucuronidate BPA, 
metabolic activation to MBP may be significant, however further research on the 
ability of the foetal liver to produce MBP is necessary. 
There is little information on the in vivo metabolism of BPA in fish. In brown trout 
exposure to 50 µg/l BPA did not result in the production of the conjugated 
metabolite bisphenol - a glucuronic acid BPAGA, during the early stages of 
development, but did from around 28 dpf, shortly before hatching (Bjerregaard et 
al. 2008). 
1.9 Alternative Bisphenol Analogues 
As the scientific evidence for biological effects of BPA increases, several 
organisations have called for legislation to reduce the manufacture/use of BPA 
for use in food contact materials and thermal paper. The European Union passed 
a directive to prohibit the manufacture of baby bottles containing BPA in 2011 
(European_Commission 2011). However, this movement has led to increased 
use of alternative bisphenols in certain products that may then be labelled BPA-
free. However, there is little information concerning the biological effects of these 
alternatives when compared to BPA, and current evidence does not indicate 
these as necessarily being safer alternatives. Alternative analogues to BPA 
possess the same basic structure of two phenol groups, joined by a carbon (or in 
the case of bisphenol S (BPS) sulphur) bridge, with the hydroxyl groups at the 
para positions (see Fig 1.2). Differences in the chemical groups attached to the 
phenolic rings and/or bridge can vary, including alkyl groups or halogens. Some 
of these bisphenols are already commonly used in various applications, for 
example in the use of food/beverage containers and thermal paper.  
1.9.1 Bisphenol S 
1.9.1.1 Occurrence 
The US EPA predicted a national production volume of 1 to 10 million lbs/year for 
BPS (U.S. EPA, 2012). BPS is commonly used as a developer in thermal paper 
due to the reduction in BPA papers, removed from the market due to fears of 
dermal absorption (Biedermann et al. 2010). (Liao et al. 2012a) analysed the 
occurrence of BPS in 16 types of paper and paper products, samples were 
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collected from USA, Japan, Korea and Vietnam. 100% of thermal receipt paper 
samples were found to contain BPS at concentrations ranging from 13.8 ng/g to 
22.0 mg/g, similar mean concentrations were found for BPA and BPS, however 
there was a negative correlation between both chemicals, possibly implying that 
as BPA is used less, BPS is used more frequently. BPS was also detected in 
87% of currency bills from 21 countries and 14 other paper products at 
concentrations ranging from <LOQ to 8.38 μg/g (Liao et al. 2012a). 
 
 
 
Figure 1.2 Chemical structures for the endogenous steroidal estrogen 17β-
estradiol (E2), Bisphenol A and the alternative analogues discussed in this 
chapter, Bisphenol F, Bisphenol S Bisphenol AF, Bisphenol B, Bisphenol E, 
Bisphenol AP, Bisphenol Z, Bisphenol P and Bisphenol M. 
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Polycarbonate incorporating BPA may also be substituted for BPS incorporating 
polyethersulfone (PES), used to make plastics and epoxy resins. In one study 
BPS was found to be present in 20.9% of food and beverage products in the USA 
at a relatively low average concentration of 0.13 ng/g.(Liao and Kannan 2013). 
BPS was also found in seven of nine canned food samples analysed by (Viñas 
et al. 2010), however in six of these samples BPS was only found in the liquid 
supernatant as opposed to the food itself, concentration ranged from 11.5 ng/g 
to 175 ng/g. However BPS was not detected in eleven different canned beverage 
samples in Spain (Gallart-Ayala et al. 2011) 
The concentration of eight bisphenol analogues, including BPS was analysed in 
indoor dust samples from four countries; BPS was found in 100% of samples at 
a mean concentration of 0.34 μg/g (Liao et al. 2012b) Analysis of aqueous 
sediment from USA, Japan and Korea found BPS to be present in 28.5% of 
samples at a mean concentration of 12.4 ng/g dry weight (dw), but as high as 
1970 ng/g dw (Liao et al. 2012c). Interestingly, when analysing vertical 
concentration in sediment cores, BPS was found to increase in concentration 
from 2001, whereas BPA was found to decline, these results correspond with 
legislation passed against the use of BPA in thermal paper in Japan in the last 
decade. In a recent study measuring the concentrations of BPS in river and 
sediment samples from several industrialised sites in China BPS was found to be 
present in all river samples and three out of five sediment samples (Yang et al. 
2014). Though sediment concentrations were relatively low, 0.12ng/g dw on 
average compared to 16ng/g dw for BPA, concentration in river samples was 
found to be much higher, highest measured concentration was 18.99 ng/l, 
compared to 74.58 ng/l for BPA. As BPS is incorporated into many products that 
frequently come into contact with consumers and appears frequently in the 
environment, it is not surprising that BPS has been detected in 81% of urine 
samples across eight different countries at concentrations up to 1.18 ng/ml (Liao 
et al. 2012d). 
BPS has also shown some resistance to degradation when compared to 
alternative bisphenols, which could lead to accumulation in the environment. 
Although degradation under anaerobic conditions was observed to be similar to 
BPA, in one study BPS was found to degrade less than the other seven 
compounds tested (Ike et al. 2006). When looking at biodegradation in seawater, 
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no notable degradation of BPS was detected after 60 days (Danzl et al. 2009). 
An isolated strain of bacteria, Sphinogomonas sp. Strain BP-7, was found to 
degrade a variety of bisphenols, however it could not degrade BPS (Sakai et al. 
2007), a recent study used the bacterium Sphingobium fuliginis OMI and found 
that aerobic degradation of BPS could be achieved, the first study to demonstrate 
this finding (Ogata et al. 2013). 
1.9.1.2 Health Effects 
There have been several in vitro assay studies to determine the potential of BPS 
to bind hormone receptors, therefore indicating the potential to elicit endocrine 
activity. Several studies have shown that BPS may bind and activate ERs, using 
a variety of reporter assays including, E-screen in MCF-7 cells (Hashimoto and 
Nakamura 2000), GFP expression system in MCF-7 cells (Kuruto-Niwa et al. 
2005), luciferase reporter assay (Kitamura et al. 2005), and MELN transactivation 
assay (Grignard et al. 2012). However, some studies have found significant 
differences in ER activation between BPS and BPA, with BPS always acting as 
the weaker estrogen (Hashimoto and Nakamura 2000, Molina-Molina et al. 2013) 
(Chen et al. 2002). In silico predictions of binding to hERα found that there was a 
37-fold higher probability of BPA exhibiting stronger binding compared with for 
BPS (Grignard et al. 2012). There is also evidence that BPS can bind to the AR 
(Fang et al. 2003), however there is conflicting evidence whether it does so in an 
agonistic or antagonistic manner (Kitamura et al. 2005, Molina-Molina et al. 2013, 
Teng et al. 2013). 
BPS has also been indicated to affect adipogenesis in 3T3-L1 cell line. This 
investigation found that BPS increased the triacylglycerol content and adipocyte-
specific fatty acid binding protein mRNA of the cultures, markers of adipogenic 
agents, with a very similar potency to BPA (92%) (Masuno et al. 2005). Potential 
genotoxicity was also determined for BPS in the HepG2 cell line at concentrations 
between 0.1 μM to 10 μM, after 24hrs; BPS induced significant DNA damage as 
determined by the comet assay (Fic et al. 2013). Analysing chromosomal 
aberration in chicken DT40 cells (Lee et al. 2013) also showed that BPS has 
genotoxic potential, though weaker than that of BPA. 
Although there are several in vitro studies indicating the ability of BPS to induce 
biological effects, there are still few in vivo studies on BPS. Female rats 
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subcutaneously injected with 20 and 500 mg BPS/kg/day were found to have a 
significantly higher uterine weight than controls, though there was no significant 
increase found at 100 mg/kg/day (Yamasaki et al. 2004). A 48hr EC50 of BPS was 
measured at 55 mg/l in the water flea Daphnia magna compared with 10 mg/l for 
BPA (Chen et al. 2002). In zebrafish (Ji et al. 2013) found that egg production 
and gonadosomatic index were significantly reduced in female zebrafish from an 
exposure concentration of 0.5 μg BPS/l when exposed for 21 days. In that study 
plasma concentration of E2 was found to be significantly increased in both male 
and female fish. Furthermore, in males there was a significant reduction in plasma 
testosterone concentration. Parental exposure to BPS resulted in a both a delay 
and reduction in hatching rate in the F1 generation, even when the offspring were 
reared in untreated water. When raised in BPS dosed water hatching rate was 
further reduced and an increase in malformation rates was observed (Ji et al. 
2013). Zebrafish exposed to a range of concentrations of BPS for 75 days 
confirmed these findings, including a significant elevation in E2 concentrations 
for exposure to 1 μg BPS/l and postponed/decreased hatching in fertilised eggs 
from exposed fish (Naderi et al. 2014). 
1.9.2 Bisphenol F 
1.9.2.1 Occurrence 
BPF is an important monomer in the production of epoxy resins which may be 
used for coatings, floorings, linings mouldings and laminates. BPF may also be 
used to produce polycarbonates used for e.g. in food packaging (Gardziella 
2000). There does not appear to be any public data on the import/production 
values of Bisphenol F in the EU, USA or elsewhere. In the USA BPF was found 
in 10.1% of selected food and beverage products, around half the number found 
for BPS, however at a higher mean concentration of 0.929 ng/g (Liao and Kannan 
2013). Out of thirteen canned food and beverage products tested BPF was only 
found to be present in two, at concentrations of 218 and 141 ng/l (Gallart-Ayala 
et al. 2011). However, in an analysis of BPA and BPF in food-contact recycled 
paper materials, BPF was found to be present in two out of eight samples, 
however concentrations were too low to accurately quantify. BPA was found in 
all samples from <LOQ to 25.4 μg/g in a paper tablecloth.(Pérez-Palacios et al. 
2012). BPF was not detected in any canned food products in British or Iranian 
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markets (Goodson et al. 2002, Rastkari et al. 2011), or in honey samples from 
glass or plastic containers from various global locations (Inoue et al. 2003). 
Where indoor dust samples were analysed in four different countries, BPF was 
found to be present in 74.4% of samples, however at a relatively lower average 
concentration of 0.054 μg/g (1.33 and 0.34 μg/g for BPA and BPS respectively) 
(Liao et al. 2012b). Occurrence of BPF in the environment has been reasonably 
well documented. In sediments from USA, Japan and Korea. Here BPF was 
found to be present in 62.2% of samples at a concentration of 69.7 ng/g dw, 
making BPF the second most abundant bisphenol present after BPA. In two 
separate studies investigating the occurrence of BPF in Germany, 75% and 58% 
of sediment samples contained BPA up to approximately 7ug/kg dw (Fromme et 
al. 2002, Stachel et al. 2003). Fromme et al also found BPF in 77% of water 
samples and 72% of sewage water samples. BPF was found in two out of five of 
the river samples in China and three out of five sediment samples (Yang et al. 
2014). The highest concentration measured in the sediment was 30.16 ng/g dw, 
only slightly lower than the 42.76 ng/g dw found for BPA. Finally, BPF has been 
detected in surface and groundwater samples in Spain (Herrero-Hernández et al. 
2013), river samples in China (Ballesteros-Gómez et al. 2007) and in raw and 
treated sewage in Spain (Ruiz et al. 2007). 
In several studies assessing the biodegradation of BPF, it was found to be more 
biodegradable than BPA and BPS, (Ike et al. 2006, Danzl et al. 2009, Toyama et 
al. 2009). However, degradation by the bacteria Sphinogomonas sp. Strain BP-
7, had no effect on BPF, despite demonstrating the ability to degrade several 
alternative bisphenols including BPA(Sakai et al. 2007). Using radio-labelled BPF 
(Cabaton et al. 2006) concluded that female rats orally dosed with BPF for four 
days mainly excreted BPF residues in the urine (43-54%) and faeces (15-20%), 
with the major metabolite being a sulphate conjugate. Immediately after the 
exposure, BPF was detectable in all tissues, with the largest amount present in 
the liver. Pregnant rats were also found to have large amounts of BPF in the 
uterus, placenta, amniotic fluid and foetuses (Cabaton et al. 2006). Incubation of 
BPF with human and rat S9 liver fractions demonstrated the production of several 
metabolites (Cabaton et al. 2008). However, estrogenic potential of metabolites 
was not assessed  
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1.9.2.2 Health effects 
Several in vitro studies have attempted to determine the potential estrogenic 
activity of BPF. In a reporter gene assay in HepG2 cells, BPF significantly 
increased luciferase activity from 10-7M, and the estrogenic response was 
approximately three times stronger in cells transfected with ERα (Cabaton et al. 
2009). In a yeast two-hybrid assay, BPF was found to induce significant levels of 
β-galactosidase activity and the estrogenic activity measured was similar to that 
of BPA in one study (Chen et al. 2002) and higher in another (Zhang et al. 2011). 
However in another similar study, BPF was found to be significantly more 
estrogenic than BPA in a fluorescence polarisation system, but not when using 
MCF-7 proliferation as an endpoint (Hashimoto and Nakamura 2000). Another 
MCF-7 proliferation study found BPF to be significantly more potent than BPA, 
having an EC50 (concentration at which half maximal activity of E2 was observed) 
of 84.8 nM compared to 410 nM (Stroheker et al. 2004). As with many other 
estrogenic chemicals there are conflicting results between some reported studies 
and some studies have demonstrated the estrogenic potency of BPF may actually 
be much lower than that of BPA. Again using the MCF-7 proliferation test, BPF 
was determined to have the lowest estrogenic activity of the five bisphenols 
tested. BPF was also found to be the weakest estrogen when comparing mRNA 
levels of the estrogen responsive Progesterone Receptor (Perez et al. 1998, 
Kanai et al. 2001). Activity of BPF in a MCF-7 estrogen luciferase reporter assay 
was found to be weaker than BPA and similar to that of BPS (Kitamura et al. 
2005). In addition BPF was found to be capable of binding to the orphan receptor 
ERRγ but was approximately thirteen times weaker than BPA (Okada et al. 2008). 
BPF increased the triacylglycerol content and adipocyte-specific fatty acid 
binding protein mRNA of the cultures in the 3T3-L1 cell line (used to study 
adipogenesis).  The relative potency of BPF for inducing triacylglycerol content 
was 89% of that of BPA (Masuno et al. 2005). No genotoxicity was found for BPF 
in the HepG2 cell line, at concentrations ranging from 0.1 μM to 10 μM, BPF (DNA 
damage over 24 hrs) (Fic et al. 2013). As with BPS, BPF showed genotoxic 
potential weaker than BPA measured by chromosomal aberration in chicken 
DT40 cells (Lee et al. 2013). However in another study the genotoxicity of BPA 
and BPF was compared in HepG2 cells, where BPA was not found to be 
genotoxic and BPF was (Audebert et al. 2011). (Cabaton et al. 2009) also found 
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that using the comet assay on HepG2 cells BPF was effective at fragmenting cell 
DNA from 78.7 µM. 
As found with BPS, there are few in vivo studies on the effects of BPF. In 
immature rats BPF induced a significant increase in wet (from 100 mg/kg/day) 
and dry (200 mg/kg/day) uterine weight, whereas BPA did not induce any 
increase in wet or dry uterine weight (Stroheker et al. 2003). (Yamasaki et al. 
2004) also found female rats subcutaneously injected with 100 to 
1000 mg/kg/day were found to have a significantly higher uterine weight 
compared with in controls, supporting a previous study that showed 200 mg/kg 
BPF increased uterine blotted weight in immature rats (Yamasaki et al. 2002). In 
contrast oral dosing of rats with BPF at 20 to 500 mg/kg/day for 28 days showed 
no estrogen-mediated effects, based on sperm analysis, estrous cycle, organ 
analysis and histology (Higashihara et al. 2007). There are very little 
ecotoxicological data concerning BPF though (Chen et al. 2002) did report the 
48hr EC50 of BPS at 56 mg/l compared to 10 mg/l for BPA in the water flea D. 
magna. 
1.9.3 Bisphenol AF 
1.9.3.1 Occurrence 
BPAF is structurally similar to BPA, where the two methyl groups are replaced 
with trifluromethyl groups, mainly used in fluroelastomers and heat resistant 
adhesives and also in the fabrication of electronic materials, gas-permeable 
membranes, and plastic optical fibres (Delfosse et al. 2012). Because of the 
potential for occupational exposure and possible exposure in the general 
population ,the USA National Institute of Environmental Health Sciences 
nominated BPAF as one of only six chemicals for comprehensive toxicological 
characterisation based on the potential for endocrine disruption and lack of 
toxicity data (NTP 2008). Production volume was reported to be <500 000 lbs by 
the US EPA in 2006 (U.S. EPA, 2006) 
In environmental samples collected around a manufacturing plant in China BPAF 
was found in river water at <LOQ to 15.3 μg/l, in sediment from 0.52 to 2000 ng/g 
dw and soil from <LOQ to 331 ng/g dw (Song et al. 2012). Contamination of river 
and sediment samples in a recent study by found BPAF at much higher levels 
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than other bisphenol chemicals present, including BPA (Yang et al. 2014). 
Average concentrations of BPAF in river and sediment samples were 74.8 ng/l 
and 663 ng/g dw respectively, compared to 26.0 ng/l and 16.1 ng/g dw for BPA 
(Yang et al. 2014). Occurrence of BPAF in indoor dust and well water was also 
assessed in this study, BPAF was found to be present ranging from 7.82 to 739 
ng/g dw in dust and <LOQ to 300ng/l in well water samples. (Liao et al. 2012b) 
determined BPAF did not occur in any dust samples from USA and China and 
only 9% of samples in Japan, however it was detected in 76% of samples in 
Korea. Mean concentration (0.0039 μg/g) was however much lower than 
observed for BPA, BPF and BPS (4.07, 0.50 and 0.43 μg/g respectively). Similarly 
BPAF was only discovered in 20.6% of river sediment samples in Korea, being 
absent in USA and Japan samples (Liao et al. 2012c). Finally BPAF was 
discovered in 10.5% of selected food products in the USA, however at the lowest 
mean concentration measured for all bisphenols analysed, this may be due to the 
main uses of BPAF not bring in food packaging materials (Liao and Kannan 
2013). 
In rats orally dosed with BPAF, the highest concentrations were found in the 
faeces, suggesting the main route of elimination is in an non-conjugated form 
(Yang et al. 2012). It is not clear if the compound is poorly absorbed, or if some 
metabolites are deconjugated by micro fauna in situ. The highest levels of BPAF 
in tissues were found in the liver, kidney and serum samples (Yang et al. 2012). 
Several metabolites of BPAF in human liver microsomes have been detected 
(Schmidt et al. 2013). These findings also support those by (Nakamura et al. 
2011) and (Yoshihara et al. 2004) where BPAF could be degraded in the same 
manner as BPA and BPF possibly creating a more potent estrogenic metabolite. 
1.9.3.2 Health effects 
BPAF has been shown to be estrogenic in a range of reporter systems, spanning 
MCF-7 based estrogen luciferase reporter, vitellogenin production in CARP-HEP 
cells and transcriptional activation assays and results vary.  Most findings indicate 
that BPAF has the potential to be a stronger estrogen than BPA (Kitamura et al. 
2005, Bermudez et al. 2010). Using an MCF-7 cells based estrogen luciferase 
reporter assay, BPAF was found to be much more potent than BPA (EC50 of 
0.05 μM compared to 0.63 μM) (Kitamura et al. 2005). A transcriptional activation 
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assay using cells expressing ERα and ERβ transfected with and ERE promoter 
found BPAF to be a significantly stronger estrogen (Bermudez et al. 2010). 
Vitellogenin production measured in CARP-HEP cells found BPAF to induce a 
significant increase at 10 μM, BPA did not at this concentration, although a 
significant increase was observed for both chemicals at 100 μM. In a competitive 
receptor-binding assay BPAF was twenty times more potent than BPA as a ligand 
for ERα and forty-eight times more potent as a ligand for ERβ, suggesting the 
binding site of, particularly ERβ, possess specific structural elements that interact 
much more favourably with the trifluromethyl groups of BPAF than the methyl 
groups of BPA. However there are some studies that show that BPAF has an 
estrogenic potency comparable to that seen for BPA (Perez et al. 1998, Rivas et 
al. 2002)and in one study was actually weaker than BPA, though still stronger 
than the other alternative bisphenols included in the study (Kanai et al. 2001). 
Although it would appear to be a potent estrogen, at least when compared to 
BPA, BPAF interacts inconsistently with the ERs. It is reported to be a strong full 
agonist for ERα, however when interacting with ERβ, BPAF has been reported to 
be both a strong agonist and antagonist (Matsushima et al. 2010, Li et al. 2012, 
Li et al. 2013). Therefore, it would appear that BPAF has the potential to be a 
more potent estrogenic chemical than BPA, though it may act as an agonist or 
antagonist to perturb physiological processes mediated through the ERs. 
In addition to binding to the ERs BPAF has also been assessed for its potential 
to bind to other nuclear receptors. Out of six bisphenols tested, BPAF was the 
weakest at binding to the orphan receptor ERRγ being much weaker than BPA 
and BPF (Okada et al. 2008, Matsushima et al. 2010). Using a competitive 
inhibition assay with the synthetic androgen R1881, BPAF was also found to be 
an AR antagonist (Teng et al. 2013). Thyroid hormone disruption may be 
mediated by impacts on deiodinase activity, which regulates the levels of active 
hormones available to bind to nuclear receptors, BPAF has demonstrated the 
ability to inhibit deiodinase activity in a dose dependant manner, similarly to 
tetrabromobisphenol A, a known thyroid disruptor, though activity is less potent 
(Butt et al. 2011). 
BPAF produced no effect on DNA damage over 24 hrs when testing for potential 
genotoxicity in the HepG2 cell line at concentrations from 0.1 μM to 10 μM (Fic 
et al. 2013).  
65 
 
Again as with other alternative bisphenols in vivo data on the effects of BPAF are 
lacking. Uterine weight of immature rats exposed to 100 mg/kg of BPAF were 
increased significantly compared with controls, demonstrating estrogenic 
properties of the chemical in vivo (Yamasaki et al. 2003). Other estrogenic effects 
include reduction in serum testosterone, increases in LH and FSH and disruption 
of estrous cycle (Feng et al. 2012, Umano et al. 2012) Other reported in vivo 
effects relate to cholesterol and steroid biosynthesis, with reduced serum 
cholesterol reported from 50 mg BPAF/kg/day 
1.9.4 Other Bisphenols 
1.9.4.1 Occurrence 
Many more bisphenols exist with differing substitutions attached to either the 
phenolic rings or bridge of the basic structure. Though these often occur at lower 
concentrations than the bisphenols previously discussed, several have shown 
endocrine activity similar to those above. These bisphenols are used in similar 
processes, such as production of polycarbonate plastics and epoxy resins. As 
more countries introduce legislation banning the use of BPA in these products it 
is possible their use and exposure could increase. Although not detected in Japan 
and the USA, sediments in Korea were found to contain BPAP, BPB, and BPZ 
(detection rate 38.2, 2.9 and 2.9% respectively, mean concentration 8.63, 0.31 
and 1.86 ng/g dw respectively) (Liao et al. 2012c). Indoor dust samples analysed 
for the same group of chemicals determined BPAP was found in only 2.63% of 
samples in the USA at a mean concentration of 0.35 ng/g dw. BPB and BPP were 
only found in dust samples from China at a rate of 10.9 and 1.82%, at mean 
concentrations of 0.99 and 0.80 ng/g dw respectively (Liao et al. 2012b).  
BPAP, BPB, BPP and BPZ were present at an average concentration of 0.059, 
0.013, 0.207 and 0.034 ng/g fresh weight respectively (detection rate 11.2, 2.62, 
3.37 and 2.25% respectively) in a selection of foodstuffs (n=267), compared to 
BPA at 3.0 ng/g fresh weight (56.9% detection rate) (Liao and Kannan 2013). In 
a study analysing the bisphenol content of canned soft-drinks BPE and BPB were 
not detected in any of the eleven samples, whereas BPA was only absent from 
one sample (Gallart-Ayala et al. 2011). BPB was also only detected in two 
samples of canned fruit and vegetables from thirty-nine samples analysed from 
a wide number of Asian and European countries, the concentration found was 
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also lower than the levels of BPA in the same samples (3.4 and 3.0 μg/kg for BPB 
and 6.2 and 55.7 μg/kg for BPA) (Cunha and Fernandes 2013). Conversely in a 
study by (Grumetto et al. 2008) it was discovered that although BPB was found 
in fewer samples than BPA (21% and 52% respectively) their mean 
concentrations were comparable. In cans with a epoxyphenolic lining mean 
concentrations were 33.4 μg/kg for BPB and 38.7 μg/kg for BPA and in cans with 
a low Bisphenol A diglycidyl ether (BADGE) lining mean concentrations were 37.7 
and 42.3 μg/kg for BPB and BPA respectively. These results are reflected in 
another study that found BPB to be detected in the majority of samples that also 
detected BPA, however often at a largely reduced concentration (Cunha et al. 
2011). 
When subjected to aerobic degradation testing, it was found that both BPP and 
BPB were both less susceptible to degradation than both BPA and BPF, though 
neither were as stable as BPS, under anaerobic degradation however BPB had 
less potential to degrade than BPA, BPF and BPS (Ike et al. 2006). When BPB 
was incubated with rat liver S9 fraction to assess the metabolic activation 
compared to BPA, similar HPLC peaks and a similar estrogenicity pattern was 
obtained, producing two metabolites less polar than the parent compound, 
displaying particularly potent estrogenicity (Yoshihara et al. 2004). Though the 
metabolites were not specifically identified, the active metabolite was thought to 
be very similar to the BPA metabolite MBP, in fact incubation of S9 with both BPA 
and BPB formed intermediary metabolites likely formed from the dimerisation of 
products from both parent chemicals (Yoshihara et al. 2004). A further study 
investigated if incubation with rat liver S9 fraction metabolically activated a range 
of bisphenols, BPB and DMBPA both increased their estrogenic potency when 
incubated with S9, whereas BPAP and BPZ both experienced a reduction in 
potency, investigation into the structure of metabolites found the potent 
estrogenic fractions to consist of analogues structurally similar to MBP.(Okuda et 
al. 2011). 
1.9.4.2 Health Effects 
The numbers of studies investigating the ability of these bisphenols to activate 
nuclear receptors are few, despite the wide range measured in environmental 
samples, even when compared to those that exist for the alternatives already 
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discussed. In an ERE-luciferase reporter assay in MCF-7 cells to assess 
estrogenic activity, BPB was found to be of a similar potency to BPAF, activating 
the ERE at a much lower concentration than BPA (EC50 was 0.07 μM for BPB, 
compared to 0.63 μM for BPA) (Kitamura et al. 2005). BPB was found to bind the 
AR with a stronger potency than BPA and the anti-androgenic activity of BPB, 
investigated by means of an ARE-luciferase reporter assay using NIH3T3 cells 
activity was determined to be in the same order as that of potent anti-androgen 
flutamide (Fang et al. 2003, Kitamura et al. 2005). BPB was also found to activate 
the hPXR in a dose-dependent manner and was one of only two chemicals tested 
that were more potent than BPA (Sui et al. 2012). 
Both BPB and BPE increased the triacylglycerol content and adipocyte-specific 
fatty acid binding protein mRNA of the cultures, the potency of BPB to increase 
triacylglycerol content was comparable to that of BPA, with BPE activity also 
being 93% of that of BPA (Masuno et al. 2005), indicating both are adipogenic 
agents, likely acting in similar fashion to BPA. BPP, BPM and BPAP exhibited 
greater genotoxicity compared to BPA based on chromosomal aberrations, with 
BPP demonstrating the strongest potency (Lee et al. 2013). 
In vivo assessment of the estrogenic potential of BPB and BPZ has been 
performed in a small number of studies using the rat uterotrophic assay, uterine 
blotted weight was found to increase in rats subcutaneously administered 20 and 
200 mg/kg BPB, watery uterine contents were also discovered in rats exposed to 
200 mg/kg (Yamasaki et al. 2002). Watery uterine fluid was also detected in rats 
similarly dosed to 150 mg/kg BPZ, uterine weight was significantly higher in rats 
exposed to 30 and 150 mg/kg. 
The acute toxicity of several bisphenols to D. magna was determined by (Chen 
et al. 2002) this study found that based on the 48-hr EC50 BPA was more toxic 
than BPE (10.0 and 18 mg/l respectively), whereas BPB and BPP (5.5 and 
1.6 mg/l respectively) were both found to be more toxic. 
All the results in the above sections indicate that it is likely that these alternatives 
to BPA may have similar estrogenic effects, though potency may vary. It would 
also appear that some are capable of disrupting signalling pathways other than 
estrogenic, as has been reported for BPA. There are many discrepancies in the 
in vitro estrogenic potential with potencies varying for individual chemicals 
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between cell systems and methodologies. Further experimental data, particularly 
in vivo work is necessary to gain a greater understanding of the possible risks 
these chemicals may have to wildlife and human health should exposure 
increase. In addition a greater understanding of how they interact with different 
ERs and exert their observed effects is also necessary. 
1.10 Methods to assess endocrine disruption 
As described in previous sections there are a wide variety of experimental 
methods and models that have been developed to determine the various effects 
of EDCs, with a large number of these employed to investigate the actions of BPA 
and its related chemicals. In vitro approaches have several advantages over in 
vivo experiments, including ethical, economical and technical. They also tend to 
be cheaper and easier to set up, especially where adequate in vivo facilities do 
not already exist. Turnaround and throughput can also be much higher in many 
cases. However there are also several limitations to using in vitro systems in that 
they may ignore compounding biological factors that could affect activity of the 
tested chemical, including bioavailability, bioconcentration, certain expressed co 
factors or metabolism, which may serve to alter chemical activity (Folmar et al. 
2002, Van den Belt et al. 2004). 
A common in vitro assay routinely used to screen estrogenic chemicals is the 
yeast estrogen screen (YES) which reports estrogenic activity of a chemical as 
an E2 equivalent. This may be used to assess either estrogenic or anti-estrogenic 
activity. Other systems include the luciferase gene-expression (ER-CALUX) 
assay, reported to be more sensitive than YES; or ER reporter assays which may 
be carried out in a variety of cell lines increasing their relevance within specific 
studies (Cabaton et al. 2009, Bermudez et al. 2010). Further to reporter lines 
there are cells that specifically respond to estrogens, for example MCF7 cells 
which have a proliferative response to estrogens (Hashimoto and Nakamura 
2000). Although in vitro methods may be useful indicators of estrogenic activity, 
in particular with regards to receptor binding, they may lack key pathways that 
could occur in vivo. 
Due to these limitations it has been necessary to still utilize a range of in vivo 
models and exposures to help further elucidate the activity of these chemicals, 
indeed with regards to BPA a great number of model species across different 
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taxa have been utilised. Various short and long term outcomes can be measured 
including reproductive, physiological and molecular endpoints. Fish have 
emerged as leading taxa in in vivo assays, due to both their environmental 
relevance, suitability as a model vertebrate and ease of use. In particular the 
zebrafish (Danio rerio) have become an increasingly used model species in 
recent decades. Attributes leading to its increased use include ease of breeding 
and developmental observation, similarities with mammalian physiology and 
development and more recently the advent of powerful tools allowing genetic 
manipulation. These properties have led to zebrafish being used in a wide range 
of studies including those to determine vertebrate embryonic development, as a 
model for studies on human disease, including cardiovascular, metabolic, 
immunological, tumour development or disorders of various tissues/organs 
(Yoder et al. 2002, Chico et al. 2008, Oka et al. 2010, Liu and Leach 2011, 
Swanhart et al. 2011, Xi et al. 2011). Zebrafish have also been widely used in 
ecotoxicology, in studies of estrogenic chemicals and others to determine the 
effects that may occur in the environment and the molecular mechanisms by 
which these effects may occur (Örn et al. 2003, Van den Belt et al. 2003, Vosges 
et al. 2010). 
A further development in recent years has been the generation of transgenic 
organisms, furthering the effectiveness and insight gained by fish in research. 
Many fish lines have emerged as new biosensor systems for ecotoxicology 
research or to assist in the modelling of human disease. It is now possible to 
visualize expression of a target gene of interest, which may be used to label 
specific cells, tissues or response pathways using reporters such as green 
fluorescent protein (GFP). This allows incorporation of both in vivo and in vitro 
advantages, throughput analysis can be rapid and highly sensitive, with fairly low 
running costs (although line establishment requires significant investment), whilst 
also taking into account the real-time action of the chemical in a live organism. 
There have been a number of transgenic zebrafish lines developed to detect 
estrogenic activity, reviewed by (Lee et al. 2015). The most effective lines general 
employ an estrogen response element (ERE) promoter, which binds the estrogen 
receptor-ligand complex initiating transcription of estrogen responsive 
genes.(Legler et al. 2000) developed the first of these models incorporating 3 x 
EREs inserted upstream of TATA minimal reporter with luciferase as the reporter. 
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Although responses were titrated down to low concentrations (3 ng/l EE2) fish 
needed to be terminated and dissected, removing one of the key benefits of 
transgenic fish – that changes may be detected in real time in vivo (Bogers et al. 
2006). Another line was created by (Gorelick and Halpern 2011) containing 5 x 
ERE upstream of a mouse c-fos minimal promoter with GFP as the reporter. This 
fish was effective in regards to tissue specificity, with responses seen in various 
tissues and to different environmental estrogens; however the sensitivity was less 
effective than other models, with E2 concentrations of 1-100 µg/l employed to 
induce responses. More recent work claimed that a response could be detected 
from environmental samples, however it should be noted that these samples were 
filtered and eluted at a much higher concentration than originally sampled 
(Gorelick et al. 2014). 
Currently the most sensitive estrogen responsive transgenic zebrafish was 
developed by (Lee et al. 2012) and incorporates a 3 x ERE and a Tol2-mediated 
GAL4FF-UAS system. This model is capable of detecting responses down to 
1 ng/l EE2 and 5 ng/l EE2. Also responses were detected in a wide variety of 
tissues, including the liver, heart, skeletal muscle, neuronal cells and the brain. 
There was also evidence of tissue specific expression patterns for different 
environmental estrogens, indicating different specific tissue toxicities (Lee et al. 
2012). 
1.11 Aims of this thesis 
Despite the fact that BPA is a chemical of concern for both human health and the 
environment and various adverse effects have been linked to its exposure, there 
is still a lack of evidence on specific tissue activity and the mechanisms by which 
these effects are mediated. As concern grows and public awareness of these 
effects increases the demand for products free of BPA is becoming increasingly 
more common. There is still very little research on the in vivo effects these 
structurally similar chemicals may have. 
The overall aim of the work presented was to use the zebrafish including the novel 
estrogen responsive transgenic zebrafish as a model organism to assess the 
tissue specificities and responsiveness for BPA and its most commonly used 
alternatives. Whilst also attempting to further determine the mechanisms of action 
for BPA with particular respect to a key target organ, using an integrated 
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physiological and molecular approach. 
In order to achieve these aims the following experimental work was conducted 
with the following specific aims: 
Aim 1 (Chapter 2): To compare the toxicity, teratogenic effects, estrogenic tissue 
targets and uptake of Bisphenol A, and its alternative replacements Bisphenol S, 
Bisphenol F and Bisphenol AF, in zebrafish.Also to determine if observed 
estrogenic effects are a result of signaling via the classical Estrogen Receptor 
pathway.To achieve this aim, initially, zebrafish were exposed for 96 hours to 
different chemicals to assess the comparative acute toxicities including effects on 
hatching rate and morphological abnormalities. Further investigations employed 
the use of ERE-Transgenic zebrafish to determine tissue responsiveness for all 
chemicals and thresholds necessary to induce responses. Exposures were also 
conducted with estrogen receptor antagonist to assess pathway(s) of action. To 
determine if observed responses could be linked to bioavailability, analyses to 
quantify the uptake of compounds into zebrafish larvae were also carried out. 
Aim 2 (Chapter 3): Once it was determined that the heart was a key tissue target 
for BPA and other related biphenolic chemicals, Chapter 3 aimed to further 
investigate the specific estrogenic mechanisms and functional health effects of 
Bisphenol A on the heart in zebrafish. The action of BPA in zebrafish was also 
compared with its metabolite 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene 
(MBP) to determine if MBP was more potent as an estrogen, as observed in 
mammalian cells. Finally we aimed to determine if this metabolite is produced in 
vivo in zebrafish.  
ERE-Transgenic zebrafish were used to achieve these aims to determine specific 
targets and mechanisms of action of BPA and the potent BPA metabolite 4-
Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene on early zebrafish heart 
development. Immunohistochemistry was conducted to more accurately 
determine specific regions of fluorescence detected in the heart. To assess 
pathways of ER mediated action exposures were also conducted in conjunction 
with estrogen receptor morpholinos. A final element of this chapter sought to 
determine if transcriptional activation via estrogen receptors in the heart resulted 
in any detectable functional differences in 5 and 14 dpf larvae, this was achieved 
using video capture and analysis of heart and blood vessels in vivo. 
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Aim 3 (Chapter 4): The final aim of this thesis was to determine how the response 
seen in the heart of ERE-TG zebrafish, which indicated estrogen dependent 
transcription, related to transcriptomic responses in the hearts of larval zebrafish. 
This transcriptomic approach aimed to produce an in depth understanding of the 
mechanisms of toxicity of these chemicals in the heart and characterise possible 
toxicological effects. 
RNA-seq using Illumina next generation sequencing was applied to determine 
gene expression profiles of ERE-TG zebrafish hearts from fish exposed to 
Bisphenol A. Measuring responses to Bisphenol A exposure was the primary aim, 
however a further aim was to determine if these responses differed from those 
observed in fish exposed to the classic steroidal estrogen 17α-ethinylestradiol 
(EE2) and the potent BPA metabolite 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-
ene (MBP), following on from work carried out in Chapter 3. 
The final thesis chapter (chapter 5) aims to provide a critical overview on the key 
findings of the research chapters, the challenges and limitations encountered and 
possible future directions for study. 
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CHAPTER 2 
 
Toxicity, Teratogenic, and Estrogenic Effects of Bisphenol A, and its 
Alternative Replacements Bisphenol S, Bisphenol F and Bisphenol AF, in 
Zebrafish 
 
Manuscript in preparation 
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Abstract 
Bisphenol A (BPA) is a chemical incorporated into plastics and resins that has 
estrogenic activity and is widely reported to be associated with adverse health 
effects in humans and wildlife. These reported effects have resulted in the 
regulation of BPA use in many countries and a growing market for BPA-free 
products and use of similarly structured BPA analogue replacements. Increased 
industrial use of BPA analogues has inevitably led to increases in their measured 
levels in both humans and environmental samples, however, little is known about 
the potential toxicity and estrogenic mode of action of these BPA replacements 
in in vivo systems. 
We compared the uptake, toxicity, and teratogenic effects of the bisphenol 
chemicals BPA, BPS, BPF and BPAF in zebrafish and assessed their estrogenic 
effect mechanisms in an estrogen responsive transgenic fish 
Tg(ERE:Gal4ff)(UAS:GFP). The rank order for toxicity was 
BPAF>BPA>BPF>BPS. Common developmental deformities observed for early 
life stage exposures included the presence of cardiac edema, craniofacial 
abnormality, spinal/tail malformations, cranial haemorrhaging, pigment reduction 
and yolk sac malformations. These effects occurred at concentrations between 
1.0 and 200 mg/l depending on compound, far exceeding most environmental 
concentrations. All bisphenol compounds induced estrogenic responses in 
Tg(ERE:Gal4ff)(UAS:GFP) zebrafish that were inhibited by co-exposure with 
ICI 182,780 showing an ER dependent mechanism. The tissues affected 
included the heart, liver, somite muscle, fins and corpuscles of stannius and the 
rank order for estrogenicity for the bisphenols tested was BPAF>BPA=BPF>BPS. 
Bioconcentration factors were determined to be 4.5, 17.8, 5.3 and 0.067 when 
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external concentrations measured 1000, 1000, 100 and 50000 µg/l for BPA, BPF, 
BPAF and BPS respectively. 
We show that some Bisphenol A replacement products induce similar toxic and 
estrogenic, effects as for BPA and BPAF was more potent than BPA.  We 
illustrate that bioavailability of the bisphenol products, as well as established 
differences in their binding affinities for ER(s) may play a role in the estrogenic 
potential for some analogues in vivo. 
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Introduction 
Endocrine disrupting chemicals (EDCs) possess structural similarities with 
endogenous hormones, and/or alter hormone biosynthesis, biodegradation or 
excretion, and exposure to them can alter biological homeostasis, in some cases 
at environmentally relevant exposure concentrations. Many groups of chemicals 
have been identified with endocrine disrupting properties and this, together with 
their widespread presence in the environment, has led to health concerns for both 
wildlife and humans. One of the best known groups of EDCs mimic and/or disrupt 
the activity of estrogen (Diamanti-Kandarakis et al. 2009). Disruption of sexual 
development in wildlife is a proven exposure consequence (reviewed in Segner 
et al. (2013) and Bhandari et al. (2015)) and in fish exposure to environmental 
estrogens causes feminisation of males and alters sexual behaviour 
characteristics (Tyler et al. 1998, Vos et al. 2000, Segner et al. 2003, Kang et al. 
2007). Estrogens, however, play much wider roles in many other developmental 
and homeostatic processes and therefore chemicals capable of disrupting normal 
estrogen signalling may have wider health effects. In humans exposure to 
estrogenic chemicals has been associated with increased incidences of breast 
(Russo and Russo 2006) and testicular cancer (McGlynn and Cook 2009), 
urogenital tract malformation (Boisen et al. 2004), decrease in immune function 
(Rogers et al. 2013), metabolic disease and heart disease (Alonso-Magdalena et 
al. 2006, Newbold et al. 2007).  
Bisphenol A (BPA) is a chemical used in a variety of industrial materials, 
particularly polycarbonate plastics and epoxy resins. Due to the ever increasing 
popularity of these durable, lightweight materials, the production of BPA has 
steadily increased, with a production of more than 2.4 million tonnes in 2009 
(Vogel 2009). BPA has been described as slightly to moderately toxic to aquatic 
organisms (Alexander et al. 1988) and has been identified also as an 
environmental estrogen. It has been measured in the urine of most humans 
(Calafat et al. 2008, Zhang et al. 2011) and although BPA is relatively easily 
conjugated and excreted, there is an almost continuous exposure for both 
humans and wildlife. 
In human epidemiological studies, BPA exposure (measured predominantly via 
urinary concentrations) has been linked to a variety of health symptoms including 
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reduced sperm quality (Li et al. 2011) and reduced fertilisation success (Fujimoto 
et al. 2011), Polycystic Ovarian Syndrome (Takeuchi and Tsutsumi 2002), obesity 
(Shankar et al. 2012), cardiovascular disease (Melzer et al. 2012, Melzer et al. 
2012), and type 2 diabetes (Shankar and Teppala 2011). However, it should be 
noted that these reported effects are statistical associations only and the findings 
have been treated with some caution (LaKind et al. 2012, Lakind et al. 2014). 
Many of the associated health effects are based on a spot analysis of BPA and 
the studies have not necessarily considered historical exposures to BPA or 
exposure simultaneously to other chemicals. Controlled exposures to BPA, in 
rodents however, have shown effects similar to those identified in human 
epidemiological studies, and they include developmental defects in reproductive 
tissues, immune system effects, and neuro-developmental effects (reviewed in 
(Richter et al. 2007). Some biological effects have also been reported in studies 
for environmentally relevant exposure doses and below the European Food 
Safety Authority currently recommended dose of 4µg/kg body weight/day 
(Newbold et al. 2009). 
The aquatic environment is a major route for the disposal of industrial and 
domestic chemicals, including bisphenols, and health impacts of BPA exposure 
are documented for a range of aquatic animal species. The majority of studies 
into the effects of bisphenol exposure, have focused on fish (Oehlmann et al. 
2009, Flint et al. 2012) and effects predominantly relate to sexual development 
and function, and include the induction of the egg precursor protein vitellogenin 
(VTG) (Larsen et al. 2006, Mandich et al. 2007), intersex (the presence of female 
oocytes in male gonads) (Mandich et al. 2007), inhibitory effects on sperm 
maturation and numbers (Sohoni et al. 2001), oocyte atresia (Mandich et al. 
2007), alterations in sex steroid level (Labadie and Budzinski 2006) and modified 
behaviour (Weber et al. 2015). Despite the possible wide range of health effects 
associated with exposure to BPA proposed in mammals and fish, studies have 
been restricted largely to effects on sexual development/reproduction. Effects of 
BPA exposure on development in fish for the most part, have been reported only 
for concentrations far exceeding those found in most natural environments (Lam 
et al. 2011, Chow et al. 2013). 
In response to the significant data sets published supporting adverse health 
effects associated with BPA exposure, several authorities have taken steps to 
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reduce human exposure. As an example, use of BPA in food contact materials 
has now been banned in Japan and Canada and in 2011 the European Union 
prohibited the manufacture and import of baby bottles containing BPA 
(European_Commission 2011). This action has increased public awareness 
about BPA, resulting in a demand for BPA-free products and the manufacture 
and use of bisphenol chemicals as alternatives to BPA (enabling those products 
to be classed as BPA-free). These alternatives (the most commonly used being 
Bisphenol AF -BPAF, Bisphenol F -BPF and Bisphenol S -BPS) possess the 
same basic structure as BPA with two phenol groups with the hydroxyl groups at 
the para positions, linked by a carbon or sulphur bridge, and with substituents 
attached to this bridge that can vary and include, for example, alkyl groups and 
halogens (see Table 1). The similarities in structure of the alterative bisphenols 
to BPA make them ideal as replacements for use in polymers, however, these 
structural similarities also give cause for concern that they may also have 
estrogenic activity and induce similar associated health effects as BPA (Kitamura 
et al. 2005). 
 
Table 1. Bisphenol A (BPA) and its structural analogues 
Compound Structure Alternative names 
BPA 
 
2,2-Bis(4-hydroxyphenyl)propane 
4,4′-Isopropylidenediphenol 
BPF 
 
Bis(4-hydroxyphenyl)methane 
4,4′-Methylenediphenol, 
BPAF 
 
4,4′-(Hexafluoroisopropylidene)diphenol 
2,2-Bis(4-hydroxyphenyl)hexafluoropropane 
Hexafluorobisphenol A 
BPS 
 
4,4′-Sulfonyldiphenol 
4-Hydroxyphenyl sulfone 
Bis(4-hydroxyphenyl) sulfone 
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Production volumes of Bisphenol F (BPF), Bisphenol S (BPS) and Bisphenol AF 
(BPAF) have increased in recent years associated with their increasing 
widespread uses. Data on production volumes for these bisphenols is limited, but 
in the US in 2012, production volumes have been estimated at 161, between 
453.6-4536, and 180 tonnes for BPF, BPS and BPAF, respectively (USEPA 
2012). BPF and BPS are used as a monomer in polycarbonate and 
polyethersulfone, respectively, and in epoxy resins. BPS has also emerged as 
the leading replacement for BPA as a developer in thermal paper, while BPAF is 
commonly used in polycarbonate, electronic products and optical cables 
(Gardziella 2000, Biedermann et al. 2010, Delfosse et al. 2012). 
BPF, BPS and BPAF are detected in food and beverage products (in the USA) at 
concentrations generally below 1ng/g (Liao and Kannan 2013). BPS has also 
been detected in thermal receipt papers, currency bills and other paper products, 
with the highest concentration of 22 mg/g in thermal paper (Liao et al. 2012). 
Indoor dust samples have been shown to carry bisphenols and BPA, BPF and 
BPS have been shown to account for >98% of the total bisphenol content in 
house dust. River and sediment samples also contain BPF and BPS, occasionally 
at concentrations similar to BPA (Fromme et al. 2002, Stachel et al. 2003, Liao 
et al. 2012). BPAF is generally found in rivers and sediments at lower 
concentrations than for BPA, BPF and BPS. (Yang et al. 2014). BPS has been 
detected in 81% of urine samples from American and Asian populations 
confirming human exposure (Liao et al. 2012). 
Toxicity of bisphenol analogues has received little attention when compared to 
BPA. Studies assessing BPF, BPS and BPAF for estrogenic activity in in vitro 
reporter systems (Hashimoto and Nakamura 2000, Kitamura et al. 2005, Zhang 
et al. 2011) have reported varying potencies. Overall, however, findings appear 
to indicate BPF and BPA possess a similar estrogenic potency, and BPAF as 
more potent than BPA. Some in vitro studies have reported BPS as being weakly 
active as a ligand for the estrogen receptor, but others indicate an equal potency 
to BPA (Masuno et al. 2005, Grignard et al. 2012). BPA and BPS have been 
reported to induce DNA damage in vitro in HepG2 cells at 0.1 µM, whereas BPF 
and BPAF showed no such effects at 10µM (Fic et al. 2013). The mechanism(s) 
of action for this effect has not been established. 
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Few studies have assessed the endocrine disrupting potential of these 
alternatives to BPA in vivo. In mammals, BPS, BPF and BPAF have been shown 
to be estrogenic in the uterotrophic assay (Yamasaki et al. 2003, Yamasaki et al. 
2004). Other effects of BPAF observed in mammals in vivo include reductions in 
cholesterol, testosterone and white blood cell counts, increase in serum thyroxin 
values and a disruption of the estrous cycle (Feng et al. 2012, Umano et al. 2012). 
In zebrafish, exposure to 0.5 µg BPS/l has been shown to impact negatively on 
reproductive endpoints and gonadosomatic index (Ji et al. 2013). An increase in 
concentrations of plasma E2 in males and females (at concentrations of 0.5 and 
50 µg BPS/l, respectively) and reduced testosterone concentrations in males (at 
50 µg BPS/l) have also been reported for aqueous exposures (Ji et al. 2013). 
These findings highlight that bisphenols marketed as safer alternatives to BPA, 
may similarly induce widespread and varied health effects. 
In this study we aimed to determine if the in vivo toxicity and sub-lethal effects of 
BPA differed from that of its commonly used alternative analogues, BPS, BPF 
and BPAF to assess the possible health implications of the increasing use of 
these chemicals in BPA-free products. As the estrogenic nature of BPA has been 
attributed to receptor interactions by the hydroxyl groups at para positions on the 
phenol groups, we hypothesised that its related analogues that possess a similar 
structure would behave similarly. To test this we employed the use of an estrogen 
responsive transgenic fish, Tg(ERE:Gal4ff)(UAS:GFP) (Lee et al. 2012) to 
investigate for target tissues and potency for estrogenic effects.  
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Materials and methods 
Fish source, culture and husbandry 
Adult zebrafish for the provision of embryos were kept in aquaria (37.5L) at the 
University of Exeter in mixed-sex stock tanks, as described in (Paull et al. 2008). 
Effects of bisphenols on embryo development and toxicity were studied in wild-
type WIK strain (originally from the Max Planck Institute, Tubingen, Germany). 
The estrogenic potency and tissue targets for estrogenic responses were 
analysed in Tg(ERE:Gal4ff)(UAS:GFP), a transgenic zebrafish developed at the 
University of Exeter (Lee et al. 2012). Fish were allowed to breed naturally and 
eggs were collected in egg collection chambers approximately 1 h post-
fertilisation (hpf). Eggs were sorted to remove any unfertilised embryos prior to 
use. 
Chemical exposures 
Bisphenol A (purity >99%), Bisphenol F (purity 98%), Bisphenol S (purity 98%) 
and Bisphenol AF (purity 97%) were purchased from Sigma-Aldrich Company 
Ltd. (Gillingham, UK). All stock chemicals were dissolved in ethanol in glass 
bottles and diluted in ethanol to the required stock concentrations prior to dilution 
in embryo test water. All tests were performed in reconstituted purified water in 
accordance with ISO (International Standard Organisation) guideline 7346-3. 
Chemicals in ethanol stock were dissolved in test water to give a final ethanol 
concentration of 0.01%. Solvent controls contained the equivalent of ethanol in 
ISO water without chemical. To confirm that the responses observed in the 
Tg(ERE:Gal4ff)(UAS:GFP) zebrafish exposed to the different bisphenol 
chemicals were mediated by an ER-dependent pathway, embryos were co-
exposed with estrogen receptor antagonist ICI 182,780 (ICI) (Tocris Bioscience, 
Bristol, UK) ICI was also dissolved in ethanol and exposed to embryos at a 
concentration of 607 µg/l (1 µM). 
Embryos were exposed to bisphenolic chemicals or to solvent control. Each 
experimental group consisted of 20 embryos exposed in 100 ml of water and 
each treatment group was run in triplicate. 20 embryos are in line with regulatory 
testing that follows OECD guidelines for Fish Embryo Acute Toxicity (FET) Test 
(Test No. 236). Although FET does not suggest a replicate number, tests were 
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run in triplicate to increase statistical power, whilst still maintaining a manageable 
workload, considering test implementation and data collection. All experiments 
were conducted in temperature controlled laboratories held at 28 ± 1 °C, under 
semi-static conditions. Exposures to determine toxic effects and morphological 
abnormalities were conducted from 0 hpf to 96 hpf in accordance with OECD FET 
testing. Throughout this period larvae were assessed on a regular basis (3, 24, 
48, 72 and 96 hpf) and mortality, hatching rate and abnormalities recorded. 
Mortality was determined based on no visible heart beat in larvae. Morphological 
abnormalities were observed and photographed using an Olympus SZX16 
microscope equipped with an Olympus XC10 camera. Exposures to determine 
estrogenic response by GFP induction assessments were conducted from 0 hpf 
(hours post fertilisation) to 120 hpf. At the end of this exposure period 120 hpf old 
larvae were processed for fluorescent imaging analysis. 
Image analysis of Tg(ERE:Gal4ff)(UAS:GFP) zebrafish 
Live Tg(ERE:Gal4ff)(UAS:GFP) larvae were anesthetised with 0.4% tricane, 
mounted in 3% methylcellulose in ISO water and placed onto a glass-bottom 35 
mm dish (MatTek, Ashland, MA, USA). All larvae were observed in lateral view 
and images were obtained using a Zeiss Axio Observer.Z1 equipped with an 
AxioCam Mrm camera (Zeiss, Cambridge, UK). All photographs were taken using 
the same parameters using a X10 objective. Exposure times adopted were 
dependent on the region photographed due to differing levels of fluorescence 
intensity in different target organs, (50ms for head region, 20ms for mid body 
region and 400ms for tail section). Exposure times were selected based on 
generating a strong enough signal for clear visual interpretation without over-
exposure (identified using the Axiovision Imaging software as over-exposed 
areas are shaded red) as this may affect intensity quantification. Exposure time 
was set by preliminary observations of 10 individual larvae of the highest 
concentration for each chemical, as this concentration would be most likely to 
cause over-exposure. Once set this was kept consistent for specific regions 
across the fish body. Photographs were processed using the Axiovision Imaging 
software and fluorescence quantification was calculated using the ImageJ 
software (http://rsb.info.nih.gov/ij/). For each picture intensity was measured as 
the mean grey value of all the pixels within a region of interest, and the region of 
interest was kept consistent between individuals. Background was subtracted 
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using the ImageJ rolling ball algorithm which removes any spatial variations of 
the background intensities as described in (Sternberg 1983). 
Determination of chemical concentration in exposure water 
For each compound (BPA, BPS, BPF and BPAF) various nominal concentrations 
were tested (Table 3), and water samples from control and bisphenol exposure 
tank were analysed in triplicate. Up to 100 mL of tank water was collected to 
which 2 % of methanol and 0.1 % of acid acetic were added. The water samples 
were then extracted through an Oasis HLB (6 mL, 200 mg) cartridge (Waters, 
Manchester, UK), which was previously conditioned with 5 mL of methanol and 5 
mL ultrapure water at a flow rate of 5-10 mL/min. Prior to the SPE extractions, 
two internal standard (BPA-d8 and 2,2’-BPF) were added. The amount of internal 
standard (IS) added was calculated so that the ratio of compound/IS was 1/1. The 
cartridge was washed with 5 mL of distilled water, and was then dried under 
vacuum and elution was performed with 5 mL of methanol. Extracts were dried, 
reconstituted in water/acetonitrile (7/3, v/v) and passed through 0.22 µm 
centrifuge filters. Recovery test of the SPE protocol performed at a low and high 
concentration for each compound (n=4 for each concentration) gave values 
ranging from 83 ± 2 to 108 ± 9% (Table 2). 
Ultra high-performance liquid chromatography tandem mass spectrometry 
(UHPLC-MS/MS) analyses were carried out using a Waters Acquity UHPLC 
system coupled to a Quattro Premier triple quadrupole mass spectrometer from 
Micromass (Waters, Manchester, UK). Samples were separated using a reverse 
phase Acquity UHPLC BEH C18 column (1.7 μm particle size, 2.1 mm × 100 mm, 
Waters, Manchester, UK) maintained at 25 °C. Injection volume was 5 µL and 
mobile phase solvents were water (A) and acetonitrile (B) in an initial ratio (A:B) 
of 70:30. Separation was achieved at 25 ◦C using a flow rate of 0.25 mL/min with 
the following gradient: 70:30 to 30:70 in 8 min; then from 30:70 to 0:100 and held 
for 4 min, then return to initial condition at 12 min and equilibration for 6 min. 
Retention times, ionisation and fragmentation settings are reported in Table 2. 
MS/MS was performed in the Multiple Reaction Mode (MRM) using ESI in the 
negative mode, and one characteristic fragment of the deprotonated molecular 
ion [M−H]− was used for quantitation. Other parameters were optimised as 
follows: capillary voltage −3.3 kV, extractor voltage 8 V, multiplier voltage 650 V, 
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source temperature 120 ◦C, desolvation temperature 300 ◦C. Argon was used as 
collision gas (P collision cell: 3×10−3 mbar), while nitrogen was used as both the 
nebulizing (100 L/h) and desolvation gas (600 L/h). Mass calibration of the 
spectrometer was performed with sodium iodide. Data were acquired using 
MassLynx 4.1 and the quantification was carried out by calculating the response 
factor of BP compounds to internal standards. Concentrations were determined 
using a least-square linear regression analysis of the peak area ratio versus the 
concentration ratio native to deuterated. Five point calibration curve (R2 > 0.99) 
covered the range 125–2500 pg (injected on column) for all compounds, within 
the linear range of the instrument. 
 
Table 2. LC-MS quantification of the target compounds performed by monitoring 
two characteristic multiple reaction monitoring (MRM) transitions 
Compound 
Parent ion 
(m/z) 
Product ion 
(m/z) 
Collision 
energy (eV) 
BPA 227.1 
212.1 20 
133.1 28 
BPF 199.1 
149.1 22 
105.0 23 
BPAF 335.0 
265.1 24 
177.0 46 
BPS 249.0 
108.0 28 
92.0 40 
 
Determination of internal chemical concentration 
For a series of selected exposure concentrations, namely 1000 µg/l BPA, 
100 µg/l BPAF, 1000 µg/l BPF and 50 000 µg/l BPS, analyses were run to 
measure internal whole body concentrations. The concentrations for these 
analyses were based on the production of a strong GFP signal in several tissues 
in the ERE-TG zebrafish, approximately comparable in intensity across 
treatments. Chemical analysis resulted in a known concentration present in an 
individual larvae per treatment, based on an estimated larval volume of 1µl BCF 
was then calculated based on the following calculation: 
BCF = 
Measured concentration per larvae (µg/L) 
Nominal external water concentration (µg/L) 
85 
 
Sample Preparation 
Fish were exposed for 120 hpf for uptake assessment. Five zebrafish larvae, 
previously anaesthetised with 0.5 g/l solution of tricaine (non-recoverable), in 300 
μL of test solution were transferred to a 96 well MultiScreenHTS BV Filter Plate 
(Merck Millipore, Ireland) The test solution was removed under vacuum and 
larvae were washed with culture water (containing tricaine), to eliminate residual 
test solution and transferred in 300 μL of pure water to a 96-well plate (Porvair 
Sciences, UK). Then 300 μL HPLC- grade acetonitrile was added and samples 
were homogenised for 3 minutes to achieve extraction of analytes. LCMS grade 
water (900ul) was added to each well and after mixing the plate was centrifuged 
at 4000 rpm for 30min. Supernatants from each well were transferred to a 96-well 
plate and removed for analysis. 
LC-MS Method 
Analyses were performed using Surveyor MS Pump Plus HPLC pump with HTC 
PAL autosampler coupled to TSQ Vantage triple quadrupole mass spectrometer 
equipped with heated electrospray (HESI II) source (all ThermoFisher Scientific, 
Hemel Hempstead, UK).  
Chromatographic separation was achieved using reversed-phase, 3 µm particle 
size, C18 Hypersil GOLD column 50 mm × 2.1 mm i.d. (Thermo Scientific, San 
Jose CA, USA). Analytes were separated using a linear gradient of (A) water and 
(B) methanol. The initial conditions for the gradient consisted of 10% solvent B, 
which was increased to 100% in 4.5 min and maintained for 1 min before 
returning to the initial 10% B. The flow rate was 500µL/min. Temperature of auto-
sampler was set at 8˚C while column was kept at ambient room temperature.  
HESI probe was operating in the negative mode; an ion-spray voltage of -4.0 kV 
was applied. The heated capillary temperature was set at 275 °C and the 
vaporizer temperature was 60 °C. Nitrogen was employed as sheath and 
auxiliary gas at a pressure of 30 and 5 arbitrary units, respectively. The argon 
CID gas was used at a pressure of 1.5 mTorr and the optimum collision energy 
(CE) for each transition was selected. Quantification of the target compounds was 
performed by monitoring two characteristic multiple reaction monitoring (MRM) 
transitions (Table 2) 
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Data analysis 
Concentration response curves were modelled using a generalised linear model 
(GLM) in R (http://www.r-project.org/) and allows for calculation of LC/EC50. For 
a given chemical, LC50 and EC50 were defined as the concentration inducing 
50% mortality or of the maximal effect, respectively. Abnormality occurrence is 
expressed as mean percentage ± standard error of the mean (SEM). 
Fluorescence data is expressed as mean fold induction above the solvent control 
± standard error of the mean (SEM). Statistical analyses of fluorescence data 
were performed in IBM SPSS Statistics 22. 
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Results 
Bisphenol Exposure Concentrations and Uptake into Embryos  
Chemical analysis of working solutions was determined to confirm bisphenol test 
concentrations at the start of the exposures. All bisphenols were determined to 
be within 20% of their nominal concentrations, indicating accurate dosing. 
Controls did not contain bisphenols at the limit of detection for the different 
bisphenols (40 ng/l for BPA, 10 ng/l for BPAF, 100 ng/l for BPF and 1.5 ng/l for 
BPS). Measured internal chemical concentrations in the larvae for the different 
bisphenols are summarised in Table 3. Uptake of BPA was determined to be 
0.31 ± 0.011 and 4.50 ± 0.42 ng/larvae for fish exposures to 100 and 1000 µg/l 
respectively, for 1000 µ/l BPF, 17.8 ± 1.3 ng/larvae, for 100 µg/l BPAF, 
0.53 ± 0.0035 ng/larvae and for 50 000 µg/l BPS, 3.34 ± 0.15 ng/larvae 
respectively. Based on these, albeit limited, analyses, the BCF for BPA, BPF, 
BPAF and BPS were 4.5 ± 0.42, 17.8 ± 1.3, 5.3 ± 0.035 and 0.067 ± 0.0030 
respectively. These values do not necessarily indicate the amount of chemical 
that has entered cells, therefore binding with receptors, there is also no indication 
as to specific tissue distribution. However, it does give an indication as to the 
concentration that may be bioavailable internally in comparison to the exposure 
water, therefore aiding in the identification of possible effect mechanisms. 
 
Table 3. Measured water and whole body concentrations in 120 hpf zebrafish 
larvae for each bisphenol. Data as shown are the mean of 3 replicates, each 
containing 5 larvae, repeated 3 times (SEM in brackets) 
 Nominal 
external water 
concentration 
(µg/l) 
Measured 
external water 
concentration 
(µg/l) 
Measured 
concentration 
per larvae 
(ng/larvae) 
Estimated 
bioconcentration 
factor  
BPA 100 94.2 (10.1) 0.31 (0.011) 3.1 (0.11) 
 1000 986.9 (15.4) 4.50 (0.42) 4.5 (0.42) 
BPF 1000 1063.3 (63.5) 17.8 (1.27) 17.8 (1.27) 
BPAF 100 93.0 (4.79) 0.53 (0.0035) 5.3 (0.035) 
BPS 50 000 52 300 (318.0) 3.34 (0.15) 0.067 (0.0030) 
 
Relative toxicity of Bisphenols on zebrafish embryo development 
In controls mortality rates were between 0 and 10%. Acute toxicities of the 
bisphenol chemicals were significantly different from one another with 96hpf LC 
50 values of BPA, BPF, BPAF and BPS of 11.84, 31.78, 1.59 and 198.76 mg/l, 
respectively (Fig. 2) and thus a rank order of BPAF>BPA>BPF>BPS from most 
toxic to least toxic. 
Embryos in control groups developed normally with a hatch rate between 85-
100% by 72hpf. All bisphenols were shown to delay the time of hatching with 
EC50 (72hpf) values of 5.71, 13.77, 0.92 and 155.47 mg/l for BPA, BPF, BPAF 
and BPS, respectively (Fig. 1). The same rank order for the bisphenols occurred 
for hatching delay as for mortality (BPAF>BPA>BPF>BPS). 
The incidence and type of deformity differed for different exposure concentrations 
and bisphenol type. Common deformities observed included the presence of 
cardiac edema, craniofacial abnormality (including a broadened-head, 
asymmetrical eye formation and lack of anterior lower jaw protrusion), spinal/tail 
malformations, cranial haemorrhaging and yolk sac malformations (Fig. 3). 
Common malformations observed for exposure to BPA were cardiac edema and 
craniofacial abnormality, with significant effects on these endpoints at 5.0 and 
10.0 mg/l and higher respectively. Ten percent of fish were also observed to have 
cranial haemorrhage at an exposure of 12.5 mg BPA/l. BPF induced a range of 
morphological defects including cardiac edema, craniofacial abnormality, spinal 
malformation, cranial haemorrhage and yolk sac deformity (Table 4 and Figure 
4) with significant effects at exposures of 10.0, 20.0, 20.0, 20.0 and 20.0 mg/l and 
above respectively. There was also a marked decline in pigmentation in zebrafish 
exposed to 10 mg BPF/l (Figure 4). The most potent bisphenol for development 
effects was BPAF, causing cardiac edema at concentrations of 1.0 mg BPAF/l. 
BPS caused developmental effects only at very high exposure concentrations; at 
200mg BPS/l cardiac edema, craniofacial abnormalities and pronounced spinal 
deformity were induced. No deformities were observed in any of the control 
groups. 
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Figure 1. Hatching success rate of 72 hpf zebrafish larvae exposed to bisphenol 
chemicals 
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Figure 2. Mortality rates of 96 hpf zebrafish larvae exposed to bisphenol chemicals 
 
 Figure 3. Examples of typical teratogenic responses of zebrafish larvae observed 
upon exposure to bisphenol chemicals: (A) normal, (B) pigment reduction, (C) 
cardiac edema, (D) spinal malformation, (E) craniofacial abnormality, (F) cranial 
haemorrhage, (G) yolk sac malformation. 
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Figure 4. (A) rates of developmental abnormality and lethality in 96 hpf zebrafish 
larvae exposed to bisphenol chemicals (B-F) and examples of observed 
abnormalities in exposed larvae: (B) Solvent Control, (C) BPA 12.5 mg/l, (D) BPF 
27.5 mg/l, (E) BPAF 2.0 mg/l, (F) BPS 200 mg/l; Scale bar represents 500 µm; 
SB=swim bladder, CH=cranial haemorrhage, CE=cardiac edema, NT=necrotic 
tail tissue, TD=tail deformities, CF=craniofacial abnormalities 
94 
 
Table 4. Developmental abnormalities (%) observed in 96 hpf zebrafish larvae 
exposed to BPA, BPF, BPAF and BPS (mg/l). Data as shown are the mean of 3 
replicates (SEM in brackets) 
 Cardiac 
edema 
Craniofacial 
abnormality 
Tail 
development 
Cranial 
haemorrhage 
Yolk sac 
deformity 
Control 0.0 0.0 0.0 0.0 0.0 
       
BPA 1.0 0.0 0.0 0.0 0.0 0.0 
 2.0 1.8 (1.8) 1.8 (1.8) 1.8 (1.8) 0.0 0.0 
 5.0 37.4 (9.0) 0.0 (0.0) 0.0 0.0 0.0 
 10.0 100.0 (0.0) 43.7 (11.7) 0.0 0.0 3.5 (3.5) 
 12.5 100.0 (0.0) 100.0 (0.0) 0.0 10.0 (10.0) 0.0 
       
BPF 1.0 1.7 (1.7) 0.0 0.0 0.0 0.0 
 2.0 1.7 (1.7) 0.0 3.3 (1.7) 0.0 0.0 
 5.0 10.0 (5.8) 3.3 (1.7) 1.7 (1.7) 1.7 (1.7) 0.0 
 10.0 64.6 (7.3) 6.7 (4.4) 8.6 (3.6) 8.5 (4.4) 1.7 (1.7) 
 20.0 100.0 (0.0) 11.7 (7.3) 11.7 (3.3) 36.7 (4.4) 21.7 (17.0) 
 27.5 98.3 (1.7) 93.2 (3.4) 93.2 (14.0) 41.4 (0.70) 26.1 (11.0) 
 35 100.0 (0.0) 90.0 (8.2) 90.0 (8.2) 40.0 (33.0) 40.0 (33.0) 
       
BPAF 0.50 3.3 (1.7) 1.7 (1.7) 1.7 (1.7) 0.0 0.0 
 0.75 3.3 (3.3) 1.7 (1.7) 0.0 0.0 0.0 
 1.0 15.6 (8.7) 0.0 0.0 0.0 0.0 
 2.0 34.6 (18.0) 2.8 (2.8) 2.8 (2.8) 0.0 0.0 
       
BPS 10 0.0 0.0 0.0 0.0 0.0 
 20 1.8 (1.8) 1.8 (1.8) 1.8 (1.8) 0.0 1.8 (1.8) 
 50 0.0 0.0 0.0 0.0 0.0 
 100 3.3 (1.7) 3.3 (1.7) 1.7 (1.7) 0.0 0.0 
 200 94.1 (3.2) 96.3 (3.7) 82.2 (3.4) 3.7 (3.7) 0.0 
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Estrogenic effects of Bisphenol chemicals measured in ERE-TG zebrafish 
larvae 
Transgenic zebrafish without chemical exposure had some detectable GFP 
expression in the otic vesicle (Fig. 5). This fluorescence was not found to be 
inducible by any of the bisphenol chemicals, with a similar level of occurrence 
and similar intensity across all treatments. No inducible GFP expression was 
detected in other tissues of unexposed larvae, however very low levels of 
autofluorescence were present in some tissues such as the yolk sac, but this did 
not affect quantitation of the estrogenic responses and were accounted for in 
background quantitations and subtractions for the individual tissues. 
For BPA exposure, GFP expression was first detected for exposure to 100 µg 
BPA/l where a distinct statistically significant signal (3.2-fold GFP induction above 
controls) was observed in the pericardial region, confirmed to be the heart by 
periodical contractile movement of the expression domains. No significant GFP 
expression was observed in any other tissues at this exposure concentration. At 
the maximum concentration for BPA (1000 µg/l) a strong GFP signal was 
observed in the heart (23.6-fold GFP induction), liver (60.4-fold GFP induction), 
and tail (11.2-fold GFP induction) where somite muscle and corpuscles of 
stannius were observed to fluoresce. GFP expression in somite muscle was most 
apparent in posterior somites, with domains consisting of single muscle myotube 
expressing in a mosaic pattern. 
BPAF, BPF and BPS demonstrated similar patterns of GFP expression to BPA, 
though concentrations necessary for comparative induction varied (Fig. 5). BPF 
had the most similar estrogenic potency with BPA, including a significant increase 
in fluorescence in the heart region at both 100 and 1000 µg BPF/l with GFP 
inductions of 3.4-fold and 29.9-fold, respectively. The heart was again the only 
tissue expressing GFP at 100 µg BPF/l. At 1000 µg BPF /l significant GFP 
induction was observed also in the liver and posterior tail region (124-fold and 13- 
fold, above controls, respectively). BPAF was observed to be the most potent 
estrogen of all bisphenol chemicals tested. Significant GFP was induced in the 
heart (2.4-fold increase) at 10 µg BPAF/l increasing to a 22-fold induction in GFP 
expression at 100 µg BPAF/l. BPAF at 100 µg/l also induced significant GFP 
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Figure 5. (A) Images of 120 hpf ERE-TG zebrafish larvae exposed to 1000µg/l 
BPA, 100 µg/l BPAF, 1000 µg/l BPF and 50000 µg/l BPS (images for exposures 
to lower concentrations not shown). Fluorescence observed in otic vesicle (ov), 
heart (h), liver (li), somite muscle (sm) and fin (f). Scale bar represents 200 µm; 
(B-D) GFP induction (fluorescence) in 120 hpf ERE-TG zebrafish larvae exposed 
to bisphenol chemicals measured by fold increase above control in the (B) heart, 
(C) liver, (D) tail somites.   
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induction in the liver and tail region (59-fold and 7.3- fold increases above 
controls, respectively). BPS was relatively weak as an estrogen in ERE-TG 
larvae; concentrations of 20mg/l and 50 mg/l induced 2.7-fold and 10.8-fold 
inductions in GFP in the heart, respectively. Somite muscle and corpuscles of 
stannius expression of GFP were also indicated for exposure to 20 mg BPS/l, 
occurring in 25.0% and 91.7% of the treated larvae, but these apparent inductions 
were not found to be statistically significant. Significant GFP induction occurred 
in the liver and tail regions only at the exposure to 50 mg BPS/l. 
Estrogen Receptor Inhibitor suppression of GFP expression in ERE-TG 
zebrafish 
Exposure of the estrogen inhibitor ICI 182,780 was carried out in tandem with 
various bisphenols to determine whether estrogen induced GFP expression in 
the ERE-TG larvae was dependent on the classic estrogen receptors (ERs). ICI 
182,780 is a high affinity nonselective estrogen receptor antagonist, devoid of 
any partial agonism. Exposure to ICI completely removed the ability for BPA, 
BPF, BPAF and BPS to induce GFP expression in all tissues. Measurements of 
fluorescence intensity were determined to be significantly reduced for all 
chemicals in the heart, liver and tail regions (Fig 6). GFP intensity was determined 
to be no higher than control in the ICI and bisphenol exposed fish.   
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Figure 6. (A) Images of 120 hpf ERE-TG zebrafish larvae exposed to 1000µg/l 
BPA in the presences and absence of estrogen inhibitor ICI 182 780, scale bar 
represents 200 µM. (B-D) GFP induction (fluorescence) in 120 hpf ERE-TG 
zebrafish larvae exposed to bisphenol chemicals in combination with estrogen 
inhibitor ICI 182 780 measured as fold increase in GFP above control in the (B) 
heart, (C) liver, (D) tail somites. Bisphenol concentrations were 1000 µg/l for BPA 
and BPF, 100 µg/l for BPAF and 20 000 µg/l for BPS; when included ICI 182 780 
concentration was 607 µg/l. 
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Discussion 
BPA is a well-documented endocrine disruptor. Its ubiquitous use in many 
everyday products has led to exposure in humans and wildlife, and BPA is 
continuously discharged into the environment. To address environmental and 
health concerns for BPA, various products have recently become available 
marketing themselves as BPA free. These products however, often contain 
structurally similar monomers including the alternative bisphenols BPF, BPAF 
and BPS (Table 1) some of which have also been reported to be endocrine active 
(Liao et al. 2012, Yang et al. 2014). Comprehensive understanding on the 
comparative toxicity and estrogenic potency of these bisphenol A alternatives for 
exposures in vivo is still lacking. We addressed this knowledge gap and 
compared the in vivo toxic and estrogenic potencies and effects of BPA, BPF, 
BPAF and BPS, in zebrafish including through the use of a novel transgenic 
zebrafish developed for detecting environmental estrogens 
[Tg(ERE:Gal4ff)(UAS:GFP)].  
We demonstrated that BPA and its commonly used alternatives, BPF, BPAF and 
BPS can be toxic in zebrafish larvae causing lethality but only for very high 
exposure concentrations (Fig. 2). Sub-lethal effects observed including, 
pericardial edema, craniofacial abnormality, pigment reduction, spinal 
malformation and yolk sac deformity (Table 4) occurred for lower exposure 
concentrations and there were distinct differences between bisphenol chemicals 
in their effects and potencies for these effects. The concentrations of the 
bisphenol chemicals required to induce toxic and developmental effects, 
however, was several orders of magnitude higher than those commonly 
measured in the environment (Fromme et al. 2002, Stachel et al. 2003, Kang et 
al. 2007, Liao et al. 2012). The highest levels of BPA reported in environmental 
waters are typically below 1 µg/l with higher concentrations more rarely measured 
up to 21 µg/l (Flint et al. 2012). For BPF, BPAF and BPS, concentrations in 
environmental samples, when detected, are generally below 1 ng/l, but have 
been recorded up to 18.99 ng BPS/l, 245.68 ng BPAF/l and 123 ng BPF/l 
(Fromme et al. 2002, Yang et al. 2014).  The current trend for replacing BPA with 
its structurally similar alternatives however will inevitably lead to increased 
concentrations of these BPA alternatives in environmental and biological samples 
in the near future (Liao et al. 2012, Yang et al. 2014).  
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Despite their similar structure, the BPA analogues had different potencies for 
effects on hatching rate and mortality with BPAF approximately 6-7 fold more 
potent than BPA for these endpoints. In contrast, BPS showed effects at 
approximately 30 and 20- fold lower for delay on hatching and toxicity 
respectively, compared with BPA. The 72 h EC50 values for hatching rate (5.71 
mg/l, Fig 1) and 96 h LC50 (11.84 mg/l, Fig 2) for BPA in our study in zebrafish 
are similar to those determined in previous studies (Lam et al. 2011, Chow et al. 
2013).  
Similar morphological abnormalities that included cardiac edema, spinal 
malformation and craniofacial abnormalities for the different bisphenols are 
consistent with those reported in the literature for BPA and may suggest similar 
modes of toxicity, albeit with variable potency (Duan et al. 2008, Gibert et al. 
2011, Lam et al. 2011). However, lesions were also observed that were more 
associated with the different bisphenol analogues. For example, lack of 
pigmentation for exposure to BPF (at concentrations of 10 mg BPF/l and above; 
Fig. 4). This may arise as a consequence of an effect on thyroid signalling as 
there is evidence that BPA can bind directly to and block the TR (Moriyama et al. 
2002, Seiwa et al. 2004, Zoeller et al. 2005) (Walpita et al. 2009). Pigmentation 
however also involves cross talk between estrogen and thyroid signalling, 
complicating possible effect mechanisms (Moriyama et al. 2002, Xu et al. 2007). 
Some pigment loss was observed in BPA exposed fish but the effect was much 
more pronounced for BPF exposures. Another phenotype that was more 
distinctive to an individual bisphenol analogue was intracranial haemorrhage for 
exposure to BPF (Fig. 4). This can arise through a weakening of local vasculature 
and previous studies have shown disruptions to thyroid and estrogen signalling 
can have these effects on vasculature (Lam et al. 2011). BPS was the least toxic 
of all the bisphenols tested, however, this analogue induced tail abnormalities not 
seen for other bisphenol and also induced the highest degree of pronounced 
curvatures of the spine (Fig. 4), again suggesting difference in some of the toxic 
mechanisms for the different bisphenols.   
BPA has been shown to induce estrogen related effects in both fish and mammals 
for concentrations that include those that are environmentally relevant (Kang et 
al. 2007, Oehlmann et al. 2009, Flint et al. 2012). In the ERE-TG zebrafish we 
found the different bisphenol analogues induced similar target tissue response 
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patterns to that seen for BPA and included the heart, liver, tail muscle somites 
and corpus stannius (Fig. 5). For all bisphenols tested the most responsive tissue 
was the heart (Fig. 5), though at higher concentrations the greatest response 
level occurred in the liver. In the heart the tissues affected for the bisphenol A 
analogues were the atrioventricular valves and the bulbus arteriosus, as reported 
previously for BPA (Lee et al. 2012, Gorelick et al. 2014) Whether these heart 
valve responses relate to adverse health effects on cardiac function associated 
with BPA exposure (in humans) is a research question that needs addressing. 
Responses in the liver are consistent with reported effects for BPA, BPAF and 
BPS for inducing the hepatic synthesis of vitellogenin in fish (Flint et al. 2012, 
Naderi et al. 2014, Yang et al. 2016). Responses in the muscle somites are 
congruent also with the role of estrogen in muscle growth and for the corpuscles 
of stannius in calcium handling (Maltais et al. 2009). 
BPAF was the most potent estrogen in the ERE-TG zebrafish inducing a 
response in the heart at 10 µg/l and other tissues at 100 µg/l compared with 
threshold concentrations at between 100 and 1000 µg/l for BPA and BPF and 
BPS was between 50 and 500-fold less potent than all other bisphenols. The 
potency order for the different bisphenols reflects that seen for their toxicity, but 
may operate mutually exclusive mechanisms.   
Several in vitro studies have shown that BPAF is more potent (around 10 times 
more potent) than BPA as estrogen in in vitro cell systems (Kitamura et al. 2005, 
Bermudez et al. 2010, Zhang et al. 2011). The reported estrogenic activity of BPF 
and BPS in relation to BPA however are much more variable (Perez et al. 1998, 
Hashimoto and Nakamura 2000, Kanai et al. 2001, Chen et al. 2002, Stroheker 
et al. 2004, Kitamura et al. 2005, Kuruto-Niwa et al. 2005). Data from these in 
vitro studies are hard to align as little is known about the metabolic capabilities 
for most cell based assay systems, whether required co-factors for receptors are 
expressed in those cells, and they do not take into account the potential for 
bioconcentration, all of which can have a significant bearing on the biological 
effect of an EDC (Folmar et al. 2002, Murk et al. 2002). Few in vivo studies have 
investigated the BPA alternatives, but BPS has been reported to affect egg 
production, plasma steroid concentration and decreased hatching and survival in 
zebrafish from 10 µg/l (Ji et al. 2013, Naderi et al. 2014). 
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The data presented on the toxicity and estrogenic activity for bisphenols 
demonstrates that care should be taken when searching for BPA alternatives. 
BPF (Gardziella 2000) is a common replacement for BPA, but here we show that 
both chemicals share a similar level of toxicity and in vivo estrogenic potency, 
with other possible off target effects not seen for BPA. BPAF is not yet used as 
widely as BPF or BPS in BPA-free materials, and given its estrogenic and toxicity 
potencies it is not an appropriate alternative to BPA. BPS, the most commonly 
used monomer in thermal paper and BPA-free replacement products 
(Biedermann et al. 2010, Liao et al. 2012) has been reported to share a similar 
potency to BPA based on in vitro studies. Our data for zebrafish would suggest 
that this is not the case in vivo. There is, nevertheless, some remaining concern 
regarding BPS because of its reported resistance to degradation and persistence 
in the environment (Ike et al. 2006, Sakai et al. 2007, Danzl et al. 2009).  
The mechanisms of action of BPA have been relatively well studied when 
compared with for its alternatives. BPA appears to be mechanistically pleiotophic.  
The best established mechanism is through its ability to bind to the ERs and 
modify gene expression, albeit at effective concentrations several orders of 
magnitude lower than that of 17β-estradiol (Gould et al. 1998, Matthews et al. 
2001, Gertz et al. 2012). BPA may exert some effects through rapid nongeonomic 
pathways independently of classic ER signalling (Vasudevan et al. 2001, Alonso-
Magdalena et al. 2005, Bouskine et al. 2009). BPA also has the ability to bind 
strongly to the estrogen related receptor ERRγ, while E2 by contrast is inactive 
on that pathway (Takayanagi et al. 2006, Okada et al. 2008). These ERRs can 
bind to EREs in ER target genes, inducing translational responses (Huppunen 
and Aarnisalo 2004), and it is therefore theoretically possible that fluorescence 
response observed in ERE-TG fish resulted partly from ERR induced promotion. 
Co-exposure of ERE-TG zebrafish larvae to ICI 182 780 however (an ER 
antagonist) abolished the GFP expression observed in all tissues for all chemicals 
tested (Fig. 6) strongly supporting the hypothesis that when activation of genes 
is induced via the ERE promoter for BPA, BPF, BPAF and BPS this activation is 
mediated through the classical ERs. It should be recognised however that the 
ERE-TG model only indicates presence of activity through ERE based gene 
activation, so cannot give evidence for nongeonomic effects. Also rapid signalling 
effects may have interactive effects with more traditional nuclear hormonal 
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receptor pathways (Vasudevan et al. 2001, Farach-Carson and Davis 2003). 
Whether these bisphenol analogues have effects on estrogen signalling either 
directly or indirectly through androgen and thyroid signalling pathways also 
warrants investigation. (Stroheker et al. 2004, Kitamura et al. 2005, Higashihara 
et al. 2007, Cabaton et al. 2009, Molina-Molina et al. 2013). 
Potency differences between the bisphenols may also relate to differences in their 
bioavailability. Albeit a limited analysis, we show uptake differed between some 
of the bisphenol analogues (Table 3). As an example there was an approximate 
4-fold higher uptake of BPF in exposed fish compared with uptake into BPA 
exposed fish (both with 1000ug/l exposure). In contrast uptake of BPAF was 
measured as possessing a similar BCF as BPA (5.3 and 4.5 respectively). BPS 
uptake concentration was similar to that for BPA; however, exposure 
concentrations were much higher for BPS, leading to a much lower BCF of 0.067. 
The similarities in the BCF of BPAF and BPA would suggest their marked 
differences in comparative estrogenic potency (10-fold higher for BPAF) 
predominantly relates to their comparative interactions with the ER(s). However 
the differences in the bioavailability of BPF and BPS compared to BPA, also 
appears to indicate that uptake may play a key role in the response of zebrafish 
to these chemicals. We do however emphasise that these analyses are based on 
whole body burdens of the bisphenols and do not consider comparative uptake 
into the different body tissues that could also affect interpretations on their 
comparative potency estimates. 
Our findings show all the bisphenols tested are toxic to fish, albeit at 
concentrations that exceed those in most, if not all, environmental compartments. 
Potency in toxicity and estrogenic activity varied across the bisphenols tested and 
these probably relate principally to ability of individual chemicals to bind to and 
activate the ERs, albeit difference in uptake and bioconcentration observed may 
play a role for some analogues. Co-treatment with an ER inhibitor indicated that 
estrogenic activity of BPA and all the analogues tested in our ERE-TG zebrafish 
was mediated by the classical ER(s) signalling pathway. 
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Abstract 
Bisphenol A was originally developed as a synthetic estrogen and inadvertent 
environmental exposure to BPA through its subsequent use in plastics and resins 
in various consumer products has been associated with adverse health effects in 
humans, which include heart defects. There is lack of agreement on its 
mechanism(s) of action, some of which stem from comparisons between in vivo 
and in vitro test systems. In vivo metabolic activation of BPA produces a 
metabolite 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) that is reported 
to be up to 1000-fold more potent as an estrogen than BPA. 
We investigated the comparative estrogenic effects of BPA and MBP in a 
transgenic, estrogen responsive (ERE-TG) zebrafish and applied a targeted 
morpholino approach to knockdown the three fish estrogen receptor (ERs) 
subtypes to determine the ER signalling pathways. We then assessed if BPA’s 
estrogenic stimulation of heart valves in ERE-TG fish had cardiovascular 
functional consequences in zebrafish larvae at 5 and 14 dpf. 
We demonstrate that the atrioventricular valves and the bulbus arteriosus were 
the primary target tissues for both BPA and MBP in the ERE-TG zebrafish. MBP 
was approximately 400-fold more potent than BPA. ER knock down with 
morpholino indicated that the signal transduction in the heart for both BPA and 
MBP were both mediated via an estrogen receptor 1 (esr1) dependent pathway. 
Measures of cardiovascular function, including blood flow/velocity, beat rate, 
stroke volume and blood vessel diameter at 5dpf and 14dpf showed no signs of 
adverse effects compared with controls except at the highest exposure 
concentration tested (2500 µg/l) where variation in atrial:ventricular beat rate ratio 
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was indicative of arrhythmia in 5dpf larvae and there was a significantly reduced 
heart beat rate in larvae at 14dpf. 
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Introduction 
Bisphenol A (BPA) originally developed as a synthetic estrogen (Dodds and 
Lawson 1936) has subsequently been used as a monomer for the production of 
plastics and resins. These materials are used in a wide range of consumer 
products, including plastic drink bottles, food and beverage can linings, thermal 
paper and dental sealants (Geens et al. 2011). BPA can leach from these 
materials and is taken up into the human body either via dermal contact or via 
the gut through ingestion. BPA enters aquatic environments predominantly 
through effluent discharge from wastewater treatment plants (WWTP), but also 
directly from manufacturing plants, landfill leachate, and degradation of plastic 
litter (Corrales et al. 2015). Concentrations of BPA in the aquatic environment are 
generally below 1µg/l (Flint et al. 2012) but reported up to 21, 19 and 12µg/l in 
the Netherlands, Japan and USA, respectively (Flint et al. 2012). Much higher 
concentrations of BPA have been reported in paper-mill effluent (370 µg/l) and in 
landfill leachates (17, 200 µg/l) (Yamamoto et al. 2001, Fukazawa et al. 2002). 
BPA possesses the ability to bind to and activate the estrogen receptor(s), 
mimicking the actions of the endogenous estrogen 17β-estradiol. Various 
adverse health effects have been attributed to BPA in mammals, including 
decreases in sperm production and fertility (Li et al. 2010, Liu et al. 2013, Zhang 
et al. 2013), polycystic ovarian syndrome (Signorile et al. 2010, Vo et al. 2010), 
obesity and diabetes (Rubin et al. 2001, Alonso-Magdalena et al. 2006) and 
cancer (Weber Lozada and Keri 2011, Song et al. 2015, Seachrist et al. 2016). 
Epidemiological data have indicated positive correlations between BPA exposure 
in human populations and various risk factors pertaining to cardiovascular 
disease (Melzer et al. 2010, Bae et al. 2012, Melzer et al. 2012, Shankar and 
Teppala 2012). BPA however has not been proven to be the causative factor in 
these heart disease conditions. Nevertheless, these reports have led to 
approaches by government bodies to regulate the use and discharge of BPA. 
Several experimental studies have reported effects of BPA on the cardiovascular 
system in rodents, in vitro cell lines and ex vivo hearts. Lifelong exposure to BPA 
(0.5 – 5 mg/kg/day) in mice was shown to modify cardiac structure and function 
with sex specific effects (Patel et al. 2013). In males there was concentric 
remodelling, whereas in females there were increases in systolic and diastolic 
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blood pressure. There was also modified calcium handling protein expression, 
suggesting increased and reduced calcium mobility in males and females 
respectively, supporting changes in cardiac function. Further female specific 
effects reported include arrhythmia, which is exacerbated in the presence of 17β-
estradiol (Yan et al. 2011, Belcher et al. 2012, Poidatz et al. 2012, Yan et al. 
2013). This arrhythmic effect was abolished when animals were treated with an 
ER antagonist, suggesting mediation via ER signalling (Yan et al. 2011). BPA has 
been shown to decrease atrial contraction rate and force in ex vivo rat hearts at 
exposure concentrations of 10-6 and 10-4 M (Pant et al. 2011). 
Several studies have shown that BPA can affect the function of ion channels in 
the cardiovascular system including via activation of Ca2+/voltage-sensitive K 
channels (Maxi-K) (Asano et al. 2010), blocking of human heart sodium channels 
(O'Reilly et al. 2012), inhibition of L-type Ca2+ channels in mouse ventricular 
myocytes (Deutschmann et al. 2013) and inhibition of T-type Ca2+ channels in 
HEK 293 cells (Michaela et al. 2014). Acute exposure to BPA (dose and exposure 
period) has been shown to decrease ventricular conduction velocity and increase 
action potential duration in female hearts, however the underlying mechanisms 
for these effects was not explored (Posnack et al. 2014). Most of the studies on 
the effects of BPA on the heart have been conducted for exposures that far 
exceed those with environmental relevance. There is also a lack of knowledge 
for effects of BPA on heart development in vivo and whether this has any 
functional consequence.  
The molecular mechanisms for BPA effects in the heart are not well established.  
BPA has been demonstrated to act through a variety of different mechanisms 
including via the nuclear estrogen receptors ERα and ERβ (three isoforms exist 
in fish ERα, ERβ1 and ERβ2) (Gaido et al. 1997, Gould et al. 1998, Cosnefroy et 
al. 2009, Delfosse et al. 2012) and the orphan receptor Estrogen Related 
Receptor γ (ERRγ). ERRγ is thought to be capable of binding to the Estrogen 
Response Element (ERE) of estrogen responsive genes, however, activation of 
ERRγ by BPA displays a greater potency than for E2. BPA may also bind the 
androgen (Sohoni and Sumpter 1998, Fic et al. 2014) and thyroid (Moriyama et 
al. 2002) receptors and has also been reported to be capable of interacting with 
membrane bound receptors to induce rapid cell responses, for conditions 
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associated with breast cancer, and the pancreas, pituitary, cerebellar cortex and 
heart (Quesada et al. 2002, Zsarnovszky et al. 2005, Gao et al. 2013).  
ERs occur in a very wide range of body tissues but the abundance of different 
isoforms varies and this can affect the cell sensitivity to a particular ligand (Böttner 
et al. 2014). In mammalian models moderate to high level expression of ERα 
occurs in uterus, testis, pituitary, ovary, kidney and epididymis, while higher 
expression for ERβ occurs in prostate, ovary, lung, bladder, brain, uterus and 
testis (Kuiper et al. 1998). In the heart, both ER subtypes occur in rodent and 
human cardiomyocytes (Grohé et al. 1997, Böttner et al. 2014). In fish too, ER 
subtype localisation in body tissues varies.  In the fathead minnow (Pimephales 
promelas) the different ERs were all expressed in brain, pituitary, liver, gonad, 
intestine, and gill; esr1 and esr2b were expressed predominantly in the liver, while 
esr2a was expressed predominantly in the intestine (Filby and Tyler 2005). 
Expression of the ER subtypes can also vary during ontogeny in fish (Halm et al. 
2004). 
Responses to BPA in vivo are not always supported by in vitro studies. A possible 
explanation for this in mammals involves the metabolic activation of BPA that 
occurs in vivo producing a metabolite, 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-
ene (MBP) that is more potent as an estrogen compared with BPA (Yoshihara et 
al. 2004). This metabolic activation may also help to explain the non-monotonic 
response sometimes observed for BPA exposure (Lagarde et al. 2015). 
Incubation of BPA with S9 liver fractions from mouse, monkey and humans all 
produce metabolites more potent as estrogens than the parent BPA compound 
and are thought to be MBP (Yoshihara et al. 2004). In rats and medaka (Oryzias 
latipes) estrogenic effects of MBP in vivo are between 400-1000 times greater 
than for BPA (Ishibashi et al. 2005, Nagae et al. 2005, Yamaguchi et al. 2005, 
Okuda et al. 2010). 3D modelling of human ERs and binding strength 
assessments for BPA, MBP and 17β-estradiol suggest that the increased spacing 
between the phenolic rings in MBP compared with BPA (see Table 1) allows key 
amino acid contacts with the ERs that are important in binding of E2 by these 
receptors (Baker andChandsawangbhuwana 2012). Despite these findings MBP 
has not yet been measured as a natural in vivo metabolite in any previous study 
and its presence is likely to be at very low concentrations. There is little 
information  on  the  metabolism  of  BPA  to  MBP  in vivo  in  fish,  but one report  
123 
 
 Table 1.  Bisphenol A, MBP and EE2 chemical structures 
Compound Structure 
BPA 
2,2-Bis(4-hydroxyphenyl)propane 
 
MBP 
4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene 
 
EE2 
17α-ethinylestradiol 
 
 
 
indicates an inability to produce the conjugated metabolite bisphenol a glucuronic 
acid in juvenile trout (Bjerregaard et al. 2008). 
In this study we aimed to more clearly understand the specific signalling 
mechanisms by which BPA acts in the heart, specifically if a single ER subtype 
was responsible. To do this we exposed fish to estrogenic chemicals in 
combination with morpholino injection specific to individual ER subtypes to 
knockout function. We also investigated if the potent BPA metabolite MBP, 
described in mammalian cells was estrogenic and if it demonstrated a similar 
tissue specific response to the parent compound in our ERE-TG fish. If metabolic 
activation is a possible mode of action for BPA we hypothesised that we would 
see a similar GFP induction pattern but at a much lower concentration. We also 
aimed to determine if we could detect MBP in larvae after exposure to BPA to 
provide evidence this metabolite is produced in vivo. Finally we set out to 
establish whether there were subsequent detectable effects on heart function in 
juvenile fish as a result of early life developmental exposure to BPA. 
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Materials and methods 
Fish source, culture and husbandry 
Adult zebrafish for the provision of embryos were kept in aquaria (37.5L) at the 
University of Exeter in mixed-sex stock tanks, as described in (Paull et al. 2008). 
All zebrafish embryos used in this study were obtained from 
tg(ERE:Gal4ff)(UAS:GFP) adults, a transgenic zebrafish developed at the 
University of Exeter (Lee et al. 2012). Fish were kept on a 12/12 light/dark cycle. 
Fish were allowed to breed naturally and eggs were collected in egg collection 
chambers approximately 1h post-fertilisation (hpf). Eggs were sorted to remove 
unfertilised and non-viable embryos prior to use. 
Chemical preparations.  
Bisphenol A (purity >99%) and 17α-Ethinylestradiol (≥98%) (EE2) were 
purchased from Sigma-Aldrich Company Ltd. (Gillingham, UK). 4-methyl-2,4-
bis(4-hydroxyphenol)pent-1-ene (MBP) was synthesised by Mark Wood at the 
University of Exeter and purity of the compound was certified as described in 
(Cipelli et al. 2014). All stock chemicals were dissolved in ethanol in glass bottles 
and diluted in ethanol to the required stock concentrations prior to dilution in 
embryo test water. All tests were performed using reconstituted purified water in 
accordance with ISO (International Organisation for Standardisation) guideline 
7346-3. Chemicals in ethanol stock were dissolved in test water to give a final 
ethanol concentration of 0.01%. Solvent controls contained the equivalent of 
ethanol in ISO water without chemical. 
Tissue responses to chemical treatments 
All exposures were conducted in a temperature controlled laboratory held at 
28 ± 1 oC, under semi-static conditions. To determine tissue differences in 
response to BPA, MBP and EE2 embryos were exposed to these chemicals at a 
series of different concentrations or to solvent control. Concentration ranges for 
EE2 were 2.0 and 20 ng/l, BPA 10, 100 and 1000 µg/l, and MBP 0.025, 0.25 and 
2.5 µg/l. Each experimental group consisted of 20 embryos exposed in 100 ml of 
ISO water and each treatment group was run in triplicate. The exposures were 
conducted from 0 hpf to 120 hpf. At the end of the exposure period 120 hpf old 
larvae were processed for fluorescent imaging analysis. 
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To investigate specific responses in the hearts of developing zebrafish to BPA 
and its putative metabolite MBP a similar exposure regime was undertaken as 
described above across a narrower chemical dosing range. In order to better 
visualise the location of GFP expression in the heart, larvae were stained with 
MF-20 monoclonal antibody (Developmental Studies Hybridoma Bank, University 
of Iowa, Iowa, USA), which stains cardiac myosin.  
Embryos were anaesthetized in 0.016% tricaine and fixed for 4 hours at room 
temperature using 4% PFA in Phosphate Buffered Saline (PBS). Following 
fixation, embryos were rinsed in PBS with 0.5% TX-100 (PBSTx). Embryos were 
then dehydrated in a series of graded methanol concentrations, before being 
rehydrated and further permabilised using a Proteinase K digestion. Embryos 
were rinsed in PBSTx and placed in a blocking solution (1% skim milk with 1% 
DMSO in PBSTx) for 3 hours at room temperature, then incubated in 1:20 
monoclonal mouse antibody MF-20 and 1:1000 rabbit anti-GFP antibody (ams 
Biotechnology) in blocking solution overnight at 4oC. After rinsing in PBSTx 
embryos were incubated for 4 h at room temperature in the dark with 1:300 
AlexaFluor 546 goat anti-mouse IgG secondary antibody and AlexaFluor 488 
goat anti-rabbit IgG in antibody buffer as before. This protocol allowed 
visualization of cardiac muscle in red and GFP in green. Prior to heart dissection, 
embryos were rinsed in PBSTx. In order to visualise hearts most effectively they 
were dissected from fixed and stained zebrafish using tungsten wire. 
Morpholino analysis and injection 
Esr1 morpholino (MO) was designed against the zebrafish esr1 translational start 
site, with the sequence 5’-AGGAAGGTTCCTCCAGGGCTTCTCT-3’. MOs for 
esr2a and esr2b have the sequences 5’-AGCTCATGCTGGAGAACAC 
AAGAGA-3’ and 5’-GAGTTCAGAGCTGTCGCATCAGTAA-3’, respectively. 
These MOs were obtained from GeneTools, LLC (Philomath, Oregon, USA). 
Each MO was used at a dilution of 1:4 of a 1mM stock, with 2nl of solution injected 
into the yolk proximal to the blastomeres of the embryo at the one- to four-cell 
stage using a microinjector (INTRACEL, PICOSPRITZER®III). Fluorescence 
imaging of MO injected and chemically exposed larvae was conducted at 72 hpf. 
Timing of the chemical exposures was slightly shorter that to those conducted 
previously as pilot studies for the morpholino demonstrated that for a combination 
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of all three esr morpholinos the maximum inhibitory effect (fluorescence intensity) 
occurred up to 72hpf.  
Image analysis of Tg(ERE:Gal4ff)(UAS:GFP) zebrafish  
For fluorescence intensity measurements live Tg(ERE:Gal4ff)(UAS:GFP) larvae 
were anesthetised with 0.016% tricane, mounted in 3% methylcellulose in ISO 
water and placed onto a glass-bottom 35 mm dish (MatTek, Ashland, MA, USA). 
All larvae were observed in lateral view and images were obtained using a Zeiss 
Axio Observer.Z1 equipped with an AxioCam Mrm camera (Zeiss, Cambridge, 
UK). For comparison of chemicals and MO injected larvae all photographs were 
taken using the same parameters under a X10 objective; images of zebrafish 
used for cardiovascular analysis were taken using the same parameters under a 
X20 objective. Exposure times adopted for image capture were dependent on the 
stage of the larvae and the body tissue studied as the response varied in different 
target organs. Exposure time for image capture was kept consistent for specific 
regions across the fish body. Photographs were processed using the Axiovision 
Imaging software and fluorescence quantification was calculated using the 
ImageJ software (http://rsb.info.nih.gov/ij/). For each picture intensity was 
measured as the mean grey value of all the pixels within a region of interest, and 
the region of interest was kept consistent between individuals. Background was 
subtracted using the ImageJ rolling ball algorithm which removes any spatial 
variations of the background intensities as described in (Sternberg 1983). 
Confocal microscopy was used on stained dissected hearts. The hearts were 
mounted in 0.7 % agarose (low melting point) and ISO water was added once the 
agarose was set to cover them. Hearts were photographed under X20 
magnification on a confocal-laser scanning microscope (ZEISS LSM510). Images 
were reconstituted using LSM510 Meta. 
Cardiovascular functional analysis 
5dpf zebrafish were maintained in ISO water in the presence or absence of BPA 
at 28oC ± 1 oC as described for the previous expression studies. For zebrafish 
exposed for 14 dpf larvae were raised in 250ml test medium with a light aeration 
to reduce risk of oxygen depletion and build-up of ammonia from the breakdown 
of food waste. Fry were fed on a microencapsulated diet (ZM Advanced Fry feed, 
127 
 
ZM Ltd, Hampshire, UK) from 5 dpf. All uneaten food was cleared on a daily basis 
and exposure water was changed on a semi-static basis. 
Following chemical exposure, larvae were anaesthetised (0.016% tricaine) 
individually, then transferred into low melting point agarose (10 mg/mL in the 
same tricane) before being placed in a total volume of 80 μL in a single well 
created by a press-to-seal silicon isolator (Sigma-Aldrich, Poole, UK) on a clear 
microscope slide. The orientation of the larva was then adjusted so that it lay on 
its side with its head to the left. Larvae were left for one minute before observation 
to acclimatise to handling; previous studies have demonstrated a highly 
reproducible fluctuation in CV activity across various treatments shortly after 
mounting (Parker et al. 2014). The slide was then transferred to an inverted light 
microscope (Leica DM IRB, Leica Microsystems UK Ltd., Milton Keynes, UK, 5 × 
objective) fitted with two high speed video cameras. One camera was positioned 
to capture the whole heart at 30 frames per second (fps. Grasshopper® GRAS-
50S5C-C, Point Grey, Richmond, Canada), and the second to capture the dorsal 
aorta, caudal to the swim bladder, at 120 fps (Grasshopper® GRAS-03K2M-C, 
Point Grey, Richmond, Canada). Both cameras were independently focused on 
their respective regions of interest to ensure optimal image quality, and set to 
record simultaneously for 5 min. 
To determine atrial and ventricular beat rates (ABR and VBR respectively), heart 
videos were analysed using MicroZebraLab™ (v3.5, ViewPoint, Lyon, France). 
This software detects changes in pixel density associated with cardiac muscle 
contraction and chamber filling, and registers this as contractions of the cardiac 
muscle in beats per minute (bpm). Analysis involved selecting two clear (with little 
overlying pigmentation) tracking zones over the atrium and the ventricle. From 
this, beat frequencies were provided for each chamber independently to allow a 
global heart rate output and also the detection of certain arrhythmias, e.g. A–V 
decoupling. Normally stroke volume is precisely calculated using the difference 
between end systolic and end diastolic volumes. However, using this system a 
surrogate measure of cardiac stroke volume (SSV) can be calculated by dividing 
the dorsal aorta flow rate (in nL/s), by the VBR per second (bpm/60). 
Blood flow videos were analysed using ZebraBlood™ (v1.3.2, ViewPoint, Lyon, 
France), which also operates by detecting changes in pixel density and combining 
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them with vessel diameter to generate a flow rate in nl/s for every frame. An area 
of the blood vessel was selected with care to exclude other neighbouring 
capillaries in which blood flow would interfere with the assessment of the main 
vessel. The software detects the motion of erythrocytes within the tracking area 
to provide a measure of blood flow. In addition vessel diameter was provided 
simultaneously at 10 cross-sections that were subsequently averaged to provide 
one value per 20 s period. 
Measured chemical exposure concentrations 
Sample preparation: 
For water samples, 1 mL of test media for concentrations 1000 µg BPA/l and 
0.25, 2.5 and 25 µg MBP/l was removed from the tank to a glass vial and 1 mL of 
HPLC-grade acetonitrile was added. Aliquots were vortex-mixed and diluted with 
mixture of HPLC-grade acetonitrile and water (1:3 v/v) before LC-MS/MS 
analysis. 
For measurement of uptake into the exposed fish, a parallel set of replicates was 
run alongside those for fluorescence analysis. In addition replicates for fish 
exposed to 25 µg MBP/l were also run for uptake analysis. Twenty zebrafish 
larvae, previously anaesthetised with 0.5 g/l solution of tricaine (non-
recoverable), in 300 μL of test solution were transferred to a 96 well 
MultiScreenHTS BV Filter Plate (Merck Millipore, Ireland). The test solution was 
removed under vacuum and larvae were washed with culture water (containing 
tricaine), to eliminate residual test solution and transferred in 300 μL of pure water 
to a 96-well plate (Porvair Sciences, UK). Then 300 μL HPLC- grade acetonitrile 
was added and samples were homogenised in their wells for 3 minutes to achieve 
extraction of analytes LCMS grade water (900ul) was added to each well and 
after mixing the plate was centrifuged at 4000 rpm for 30min. Supernatants from 
each well were transferred to a 96-well plate and removed for analysis. 
LC-MS Method 
Measurement of BPA and MBP were performed using Surveyor MS Pump Plus 
HPLC pump with HTC PAL autosampler coupled to TSQ Vantage triple 
quadrupole mass spectrometer equipped with heated electrospray (HESI II) 
source (all ThermoFisher Scientific, Hemel Hempstead, UK).  
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Chromatographic separation was achieved using reversed-phase, 3 µm particle 
size, C18 Hypersil GOLD column 50 mm × 2.1 mm i.d. (Thermo Scientific, San 
Jose CA, USA). Analytes were separated using a linear gradient of (A) water and 
(B) methanol. The initial conditions for the gradient consisted of 10% solvent B, 
which was increased to 100% in 4.5 min and maintained for 1 min before 
returning to the initial 10% B. The flow rate was 500µL/min. Temperature of auto-
sampler was set at 8˚C while column was kept at ambient room temperature.  
HESI probe was operating in the negative mode; an ion-spray voltage of -4.0 kV 
was applied. The heated capillary temperature was set at 275 °C and the 
vaporizer temperature was 60 °C. Nitrogen was employed as sheath and 
auxiliary gas at a pressure of 30 and 5 arbitrary units, respectively. The argon 
CID gas was used at a pressure of 1.5 mTorr and the optimum collision energy 
(CE) for each transition was selected. Quantification of the target compounds was 
performed by monitoring two characteristic multiple reaction monitoring (MRM) 
transitions (Table 2). 
 
Table 2. LC-MS quantification of the target compounds performed by monitoring 
two characteristic multiple reaction monitoring (MRM) transitions 
Compound 
Parent ion 
(m/z) 
Product ion 
(m/z) 
Collision 
energy (eV) 
BPA 227.1 
212.1 20 
133.1 28 
MBP 267.1 
133.1 23 
117.0 49 
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Data analysis 
Fluorescence data are expressed as mean fold induction above the solvent 
control ± standard error of the mean (SEM). Data quoted in the text, or shown 
graphically, for cardiac function parameters are presented as the mean ± SEM 
over the 5 minute observation period. Data for A:V beat ratio at 5 dpf was 
separated into 0.5 minute time segments to clearly visualise observed 
fluctuations in A:V ration in exposure groups. Significant differences between 
groups were analysed using a one-way ANOVA, and a Tukey posthoc test was 
carried out where significant differences were detected (P-value < 0.05). A 
Kolmogorov-Smirnov test was used to compare the distribution curves between 
treatments for A:V beat rate data and differences were reported as significant if 
p < 0.05.-Statistical analyses of data were performed in IBM SPSS Statistics 22.   
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Results 
Measured exposure concentrations 
Chemical analysis of working solutions was determined to confirm test 
concentrations of BPA and MBP at the start of the exposures. Bisphenol A was 
determined to be within 20% of nominal concentrations, indicating accurate 
dosing. The analytical method could not detect MBP at a concentration of 
0.25 µg/l as this was below the limit of detection. However accurate dosing 
(±20%) was confirmed at 2.5 and 25 µg MBP/l. No chemical was detected in 
control exposure medium. 
Uptake and metabolism of BPA in exposed embryos 
Larvae exposed to BPA at a concentration of 1000 µg/l were determined to have 
an internal load of 2.3 ± 0.17 ng BPA/larvae, equating to an estimated 
bioconcentration factor (BCF) of 2.3 (Table 3). MBP was not detected in 5 dpf 
zebrafish embryos exposed to BPA. Similarly in larvae exposed to MBP (0.25 µg/l 
and 2.5 µg/l) MBP was not detected with the analytical method applied. MBP was 
detected in larvae exposed to the highest MBP concentration (25 µg/l) with an 
internal concentration of 0.66 ± 0.16 ng MBP/larvae, equating to a BCF of 26.4. 
 
Table 3. Measured exposure water and internal (whole body) concentration of 
BPA and MBP in 120 hpf zebrafish larvae. Data for zebrafish larvae are the mean 
of 3 replicates, each replicate consisting of 20 larvae, (SEM in brackets). Larvae 
exposed to BPA were assessed for internal concentration of BPA and MBP, 
larvae exposed to MBP were assessed for internal concentration of MBP only. 
 Nominal 
external 
concentration 
(µg/l) 
Measured 
external 
concentration 
(µg/l) 
Concentration 
BPA per larvae 
(ng/larvae) 
Concentration 
MBP per larvae 
(ng/larvae) 
SC 0.0 <LOQ <LOQ <LOQ 
BPA 1000 980.3 (0.12) 2.3 (0.17) <LOQ 
MBP 0.25 <LOQ  <LOQ 
 2.5 2.1 (0.15)  <LOQ 
 25 28.2 (0.53)  0.66 (0.16) 
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Tissue expression of GFP in response to BPA, MBP and EE2 in ERE-TG 
zebrafish larvae 
Some ERE-TG zebrafish were observed to show detectable GFP expression in 
the otic vesicle in the absence of chemical treatment (Fig. 1). This fluorescence 
was not inducible by the chemicals tested, and had a similar level of occurrence 
across treatments. No GFP fluorescence was detected in other tissues of 
unexposed control larvae. 
There was no significant induction of GFP as detected by fluorescence in ERE-
TG zebrafish exposed to 10 µg/l BPA (Fig 1). At 100ug BPA/l there was a 
significant increase in GFP fluorescence in the heart (3.2 ± 0.7 fold above 
control). Exposure to 1000 µg BPA/l resulted in a GFP signal in the heart, liver 
and tail region, with fold increases above control of 25.7 ± 2.0, 55.6 ± 5.5 and 
10.4 ± 1.8, respectively. Fluorescence in the tail was associated with individual 
muscle myotubes expressing in a mosaic pattern and in the corpuscles of 
stannius. 
Exposure to MBP resulted in a very similar pattern of fluorescence expression, to 
that for BPA, but MBP was considerably more potent. A response in the heart 
was detected at an MBP concentration of 0.25 µg/l (3.5 ± 0.6 -fold increase above 
control) increasing to 32.6 ± 1.6 fold above controls at 2.5 µg MBP/l. At 2.5 µg 
MBP/l fluorescence was also detected in the liver and tail regions at levels of 
78.4 ± 13.1 and 12.1 ± 0.9 fold above the control, respectively. 
Responses to EE2 differed to the phenolic compounds. Here the most responsive 
tissue was the liver, at an exposure of 2 ngEE2 /l (8.6 ± 2.1 fold increase above 
controls). At an exposure of 20 ng EE2/l fluorescence was detected in the heart 
(9.6 ± 0.9 fold above controls), liver (128.2 ± 16.3 fold above controls) and tail 
regions (13.2 ± 0.6 fold above controls). Responses to EE2 were much more 
pronounced in liver and somites compared with the heart. 
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Figure 1. (A) Representative images of 120 hpf ERE-TG zebrafish larvae for 
controls and exposures to 1000µg BPA/l, 2.5 µg MBP/l and 20 ng EE2/l (images 
for lower exposure concentrations are not shown); (B-D) GFP induction in 120 
hpf ERE-TG zebrafish larvae exposed to test chemicals (BPA and MBP 
concentrations indicated in µg/l, EE2 concentrations in ng/l) is presented as fold-
increase above controls for the (B) heart, (C) liver, (D) tail somites. 
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Concentration dependent chemical responses in dissected hearts  
To better identify regions in the heart responding to BPA and MBP, zebrafish 
hearts were stained to identify myocardium tissue and dissected out for 
microscopy analysis (Fig. 2). This approach identified the main GFP expression 
domains within the heart as the atrioventricular valve and the bulbus arteriosus 
structural features that are essential for regulating blood flow in fish. At the higher 
exposure concentrations (1000 µg/l for BPA and 2.5 µg/l for MBP) GFP 
fluorescence was seen to extend from the atrioventricular value throughout the 
ventricular tissue. No evidence was observed to indicate that the overall 
morphology of valves or bulbus arteriosus was affected by the chemical 
treatments. 
Concentration dependent responses in the heart were observed for both BPA 
and MBP as detected by fluorescence intensity. Equivalent fold inductions above 
control for BPA and MBP occurred at concentrations of 1000 µg/l and 1 µg/l 
respectively (fold increase above control 23.6 ± 2.6 and 23.4 ± 3.5 respectively) 
giving MBP a relative potency of 1000 times greater than BPA for effects on the 
heart valves. 
Estrogen Receptor signalling pathways for BPA and MBP in ERE-TG 
zebrafish 
To determine which ER(s) was responsible for the tissue specific responses to 
the test chemicals, we treated the ERE-TG zebrafish larvae with morpholinos for 
the different ER subtypes in the presence of BPA, MBP and EE2.  
Non-injected fish exposed to BPA, MBP and EE2 at 1000 µg/l, 2.5 µg/l and 
20 ng/l respectively, showed significant increases in GFP signal in the heart, liver, 
anterior trunk and tail regions (Fig 3). Injection with the morpholino for esr1, 
induced a suppression of GFP signal in the heart, liver and trunk, but there was 
no observed suppression of GFP in the tail region for these morphants. GFP 
expression was reduced for all chemical exposures in the heart and liver to levels 
that did not differ from controls (i.e. complete suppression of the GFP). GFP was 
reduced in the trunk region in fish exposed to BPA. However, although reduced 
MBP and EE2 exposed fish still demonstrated significantly higher fluorescence 
than unexposed fish. 
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Figure 2. Composite z stacks of hearts dissected from 120 hpf ERE-TG zebrafish 
larvae exposed to a gradient of concentrations of BPA (A) and MBP (B). Hearts 
were immunostained with MF-20 to identify cardiac tissue. GFP induction 
(fluorescence) was measured and quantified using fluorescence microscopy and 
image analysis in zebrafish hearts for BPA (C) and MBP (D) exposures.  
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Figure 3. (A) Images of ERE-TG zebrafish larvae at 72hpf for controls and larvae 
exposed to 1000 µg BPA /l, 2.5 µg MBP/l and 20 ng EE2/l injected with 
morpholinos against esr1, or esr2a & esr2b at 1-4 cell stage; (B-E) Fluorescence 
response in 72 hpf ERE-TG zebrafish larvae exposed to BPA, MBP and EE2 in 
combination with the injected morpholino(s) against esr1 or esr2a & esr2b was 
measured by fluorescence microscopy and image analysis and expressed as fold 
* 
* 
* 
* * * 
* 
* 
* 
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increase above controls for target tissues; (B) heart, (C) liver, (D) trunk muscle, 
and (E) tail somites (* indicates a significant difference from relevant control 
treatment p=<0.05). 
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In contrast with the esr1 morphants, zebrafish injected with morpholinos for esr2a 
and esr2b still exhibited high induction of GFP in the heart when exposed to the 
estrogenic chemicals (BPA, MBP and EE2). There was no significant increase 
observed in GFP fluorescence for BPA, MBP and EE2 exposed morphants in the 
trunk, tail and liver regions when compared to the controls, thus, indicating that a 
combined knockdown of esr2a and esr2b may prevent estrogen signalling in 
these tissues. 
Effects of BPA on heart function in 5 and 14 dpf zebrafish 
To assess if the ER signalling responses in atrioventricular valves and bulbus 
arteriosus for BPA translated to any significant effects on heart function and blood 
flow, we used non-invasive video analysis of the heart and dorsal aorta to 
measure multiple cardiovascular endpoints; including beat rate, atrial:ventricular 
beat ratio, blood flow/velocity, stroke volume and blood vessel diameter. These 
studies were conducted on fish at 5dpf and 14dpf for exposures to both 1000 µg 
BPA/l, and 2500 µg BPA/l. For the 5dpf fish GFP induction in the heart was 
8.9 ± 1.2 fold above controls for 1000 µg BPA /l and 10.8 ± 1.4 fold above 
controls for 2500 µg BPA /l and for the 14dpf fish, 50.7 ± 11.5-fold above controls 
for 1000 µg BPA/l and 44.7 ± 7.7- fold above controls for 2500 µg BPA/l (Fig. 4). 
At 5 dpf, there were no significant effects of BPA exposure at either exposure 
concentration on heart beat rate, dorsal aorta diameter, speed or volume of blood 
flow (Fig. 5). There appeared to be a slight reduction in the surrogate stroke 
volume in fish treated with 2500 µg/l, however this was not statistically significant. 
No significant differences were found between the means of the atrium to 
ventricle (A:V) beat ratio values.  However, a Kolmogorov-Smirnov analysis which 
compares the distribution pattern around the means showed that the 2500 µg/l 
treatment group had a significantly different distribution from the control and 
1000 µg/l treatment group. This may be seen more clearly when measurements 
are split into time bins (Fig 5H), where A:V ratio fluctuates erratically throughout 
the 5 minute observation period for those fish. 
Pigment formation at 14 days precluded accurate detection of atrial and 
ventricular beat rates due to an inability to clearly visualise the heart. Heart beat 
rate however was calculated from the blood pulses of the dorsal aorta. There was 
no effect of BPA exposure on volume or speed of blood flow, dorsal aorta 
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diameter, or surrogate stroke volume (Fig 6). However, there was a significant 
reduction observed in the arterial beat rate of fish exposed to 2500 µg/l BPA. 
 
 
 
Figure 4. GFP induction (fluorescence) in hearts of ERE-TG zebrafish used for 
analysis of cardiac function at 5 dpf (A) and 14 dpf (B) measured as fold- increase 
above controls; (C) images of hearts in ERE-TG zebrafish exposed to 1000 and 
2500 µg/l BPA at 5 dpf and 14 dpf; 5 dpf control includes heart outline. 
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Figure 5. Measurements of cardiovascular function in 5 dfp zebrafish for control 
and BPA exposed fish; flow rate (A) and linear velocity (B) of blood through dorsal 
aorta, dorsal aorta diameter (C), surrogate stroke volume (D), atrial and 
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ventricular beat rates (E-F) and atrial to ventricular beat ratio (G); (H) splits data 
for atrial to ventricular beat rate into time segments for 30s  
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Figure 6.  Measurements of cardiovascular function in 14 dfp zebrafish for control 
and BPA exposed fish; dorsal aorta diameter (A), linear velocity (B) and blood 
flow (C), estimated beat rate based on arterial blood flow (D) and surrogate stroke 
volume (E) (* indicates a significant difference from relevant control treatment 
p=<0.05).  
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Discussion 
Several epidemiological studies have inferred that BPA exposure in humans is 
linked to an increased occurrence of cardiovascular disease (Melzer et al. 2010, 
Bae et al. 2012, Melzer et al. 2012, Shankar and Teppala 2012), however, there 
is little direct experimental evidence to support this and the mechanisms by which 
this may occur are not known. Here we used an ERE-TG zebrafish in combination 
with morpholino knockdown of ER subtypes to determine the signalling 
mechanisms for BPA and its metabolite MBP in the heart and across other body 
tissues and assessed for effects of early life exposure to BPA on subsequent 
heart function.  
Estrogenic responses to BPA occurred in the heart, liver, muscle somites and 
corpus stannius as identified previously in different lines of estrogen responsive 
transgenic zebrafish (Lee et al. 2012, Gorelick et al. 2014). In the heart, the 
atrioventricular valves and bulbus arteriosus, were the primary targets for BPA 
(Fig 2). BPA’s metabolite in mammals, MBP, showed similar patterns of 
estrogenic responses to BPA in the ERE-TG zebrafish, including for the heart 
valves and bulbus arteriosus, but with higher estrogenic potency.  Across the 
different responding body tissues, MBP was between 400-to 1000 times more 
potent than BPA, which is highly consistent with findings reported for relative 
estrogenic potencies in mammals in vivo (Ishibashi et al. 2005, Nagae et al. 2005, 
Yamaguchi et al. 2005, Okuda et al. 2010). For the heart the threshold 
concentration for induction of GFP was 100 µg/l for BPA, compared with 0.25 µg/l 
for MBP. It is possible that some effects for BPA in the ERE-TG zebrafish derived 
from its metabolism, however, we did not detect MBP in 5 dpf zebrafish exposed 
to BPA even at 1000 µg BPA/l. This may indicate that zebrafish larvae do not 
possess the effective liver function to metabolise BPA to MBP, or that the level of 
MBP in these larvae was below the detection limit for our analysis method. We 
were though able to detect MBP in larvae on exposure to the highest 
concentration of MBP tested (25 µg MBP/l). Thus, from our study we are not able 
to conclude whether or not zebrafish are able to metabolise BPA to MBP.   
Induction of GFP by both BPA and MBP was inhibited in the hearts of ERE-TG 
larvae injected with morpholinos against esr1 (Fig 3). In the body trunk muscle 
and liver, morpholinos against esr1 and against esr2a and esr2b together 
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inhibited GFP expression, whereas in the tail myotubes esr2a and esr2b 
morpholinos were effective, but the esr1 morpholino was not. These findings 
indicate different ER response pathways for the bisphenols in the different body 
tissues. Studies on a zebrafish liver cell line, transfected with different ERs found 
that BPA most strongly activated ERα (esr1), with some activation of ERβ2 
(esr2a) and no detectable effect on ERβ1 (esr2b) (Cosnefroy et al. 2012). It is 
possible that the preferences indicated for different ERs could lead to different 
chemicals activating ERs preferentially in specific tissues, leading to the differing 
response patterns observed. In most studies in mammals, it has been indicated 
that BPA preferentially binds to and activates ERβ (Kuiper et al. 1997, Matthews 
et al. 2001, Yoshihara et al. 2004, Takemura et al. 2005). However, binding 
activity to specific ERs in these studies has not been confirmed as occurring in 
particular tissues in vivo but rather in cell lines. 
Whole mount in situ hybridisation of esr transcripts conducted in 5 dpf zebrafish 
by Gorelick and co-workers has shown esr1 transcripts present in the 
atrioventricular valves and bulbus arteriosus and esr2a (reported as esr2b) 
transcripts in the liver; esr2b (reported as esr2a) transcripts were not detected; 
(Gorelick et al. 2014). Esr1 therefore appears to play a crucial role in transducing 
the estrogenic signal in the cardiac tissue during early life and would explain why 
estrogenic chemicals with a higher affinity for esr1 (over esr2a or esr2b) show 
activation responses in the heart before that seen in other tissues. In the liver the 
fact that the GFP signal was knocked down using the esr1 morpholino, as well 
as for esr2a and esr2b, indicates hepatic expression of esr1 transcripts, which 
contrasts with the studies reported for another transgenic zebrafish line for the 
same life stage (Gorelick et al. 2014). It has been shown that esr1 is expressed 
in livers in many fish species (including the zebrafish) at later life stages, where 
is plays a role in regulating the expression of estrogen responsive genes, 
including signalling pathways for induction of vitellogenin (Nelson and Habibi 
2010, Chen and Chan 2016).  Cross-talk between the esr sub-types is likely to 
occur in the liver (and other body tissues) and there may be involvement of other 
factors in estrogen signalling, that lead to a reduced GFP signal when either 
receptor subtype is knocked down/out. 
The fact that BPA and MBP target the atrioventricular valves and bulbus 
arteriosus, tissues responsible for regulating blood flow from an early life stage, 
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and here during a critical stage of their development, could have functional 
consequences. The valves of the atrioventricular canal are crucial for maintaining 
unidirectional blood flow in the heart, completely blocking retrograde blood flow 
by 72 hpf (Scherz et al. 2008) with the valve leaflets developed by 102 hpf (Staudt 
and Stainier 2012). The bulbus arteriosus functions as a type of capacitor to 
maintain a continuous blood flow (Hu et al. 2000). The first five days of life are 
crucial for correct valve development in zebrafish with the valves forming from 
migration of endocardial cells in this time (Stainier 2001). Further development 
serves to lengthen and thicken the valves (Martin and Bartman 2009). In humans 
it has been estimated that 5% of children may carry some form of congenital valve 
deformation, and 10-20% of all congenital heart diseases are caused by defects 
in the atrioventricular canal (Loffredo 2000, Pierpont et al. 2007). This places a 
strong emphasis on the need to better establish whether chemicals such as BPA, 
that are active in these tissues during their development, have any effect on valve 
function or can contribute to congenital heart disease, and to establish the 
mechanisms for any such effects. 
To determine if the fluorescent signal observed in zebrafish heart valves in 
response to BPA had any effect on cardiac function or output we used non-
invasive video capture to measure various endpoints (Fig 5&6). This method has 
previously been used effectively in the assessment of integrated cardiovascular 
function following drug treatment (Parker et al. 2014). Endocardial cushion 
(precursors to functioning valves) development is thought to be complete around 
5dpf while valve elongation is thought to occur from around 6 dfp completing 
around 14 dpf (Martin and Bartman 2009, Staudt and Stainier 2012). It was 
therefore postulated that if BPA was significantly impacting heart valve function 
in zebrafish larvae, alterations would be detected at this time. At 5dpf the only 
significant endpoint measured was the difference in A:V beat ratio distribution. 
A:V beat ratio was relatively conserved in control larvae with little variation 
observed throughout the 5 minute observation window. However, in fish exposed 
to 2500 µg/l BPA A:V beat ratio differed over the assessment period (Fig 5H), 
indicating it is possible that, although not decoupling atrial and ventricular beat 
rates in a uniform manner, BPA exposure could lead to an erratic beat in either 
or both chambers. It is unlikely that A:V beat ratio would be linked to a disruption 
of the heart valves, however in dissected hearts fluorescent cells extending into 
146 
 
the ventricle were observed, possibly indicating BPA action here. Previous 
studies have indicated that BPA may promote arrhythmia in mammalian hearts 
by alteration of myocyte Ca2+ handling, mediated by ERβ-signalling (Yan et al. 
2011, Belcher et al. 2012, Gao et al. 2013). Estrogen responsive fluorescent 
signalling in our ERE-TG fish appears to be mediated by an esr1 dependent 
pathway, however, it may be possible that at the higher concentration of 2500 µg/l 
further pathways are being induced. The only significantly affected endpoint at 14 
dpf was a reduction in arterial beat rate in zebrafish exposed to 2500 µg/l. The 
mechanism for his is not known. BPA however has been shown to affect thyroid 
signalling (Moriyama et al. 2002, Zoeller et al. 2005) and reduced circulating 
thyroid hormones leads to a reduction in heart rate in humans (Cingoz 2015).  
In conclusion, we demonstrate that the estrogenic BPA metabolite MBP targets 
the same tissues and has a mode of action similar to its parent compound and 
distinct from that of the classic steroidal estrogen EE2, but the potency of MBP is 
several orders of magnitude higher than for BPA.  We demonstrate that key 
targets in the heart for both BPA and MBP appear to be the developing 
atrioventricular valves and bulbus arteriosus, but that early life stage exposure to 
these bisphenols, even at high concentrations and exceeding those in most 
environments by several orders of magnitude, did not subsequently affect heart 
function, up to 14dpf. We cannot say whether chronic, lifelong exposure to these 
bisphenols has functional consequences for the heart in fish, as has been 
reported in humans.  
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CHAPTER 4: Transcriptomic responses in the hearts of larval zebrafish in 
response to Bisphenol A exposure 
Introduction 
Bisphenol A is an organic synthetic chemical used mainly in the production of 
plastics and epoxy resins. The uses for these materials are diverse and 
widespread making BPA one of the most commonly produced industrial 
chemicals. As a result of the application of BPA in materials that have human 
contact, exposures by consumers, including infants has resulted in the detection 
of BPA, or BPA metabolite in human blood, urine and breast milk. BPA has been 
determined to be present in urine of more than 90% of individuals as reported by 
biomonitoring studies conducted in the USA, China and Korea (Ye et al. 2015, 
Zhang et al. 2015, Park et al. 2016). As the ultimate sink for various 
environmental contaminants the aquatic environment receives BPA from Waste 
Water Treatment Plants, landfill leachates, ground runoff and natural degradation 
of BPA containing products. In general BPA has been measured at below 1 µg/l 
in environmental waters. However, higher concentrations have been recorded, 
up to 21 µg/l in a river water sample from the Netherlands, 12 µg/l in stream water 
from the USA, and 3.9 µg/l in estuary water in China (Belfroid et al. 2002, Kolpin 
et al. 2002, Dong et al. 2009). The widespread use of this chemical and the 
frequent measurements in humans and environmental samples has raised 
concerns about its toxicity and the risks that it may pose for human health and 
wildlife. 
Originally developed as a synthetic estrogen before being utilised as an industrial 
monomer, most studies have focussed on the disruptive effects of BPA as an 
estrogenic chemical. By mimicking the actions of the endogenous estrogen 17β-
estradiol (E2) BPA may bind to and activate the estrogen receptor (ER). The ER 
is part of the family of nuclear receptors, ligand-activated transcription factors that 
bind directly to DNA (in the case of ERs at estrogen response elements (EREs)) 
and regulate the expression of estrogen dependent genes. In mammals there are 
two ER subtypes esr1 and esr2, whereas the majority of teleost fish possess a 
third distinct esr2, therefore comprising esr1, esr2a and esr2b (Filby and Tyler 
2005). These ERs display distinct expression patterns. In zebrafish larvae esr1 
transcripts have been found to be highly expressed in the heart valves while 
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esr2a transcripts are largely found to be expressed in the liver (Gorelick et al. 
2014). Both esr2a and esr2b transcripts have also been detected in the 
developing brain and lateral line system (Tingaud-Sequeira et al. 2004). In 
addition to the classic nuclear-receptor genomic signalling pathway, BPA can 
also exert actions through rapid response non-genomic signal transduction 
pathways (Gao and Wang 2014). This rapid signalling of BPA has been reported 
in various cell types including the pituitary, pancreas, cerebellar cortex and the 
heart (Alonso-Magdalena et al. 2005, Wozniak et al. 2005, Zsarnovszky et al. 
2005, Gao et al. 2013). A further possible mode of action for BPA that may explain 
some of the discrepancies reported between in vivo and in vitro studies could be 
metabolic activation, which may not occur in many in vitro systems (Welshons et 
al. 2006, Vandenberg et al. 2009). Previous studies have reported that in 
mammals BPA may be metabolised to the more potent estrogen 4-methyl-2,4-
bis(4-hydroxyphenyl)pent-1-ene (MBP) in the liver (Yoshihara et al. 2001, 
Yoshihara et al. 2004, Okuda et al. 2011). We also demonstrated in Chapter 3 
that MBP is several orders of magnitude stronger in inducing a fluorescent 
response in our ERE-TG zebrafish. Interestingly, we found MBP displays a highly 
conserved expression pattern with its parent compound, with the heart appearing 
to be a key tissue target in larval zebrafish. 
Several epidemiological and experimental studies have suggested potential links 
between BPA exposure and disease including diabetes, obesity, reproductive 
disorders, kidney disease and cancer (Fenichel et al. 2013, Rochester 2013, 
Rezg et al. 2014). An increasing amount of evidence has also identified the 
cardiovascular (CV) system as a potential target for BPA. These findings suggest 
that BPA exposure may be a risk factor for a range of CV abnormalities such as 
vascular diseases and cardiac arrhythmias, and highlight the need for further 
assessment of the impact of BPA and other environmental EDCs on the CV 
system, with particular respect to the underlying molecular mechanisms. We have 
also demonstrated in previous chapters in this thesis that BPA targets the heart 
valves in estrogen responsive transgenic zebrafish, demonstrating that BPA is 
binding to and activating ERs in these tissues and promoting transcriptional 
responses. 
A limited number of studies have shown that BPA is able to alter transcriptional 
responses in the heart. Foetal rhesus monkeys exposed during gestation 
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(mothers fed 400 µg/kg/day) were found to have significant down regulation of 
myosin heavy chain, cardiac isoform alpha (Myh6) in the left ventricle and 
upregulation of Adam 12-l in atrium and ventricles (Chapalamadugu et al. 2014). 
Male rats exposed to 50 µg/kg/day from their first feed were determined to have 
a decrease in expression of PGC-1α in hearts at 24 and 48 weeks (Jiang et al. 
2015). Functional impacts were also measured at both time points and they 
included cardiomyopathy and significantly reduced ATP production. Proteomic 
analysis of left ventricles from females fed 250 µg/l BPA in their drinking water 
found an increase in proteins involved in fatty acid transport and oxidation 
(Ljunggren et al. 2016). 
As ERs are present in cardiac tissue, it is perhaps not surprising to find 
transcriptional responses on exposure to BPA. Several studies have also noted 
responses in cardiac tissue/cells to the natural estrogen 17β-estradiol (E2) and 
the manufactured steroidal estrogen 17α-ethinylestradiol (EE2) (Nakajima et al. 
1999, Cong and Ni 2014, Pugach et al. 2016, Salla et al. 2016). It appears that 
ERα may be a key transcription factor in the heart and BPA has been described 
to interact with ERα in a manner that differs compared with E2 (Gould et al. 1998). 
It is therefore possible that global transcriptional responses observed in the heart 
may differ between BPA and the more potent steroidal estrogens. 
Transcriptomic approaches can comprehensively investigate global molecular 
mechanisms of toxicity and therefore, potentially provide valuable information for 
understanding or predicting adverse health outcomes to exposure. Historically 
qPCR and microarray technologies have been used successfully to conduct 
transcriptional profiling in model organisms exposed to a wide range of chemical 
stressors. High-throughput RNA sequencing (RNA-Seq) has more recently 
emerged as a sensitive and reproducible tool that can be used to conduct non-
biased transcriptomic analysis (Rapaport et al. 2013, Uren Webster et al. 2015). 
RNA-Seq has been used to determine transcription responses in a number of 
studies using larval zebrafish, however, whole larvae tend to be analysed which 
does not allow assessments on tissue specific responses. 
In this project, we employed RNA-Seq on an Illumina HiSeq 2500 platform to 
characterize the global cardiac transcriptomic responses of larval zebrafish 
following exposure to  BPA, MBP and EE2 to help characterise possible 
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toxicological effects of these compounds. Specifically, we aimed to determine if 
response pathways were conserved between BPA and the classical steroidal 
estrogen EE2 or if there were distinct differences in their gene targets possibly 
brought about by their reported differing interactions with the ERs. We also 
aimed to determine if BPA induced similar transcriptional responses to its potent 
metabolite MBP. Previous studies have focussed on whole body transcriptional 
responses when using larvae, we aimed to demonstrate it is possible to isolate 
DNA from individual tissues, giving a clearer indication as to specific tissue 
dependant mechanisms of toxicity.  
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Materials and Methods 
Fish source, culture and husbandry 
Adult zebrafish for the provision of embryos were kept in aquaria (37.5L) at the 
University of Exeter in mixed-sex stock tanks, as described in (Paull et al. 2008). 
All zebrafish embryos used in this study were obtained from 
tg(ERE:Gal4ff)(UAS:GFP) adults, a transgenic zebrafish developed at the 
University of Exeter (Lee et al. 2012). Fish were kept on a 12/12 light/dark cycle. 
Fish were allowed to breed naturally and eggs were collected in egg collection 
chambers approximately 1h post-fertilisation (hpf). Eggs were sorted to remove 
unfertilised and non-viable embryos prior to use. 
Chemical exposures and sampling 
Bisphenol A (purity >99%) and 17α-Ethinylestradiol (≥98%) (EE2) were 
purchased from Sigma-Aldrich Company Ltd. (Gillingham, UK). 4-methyl-2,4-
bis(4-hydroxyphenol)pent-1-ene (MBP) was synthesised by Mark Wood at the 
University of Exeter and purity of the compound was certified as described in 
(Cipelli et al. 2014). All stock chemicals were dissolved in ethanol in glass bottles 
and diluted in ethanol to the required stock concentrations prior to dilution in 
embryo test water. All tests were performed using reconstituted purified water in 
accordance with ISO (International Organisation for Standardisation) guideline 
7346-3. Chemicals in ethanol stock were dissolved in test water to give a final 
ethanol concentration of 0.01%. Solvent controls contained the equivalent of 
ethanol in ISO water without chemical. 
Chemical exposure concentrations were based on pilot studies which aimed to 
determine a threshold concentration for exposure that produced a fluorescent 
GFP signal of equal intensity across all treatments for a given exposure time 
period. These concentrations were determined to be 150 µg BPA/l, 0.50 µg/l MBP 
and 10 ng EE2/l over a 96 hr exposure. Financial and practical constraints limited 
this study to one concentration of each chemical treatment only. 96hpf was 
chosen as a time point as there are various genetic and morphological changes 
in the endocardial cushions as they form into valves between 72hpf and 120hpf. 
By selecting a threshold concentration at this time point we aimed to capture gene 
expression changes in the mid period of the response cascade of signalling.  
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All exposures were conducted in a temperature controlled laboratory held at 
28 ± 1 oC, under semi-static conditions. Each experimental group consisted of 50 
embryos exposed in 100 ml of test media and each treatment group was run in 
triplicate. Hearts removed from larvae were pooled within treatment groups to 
ensure sufficient RNA was obtained; the experiment was repeated twice to obtain 
three experimental replicates per treatment. The exposures were conducted from 
0 hpf to 96 hpf. At the end of the exposure period five 96 hpf old larvae from each 
vessel were processed for fluorescent imaging analysis, remaining larvae were 
processed for heart extraction. 
Hearts were extracted and isolated from other tissue from 96 hpf zebrafish larvae 
as described in (Burns and MacRae 2006), with the alteration that we used Gibco 
Leibovitz’s L-15 Medium, no phenol red due to possible estrogenic activity of 
phenol red. Following purification hearts were snap frozen in liquid nitrogen and 
stored at -80oC prior to transcript profiling. 
Image analysis 
For fluorescence intensity measurements live Tg(ERE:Gal4ff)(UAS:GFP) larvae 
were anesthetised with 0.016% tricane, mounted in 3% methylcellulose in ISO 
water and placed onto a glass-bottom 35 mm dish (MatTek, Ashland, MA, USA). 
All larvae were observed in lateral view and images were obtained using a Zeiss 
Axio Observer.Z1 equipped with an AxioCam Mrm camera (Zeiss, Cambridge, 
UK). All photographs were taken using the same parameters and exposure time 
under a X10 objective. Photographs were processed using the Axiovision 
Imaging software and fluorescence quantification was calculated using the 
ImageJ software (http://rsb.info.nih.gov/ij/). For each picture intensity was 
measured as the mean grey value of all the pixels within a region of interest, and 
the region of interest was kept consistent between individuals. Low level 
background fluorescence from excitation source, camera noise, ambient light etc. 
was subtracted using the ImageJ rolling ball algorithm which removes any spatial 
variations of the background intensities as described in (Sternberg 1983). 
RNA extraction, library preparation and sequencing 
Transcript profiling was conducted on the hearts of 3 replicates per treatment 
group. RNA was extracted from hearts using an RNeasy Micro extraction kit 
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(Qiagen), incorporating on-column DNase treatment, according to the 
manufacturer’s instructions. The concentration, purity and integrity of RNA were 
determined using an Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., USA). 
All RNA used for library construction was of high quality with RIN scores > 7. 
cDNA libraries from all samples were then prepared using the epicentre 
TotalScriptTM RNA-Seq Kit (Epicentre, Madison, WI, USA), multiplexed with 12 
samples per lane and sequenced using an Illumina HiSeq 2500, to generate 150 
bp paired reads. 
Transcriptome analysis 
Raw reads were subject to quality-related processing where low quality (phred 
score <30) and adapter sequences were removed using Fastq-mcf 
(https://expressionanalysis.github.io/ea-utils/). Filtered reads were then aligned 
to the zebrafish reference genome (Ensembl Danio rerio Zv9 release 79) using 
Tophat2 (v2.0.13) (Trapnell et al. 2009) with standard settings. Cufflinks (v2.2.1) 
(Trapnell et al. 2010) was used to quantify the transcripts, followed by differential 
expression analysis using CuffDiff2 (Trapnell et al. 2013). Transcripts with a false 
discovery rate (FDR) < 0.1 were considered differentially expressed 
(Benjamini−Hochberg correction). Functional analysis was performed for 
differentially expressed genes from each treatment group using the Database for 
Annotation, Visualization and Integrated Discovery (DAVID v6.7) (Huang da et al. 
2009) with all genes detected as being expressed in the heart as a background. 
Gene ontology (GO) terms for Biological Process, Cellular Component and 
Molecular Function and Kyoto Encyclopaedia of Gene and Genomes (Kegg) 
pathways were considered significantly over-represented when P < 0.05. 
As the sequence for the GFP gene contained in our ERE-TG zebrafish was not 
contained in the Ensembl zebrafish genome the aligner bowtie2 (v2.2.5) 
(Langmead and Salzberg 2012) was used to align all the reads to the eGFP 
sequence (Table 1). This determined the abundance of fragments that aligned to 
the sequence allowing calculation of fragments per kilobase of exon per million 
fragments mapped (FPKM) for each replicate, providing a quantification of 
transcript abundance. 
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Table 1. eGFP sequence used to determine transcript expression based on 
FPKM values 
GAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAG
CTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCTGGCGAGGGCG
AGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACC
GGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACG
GCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTC
TTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTT
CAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGC
GACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGG
ACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAAC
GTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGCGAACTTCAA
GATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTAC
CAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACC
ACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCG
CGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCG
GCATGGACGAGCTGT 
 
Data analysis 
Data for FPKM values, and fluorescence intensities were expressed as 
mean ± standard error of the mean (SEM) and significant differences were 
analysed with either a Student’s t-test or one-way ANOVA, depending if testing 
between two or more groups respectively. Data were tested for normality of 
distribution (Shapiro–Wilk test) and homogeneity of variance (Levene's test) prior 
to analysis. Where a significant difference was detected a Tukey posthoc test 
was carried out (P-value < 0.05). Analyses were performed with SPSS Statistics 
23.0. 
 
Repeat study 
Following the above experiment we lacked some confidence in the initial results 
as read number was not as high as expected, there were also a high number of 
genes where no expression was detected in some treatments. It was unclear if 
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this was due to practices with the sequencing, including multiplexing samples 
with a separate study, or if it was due to the low levels of RNA used in this study 
compared to traditional library preparation methods; TotalScript library 
preparation uses 5ng total RNA. We therefore conducted a further study 
repeating the exposure to BPA with also a relevant control in an attempt to 
determine library preparation efficiency. 
Preparation of samples adopted an identical approach to that described above 
for the original experiment. Analysis was also as described above with the only 
difference being that quality processing and adapter trimming was performed 
using fastx toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) as in this case a 
higher number of filtered reads was obtained. 
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Results 
Fluorescence Intensities in hearts of exposed ERE-TG zebrafish 
In order to determine if a measured fluorescence response across the different 
treatments was related to the expression of any specific identifiable gene/s in 
hearts a sub set of fish were sampled and fluorescence images captured to 
determine intensity (Fig. 1). ERE-TG fish without chemical exposure were not 
observed to possess any induced GFP fluorescence, any weak GFP detected as 
autofluorescence was accounted for as background level expression. In the first 
study ERE-TG fish exposed to 150 µg/l BPA, 0.50 µg/l MBP and 10 ng/l EE2 
were all determined to have GFP induction in atrioventricular valves and bulbus 
arteriosus, indicating estrogen dependent transcription present in these tissues. 
GFP induction was measured to be 4.2 ± 0.7, 4.0 ± 1.8 and 2.6 ± 0.2 fold 
increase above the controls for ERE-TG fish exposed to 150 µg/l BPA, 0.50 µg/l 
MBP and 10 ng/l EE2 respectively. These values were not found to be 
significantly different from each other, indicating a similar level of intensity 
induced across all treatments. 
In the study where we repeated the exposure to BPA only, there was again no 
induced signal observed in the hearts of unexposed fish, whereas hearts from 
fish exposed to 150 µg/l were found to express GFP in atrioventricular valves and 
bulbus arteriosus, GFP intensity was measured as being 4.2 ± 0.7-fold increase 
above controls. 
RNA-Seq Analysis 
Following waterborne exposure of larvae, zebrafish hearts were removed and we 
extracted total RNA to analyse for transcriptional responses using RNA-Seq. For 
the first exposure study we obtained between 9,418,706 and 11,954,691 paired 
end raw reads, reduced to between 8,911,315 and 11,148,867 paired end reads 
after filtering through quality control analysis using Fastq-mcf. The mapping level 
to the reference genome (Zv9 Ensembl release 79) for the samples ranged from 
88.9% to 92.0%. For the second exposure to BPA quality control analysis was 
carried out using fastx toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). Paired 
end raw reads obtained were between 29,950,946 and 44,558,632 while filtered  
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C       D 
      
Figure 1. Images of 96 hpf ERE-TG zebrafish larvae used for transcriptomic 
analysis, exposed to either 150 µg BPA/l, 0.50 µg MBP/l and 20 ng EE2/l, in the 
first study (A) or 150 µg BPA/l in the second study (B); control fish were exposed 
to solvent vehicle only; Scale bar represents 200 µm. (C-D) GFP induction 
(fluorescence) in the hearts of 96 hpf ERE-TG zebrafish larvae exposed to 150 µg 
BPA/l, 0.50 µg MBP/l and 20 ng EE2/l in the first study (C) or 150 µg BPA/l in the 
second study (D).  
A 
B 
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reads were between 27,585,887 and 40,937,865. Percentages of genes mapped 
to the reference genome were between 89.3% and 94.0%. 
Differentially expressed transcripts were determined using the CuffDiff2 
programme. The total number of transcripts differentially expressed in hearts 
exposed to BPA, MBP and EE2 treatment groups compared to the controls in the 
first study was 26 (16 of which were up-regulated), 54 (33 of which were up-
regulated) and 64 (33 of which were up-regulated) respectively (Fig. 2 and Table 
2). Only one transcript was found to be differentially expressed across all 
treatment groups. Transcripts for the gene slc4a1a were up-regulated in all 
treatments. Of the 26 differentially expressed transcripts observed in BPA 
exposed zebrafish there were 4 transcripts in common with MBP (3 upregulated 
and 1 downregulated) and 4 transcripts in common with EE2 (2 upregulated and 
2 downregulated). MBP and EE2 exposed fish we found to also have 5 (3 
upregulated and 2 downregulated) differentially expressed transcripts in 
common. In the repeat study the total number of transcripts differentially 
expressed in the 150 µg BPA/l treatment group compared to the controls was 130 
(23 of which were up-regulated) (Table 3). No common transcripts were found 
differentially expressed after exposure to 150 µg BPA/l in both the first and repeat 
study. The only common differentially expressed transcript that was observed 
between a treatment group and the control in the original and second BPA 
exposure study was for the gene krt4. krt4 was found to be up-regulated 1.9-fold 
after exposure to 0.5µg MBP/l, however in the second study it was down-
regulated 2.7-fold from the control after exposure to 150 µg BPA/l. 
As the GFP gene did not appear in the reference genome we separately 
calculated the transcript abundance of GFP in the hearts of fish in this study. 
Differences in GFP expression were compared using fragments per kilobase per 
million (FPKM) (Fig. 3). FPKM is calculated with the following formula Xi/(Li*N) * 
109, where Xi and Li are the total number of reads mapping to a particular gene 
and the length of the gene in bases, N is the total number of reads sequenced. 
FPKM therefore, gives a value to the number of transcripts out of all those 
sequenced that map to a gene of a given sequence, indicating expression level. 
In the first study FPKM values for GFP were determined for the Control, 150 µg 
BPA/l, 0.5 µg MBP/l and 10 ng EE2/l treatment groups to be 2.6 ± 1.3, 
110.9 ± 22.8, 22.7 ± 1.8 and 21.4 ± 5.2. In the second BPA exposure study 
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FPKM values for GFP were determined to be 0.59 ± 0.4 and 42.1 ± 4.7 for the 
control and BPA treatment groups respectively. Although there were no 
significant differences in transcript expression between controls and treatment 
groups we also calculated FPKM values for the 3 estrogen receptor (ERs) genes 
esr1, esr2a and esr2b, to expand on our understanding of estrogen signalling in 
the heart (Fig. 3). In the first exposure study esr1 transcript FPKM values were 
determined to be 1.7 ± 0.3, 2.3 ± 0.9, 4.9 ± 1.1 and 1.7 ± 1.0 for control, BPA, 
MBP and EE2 groups respectively. No transcripts were detected in any treatment 
group for esr2a. Only one replicate in each of the Control, BPA and EE2 treatment 
groups were found to have transcripts present for esr2b with FPKM values of 
0.040, 0.53 and 0.28, respectively. In the second BPA exposure study transcripts 
for all 3 ER genes were observed in all replicates for both treatments FPKMs 
were 4.2 ± 0.5 and 3.8 ± 0.5 for esr1, 0.46 ± 0.2 and 0.30 ± 0.07 for esr2a and 
0.77 ± 0.1 and 0.63 ± 0.1 for esr2b for Control and BPA treated groups, 
respectively. 
GO Functional Analysis and KEGG pathways 
We performed functional analysis of Gene Ontology (GO), whereby differentially 
expressed genes may be assigned functional terms which may be enriched. The 
list of over-represented GO terms and Kegg pathways are shown in Table 4. In 
the original study no significantly enriched terms were determined for differentially 
expressed genes in the hearts of zebrafish exposed to either BPA or MBP. The 
only enriched term found for those fish exposed to EE2 was protein complex 
within the cellular component classification. 
In the second BPA exposure study a number of significantly (p<0.05) enriched 
terms were determined in the hearts of zebrafish exposed to BPA. In the 
biological processes classification, the majority of terms were associated with 
membrane transport and localisation. Terms associated with membrane transport 
activity were also significantly enriched in the molecular function classification. 
The most significantly enriched terms in the cellular component classification 
were involved in cell to cell gap junctions. Three KEGG pathways were also 
identified as being over-represented, these are associated with phenylalanine 
biosynthesis and metabolism and drug metabolism (Table 4). 
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Figure 2. Venn diagram displaying the numbers of differentially expressed 
transcripts in each treatment group. Red and green numbers represent up- and 
down-regulated genes respectively 
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A          B 
    
C          D 
     
Figure 3. Fragments Per Kilobase of transcript per Million fragments (FPKM) 
values demonstrates expression level of various transcripts; (A and C) GFP; (B 
and D) Estrogen Receptor genes esr1, esr2a and esr2b; for original (A and B) 
and repeat (C and D) study. 
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Table 2. Fold changes of all differentially-regulated transcripts in the hearts of 
96 hpf zebrafish larvae exposed to either 150 µg BPA/l, 0.50 µg MBP/l or 
10 ng EE2/l. Values presented are log2 transformed fold changes calculated by 
CuffDiff2. Significant differences in expression (FDR <0.1) are indicated by red 
(up-regulated) and green (down-regulated) shading. 
  BPA MBP EE2 
Name Ensembl ID Log2 FC Log2 FC Log2 FC 
acaa2 ENSDARG00000038881 1.08 0.50 1.00 
acacb ENSDARG00000061994 -1.99 -1.30 -1.32 
actn2 ENSDARG00000038785 -0.42 -0.73 -0.20 
anapc1 ENSDARG00000075687 -1.98 -1.76 -1.29 
angptl4 ENSDARG00000035859 0.64 0.84 1.37 
ank3b ENSDARG00000077582 -0.13 -2.44 -2.82 
ap3s2 ENSDARG00000039882 0.14 -1.18 -6.87 
apc ENSDARG00000058868 1.77 1.29 1.98 
arf1 ENSDARG00000009484 -0.59 4.09 -1.63 
asb2a.1 ENSDARG00000096748 2.17 4.72 2.56 
b2ml ENSDARG00000015887 -1.48 -2.14 -3.22 
bcl11aa ENSDARG00000061352 0.08 -2.98 -0.20 
BOLA2B ENSDARG00000051780 -1.34 -1.82 -2.09 
btbd10b ENSDARG00000020252 0.77 0.44 1.29 
BX323876.2 ENSDARG00000052948 -0.60 -1.37 -0.47 
c1qbp ENSDARG00000039887 0.92 0.92 0.50 
C25H12orf73 ENSDARG00000045797 0.03 -1.42 2.49 
calm1a ENSDARG00000021811 -0.39 -0.59 -1.13 
caprin1b ENSDARG00000054272 -0.34 -1.45 0.14 
capza1a ENSDARG00000034240 -0.07 0.03 -1.59 
cd151 ENSDARG00000038288 -0.54 -0.94 -0.49 
CDCA2 ENSDARG00000068759 -0.15 2.47 0.33 
cep97 ENSDARG00000102407 4.05 5.08 3.28 
cfd ENSDARG00000039579 0.20 0.67 0.87 
cltca ENSDARG00000043493 0.10 -0.88 -0.01 
cnbpb ENSDARG00000070922 -0.56 -1.35 -0.85 
COL5A2 (2 of 2) ENSDARG00000031678 -0.19 -0.71 -0.04 
cpt1b ENSDARG00000058285 -0.33 -0.09 1.63 
dis3 ENSDARG00000060559 3.03 -0.61 3.19 
dkc1 ENSDARG00000016484 -0.33 -0.37 -1.06 
dolpp1 ENSDARG00000036915 2.47 1.52 1.42 
eif2s1a ENSDARG00000005827 -0.64 -0.15 -1.86 
ell2 ENSDARG00000006251 -0.23 1.26 1.81 
emc1 ENSDARG00000057255 0.80 1.61 0.71 
ENSDARG00000051775 ENSDARG00000051775 1.27 2.58 0.02 
ENSDARG00000059604 ENSDARG00000059604 1.69 4.42 1.55 
fabp11a ENSDARG00000017299 0.31 0.78 0.44 
FAM188B,nexn ENSDARG00000077696 -0.67 0.26 -1.10 
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FAM96A ENSDARG00000104940 2.07 0.56 2.88 
farsb ENSDARG00000016864 0.93 0.48 1.52 
fbxw11b ENSDARG00000017230 1.83 0.02 2.51 
fnbp4 ENSDARG00000051800 -0.68 -0.82 -1.68 
fndc3bb ENSDARG00000062023 -1.41 -1.03 -0.74 
fosl2 ENSDARG00000040623 0.09 -0.35 2.60 
foxk1 ENSDARG00000037872 -1.75 -0.30 -1.13 
fzd7a ENSDARG00000060004 -0.46 -0.92 -1.61 
gfer ENSDARG00000070061 -1.78 -0.58 -5.27 
gps1 ENSDARG00000040650 0.73 1.89 0.22 
h1fx ENSDARG00000054058 -0.02 0.83 -0.55 
hbae1 ENSDARG00000089475 0.39 0.76 0.89 
hbae3 ENSDARG00000079305 0.35 0.71 0.85 
hbbe1.1 ENSDARG00000089963 0.40 0.31 0.84 
hbbe2 ENSDARG00000045143 0.41 0.53 0.63 
hdac9b ENSDARG00000056642 -1.73 -0.64 -1.84 
hivep1 ENSDARG00000103658 0.72 0.60 2.15 
hmgb3b ENSDARG00000006408 1.15 1.70 0.65 
ivd ENSDARG00000042853 -0.84 -1.26 -0.40 
jam3b ENSDARG00000061794 1.68 0.26 -0.07 
kansl2,mlh3 ENSDARG00000056318 -0.19 0.01 3.12 
kmt2d ENSDARG00000037060 -1.60 0.02 -1.84 
krt4 ENSDARG00000017624 -1.06 1.93 0.27 
lmna ENSDARG00000013415 1.09 1.66 0.89 
lmo2 ENSDARG00000095019 2.57 2.71 2.16 
lmod2b ENSDARG00000045864 -0.16 -0.59 -0.99 
lrrc15 ENSDARG00000070792 0.27 1.33 0.35 
mcamb ENSDARG00000005368 -0.17 -0.19 0.75 
minos1 ENSDARG00000101619 -1.11 -0.89 -0.41 
mtch2 ENSDARG00000019732 -0.37 -0.66 -1.06 
mtmr3 ENSDARG00000093364 0.82 2.44 2.17 
myom1b ENSDARG00000104836 0.32 0.31 0.89 
napab ENSDARG00000020405 0.67 1.61 0.12 
nars ENSDARG00000061100 -0.54 -0.42 -0.77 
ncl ENSDARG00000002710 -0.43 -0.65 -0.78 
ndufv1 ENSDARG00000036438 0.78 0.65 0.61 
PARD3B (1 of 2) ENSDARG00000092671 -0.09 -2.87 -1.16 
pbx4 ENSDARG00000052150 0.99 0.32 0.16 
pcid2 ENSDARG00000013802 0.82 -4.39 0.26 
PET100,brd4 ENSDARG00000098017 1.58 1.95 1.38 
pfkpb ENSDARG00000012801 0.67 1.92 -0.56 
pfn2l ENSDARG00000012682 -0.29 0.07 -1.03 
pkma ENSDARG00000099730 -0.62 -0.89 -0.50 
plekhg5a ENSDARG00000025902 -2.32 -2.70 -1.79 
psmd3 ENSDARG00000018124 1.06 0.17 0.57 
ptenb ENSDARG00000056623 0.84 -0.21 1.67 
qpctla ENSDARG00000061691 -1.75 -0.68 -0.23 
RAPGEF2 (2 of 2) ENSDARG00000005482 0.02 3.32 0.37 
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rb1 ENSDARG00000006782 0.93 1.64 1.86 
rfc1 ENSDARG00000054799 2.51 1.45 0.36 
sap130a ENSDARG00000056924 1.52 3.02 0.43 
sap130b ENSDARG00000079352 -3.25 -2.18 -3.17 
sbf1 ENSDARG00000062968 1.95 1.02 0.91 
sdad1 ENSDARG00000105117 0.59 0.64 1.80 
sec11a ENSDARG00000008936 -0.98 -1.10 -1.33 
sema6dl ENSDARG00000011533 0.77 2.07 -0.72 
sept7b ENSDARG00000052673 -0.65 -0.85 -1.44 
sept8a ENSDARG00000032606 1.08 0.94 1.87 
serf2 ENSDARG00000074340 -0.05 -0.21 -0.89 
si:ch211-281l24.3 ENSDARG00000068637 0.43 1.87 0.25 
si:ch211-286b5.5 ENSDARG00000096661 0.70 1.96 0.05 
si:ch211-5k11.2 ENSDARG00000088330 0.45 1.53 1.37 
si:dkey-199f5.8 ENSDARG00000018853 0.28 1.19 -0.49 
si:dkey-228a15.1 ENSDARG00000095698 0.21 -1.29 -5.17 
si:dkey-261m9.6 ENSDARG00000093195 0.91 1.46 1.52 
si:dkey-4c15.13 ENSDARG00000095704 -3.93 -0.19 -0.96 
si:dkeyp-117h8.4 ENSDARG00000043004 -1.50 -5.94 -3.21 
slc12a7b ENSDARG00000062058 0.78 2.42 1.94 
slc38a2 ENSDARG00000045886 -0.31 -1.03 -0.60 
slc4a1a ENSDARG00000012881 0.69 0.73 1.14 
soga1 ENSDARG00000063075 -0.82 -1.68 -0.64 
sptb ENSDARG00000030490 0.02 -1.17 -0.70 
srgap2a ENSDARG00000032161 0.40 2.48 0.69 
ssr1 ENSDARG00000101627 -0.57 -1.91 -1.07 
ssr2 ENSDARG00000005230 0.26 0.89 0.44 
st3gal2l ENSDARG00000007494 0.08 -0.25 1.16 
stard13b ENSDARG00000098954 0.17 2.99 0.26 
thop1 ENSDARG00000013776 1.19 1.16 1.64 
tie1 ENSDARG00000004105 -0.67 -1.67 -1.79 
timm23a ENSDARG00000071396 2.16 1.80 0.85 
tspo ENSDARG00000026655 0.71 0.68 1.09 
ttna ENSDARG00000028213 -0.14 -0.28 -0.77 
ubr5 ENSDARG00000018192 0.86 0.56 1.54 
uchl3 ENSDARG00000030177 1.00 1.19 1.74 
uck2b ENSDARG00000022213 0.29 0.86 1.58 
wasf2 ENSDARG00000024209 -0.65 -1.89 -0.31 
wwp2 ENSDARG00000061345 -1.03 -1.25 -2.24 
zfhx3 ENSDARG00000103057 -0.27 -0.34 -1.05 
zfp36l2 ENSDARG00000021806 -0.24 -0.41 -0.91 
zgc:101560 ENSDARG00000099870 -0.45 0.14 -1.43 
zgc:112966 ENSDARG00000095369 5.38 3.94 - 
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Table 3. Fold changes of all differentially-regulated transcripts in hearts of 96 hpf 
zebrafish exposed to 150 µg BPA/l in second study. Values presented are log2 
transformed fold changes calculated by CuffDiff2. Significant differences in 
expression (FDR <0.1) are indicated by red (up-regulated) and green (down-
regulated) shading. 
  BPA 
Name Ensembl ID Log2 FC 
adamtsl7 ENSDARG00000055439 -2.59 
ahcyl1 ENSDARG00000056331 -3.48 
akr1b1 ENSDARG00000006215 -2.32 
and1 ENSDARG00000088514 -3.56 
and2 ENSDARG00000079302 -4.19 
and3 ENSDARG00000056873 -4.77 
apoda.1 ENSDARG00000060345 -1.96 
apoea ENSDARG00000102004 2.33 
apoeb ENSDARG00000040295 -3.3 
aqp3a ENSDARG00000003808 -3.34 
asah2 ENSDARG00000012829 2.2 
aspa ENSDARG00000005154 -2.63 
ass1 ENSDARG00000103044 -3.09 
aste1 ENSDARG00000070132 -3.37 
atp8b5b ENSDARG00000079235 2.16 
ca2 ENSDARG00000014488 -1.83 
CABZ01007794.1 ENSDARG00000088655 -3.04 
CABZ01045617.2 ENSDARG00000091047 3.14 
CABZ01048956.1 ENSDARG00000089465 -2.18 
CABZ01074130.1 ENSDARG00000105274 -4.55 
MGAM ENSDARG00000101629 4.19 
camk2d1 ENSDARG00000043010 -1.33 
capn12 ENSDARG00000010758 -2.87 
cd36 ENSDARG00000032639 2.31 
CES1 (1 of 3) ENSG00000198848 2.01 
cfl1l ENSDARG00000012972 -2.71 
ciarta ENSDARG00000058094 -1.67 
ckmt1 ENSDARG00000016598 2.95 
cldn7b ENSDARG00000014047 -3.04 
cldnb ENSDARG00000009544 -2.61 
cldnh ENSDARG00000069503 -2.46 
cldni ENSDARG00000054616 -2.86 
CR385063.1 ENSDARG00000044212 -2.12 
cspg5a ENSDARG00000069981 -2.03 
CT583700.1 ENSDARG00000090579 -2.56 
CU019646.2 ENSDARG00000091234 -1.9 
CU856173.1 ENSDARG00000091560 1.58 
cubn ENSDARG00000087013 -3.63 
cx32.3 ENSDARG00000041787 -2.82 
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cxcl12a ENSDARG00000037116 -2.37 
cyp2k16 ENSDARG00000102981 1.98 
cyt1l ENSDARG00000036832 -2.26 
dgat2 ENSDARG00000018846 2.55 
dpys ENSDARG00000079543 -3.13 
egfl6 ENSDARG00000045958 -2.47 
si:dkey-110c1.10 ENSDARG00000061810 -0.93 
ENSDARG00000067760 ENSDARG00000067760 -2.7 
ENSDARG00000075668 ENSDARG00000075668 -2.77 
ENSDARG00000078528 ENSDARG00000078528 1.95 
epcam ENSDARG00000040534 -1.65 
f2 ENSDARG00000036041 -0.87 
fa2h ENSDARG00000090063 2.54 
fbln1 ENSDARG00000103311 -2.28 
fmodb ENSDARG00000010294 -2.53 
FOS ENSDARG00000031683 -2.84 
fras1 ENSDARG00000054619 -1.76 
frem2a ENSDARG00000076856 -2.58 
ftcd ENSDARG00000007421 -2.27 
glis3 ENSDARG00000069726 -2.38 
gpx1b ENSDARG00000006207 -2.76 
grid2ipa ENSDARG00000076103 -2.12 
GSTAL ENSDARG00000039832 2.01 
hnf1ba ENSDARG00000006615 -3.4 
hoga1 ENSDARG00000018944 -1.89 
hpdb ENSDARG00000044935 -3.38 
IM:7150988 ENSDARG00000098058 -3.14 
isg15 ENSDARG00000086374 -3.7 
jdp2b ENSDARG00000020133 -2.93 
kcnj13 ENSDARG00000043443 -1.81 
krt4 ENSDARG00000017624 -2.68 
krt5 ENSDARG00000058371 -2.7 
lgmn ENSDARG00000039150 -2.15 
mid1ip1a ENSDARG00000041051 -2.41 
mslna ENSDARG00000098949 -0.9 
mxra5b ENSDARG00000076309 -2.88 
myh6 ENSDARG00000090637 -2.35 
myh9a ENSDARG00000063295 -1.65 
MYO7B (1 of many) ENSDARG00000044441 2.47 
nr1d1 ENSDARG00000033160 -2.61 
pah ENSDARG00000020143 -3.65 
pax2a ENSDARG00000028148 -1.31 
pdzk1 ENSDARG00000022261 -2.22 
PDZK1IP1L ENSDARG00000017127 -5.01 
pnp4b ENSDARG00000029230 1.62 
prlra ENSDARG00000016570 -2.03 
ptgdsb ENSDARG00000027088 -3.41 
pyroxd2 ENSDARG00000014101 -1.57 
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rasd1 ENSDARG00000019274 -2.13 
rbm47 ENSDARG00000061985 -1.8 
s100a10a ENSDARG00000037425 1.98 
si:ch211-153b23.5 ENSDARG00000058206 -3.86 
sgk1 ENSDARG00000025522 -1.66 
si:ch211-117m20.5 ENSDARG00000091996 -2.33 
si:ch211-125o16.4 ENSDARG00000056836 -3.44 
si:ch211-157c3.4 ENSDARG00000087093 -1.02 
si:ch211-220g18.3 ENSDARG00000092905 -1.94 
si:ch211-251b21.1 ENSDARG00000007275 -2.36 
si:ch73-65n21.1 ENSDARG00000098037 1.86 
si:dkey-188i13.7 ENSDARG00000078389 -3.23 
si:dkey-188i13.7 ENSDARG00000078389 -3.11 
si:dkey-33c14.3 ENSDARG00000097118 -2.1 
slc13a2 ENSDARG00000053853 2.92 
slc13a3 ENSDARG00000069478 -3.37 
slc22a7b.1 ENSDARG00000056643 -3.44 
slc26a1 ENSDARG00000029832 -4.53 
slc2a12 ENSDARG00000036865 -3.21 
slc4a2a ENSDARG00000028173 -3.77 
slc4a4a ENSDARG00000013730 -2.52 
slc4a4b ENSDARG00000044808 -1.75 
slc5a8l ENSDARG00000003697 -2.65 
slc6a19b ENSDARG00000056719 -2.22 
socs3a ENSDARG00000025428 -2.86 
sp8b ENSDARG00000056666 -1.33 
stat1b ENSDARG00000076182 -1.83 
tat ENSDARG00000069630 -1.74 
tfap2a ENSDARG00000059279 -2.27 
tmc4 ENSDARG00000031757 -3.32 
tmem176l.4 ENSDARG00000074390 -2.56 
TMEM27 ENSDARG00000041644 -3.89 
tmprss2 ENSDARG00000098686 -3.42 
tnnc1b ENSDARG00000037539 -3.26 
ugt1a1 ENSDARG00000006220 4.12 
upp1 ENSDARG00000040869 -1.82 
vil1 ENSDARG00000040466 2.23 
zgc:100868 ENSDARG00000004748 -1.93 
zgc:123068 ENSDARG00000017489 -4.86 
ZGC:158614 ENSDARG00000061634 1.58 
zgc:172079 ENSDARG00000056762 2.27 
ZGC:64085 ENSDARG00000025757 -3.66 
zgc:65811 ENSDARG00000100904 -2.25 
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Table 4. Gene Ontology Terms and Kegg Pathways over-represented in the list of differentially expressed transcripts for each 
treatment group in original and repeat exposures. Values presented are the P-values and adjusted P-values associated with this 
over-representation. Analysis was conducted using the Database for Annotation, Visualization and Integrated Discovery (DAVID ) v6 
.7 (Huang da et al. 2009) using the total number of transcripts observed to be expressed in the heart across all treatments as a 
background. 
BIOLOGICAL PROCESS (BP ALL) 
 First Study  Second Study 
150 µg BPA/l 0.5 µg MBP/l 10 ng EE2/l 150 µg BPA/l 
 P Value FDR P Value FDR P Value FDR P Value FDR 
Localisation       3.4E-3 7.5E-1 
Aromatic amino acid family metabolic process       5.4E-3 6.6E-1 
Ion transport       6.0E-3 5.5E-1 
Transport       6.4E-3 4.8E-1 
Establishment of localisation       7.0E-3 4.3E-1 
Sodium ion transport       9.5E-3 4.7E-1 
Transmembrane transport       3.7E-2 8.8E-1 
Monovalent inorganic cation transport       4.1E-2 8.8E-1 
MOLECULAR FUNCTION (MF ALL) 150 µg BPA/ L 0.5 µg MBP/ L 10 ng EE2/ L 
150 µg BPA/ L 
Repeat 
 P Value FDR P Value FDR P Value FDR P Value FDR 
Secondary active transmembrane transporter 
activity  
 
 
 
 
 1.2E-3 2.1E-1 
Transporter activity       1.9E-3 1.7E-1 
Active transmembrane transporter activity       1.2E-2 5.6E-1 
Substrate-specific transmembrane transporter 
activity  
 
 
 
 
 1.9E-2 6.1E-1 
Structural molecule activity       2.2E-2 5.9E-1 
Transmembrane transporter activity       3.0E-2 6.3E-1 
Substrate-specific transporter activity       4.0E-2 6.8E-1 
Anion:anion antiporter activity       4.1E-2 6.4E-1 
Actin binding       4.8E-2 6.6E-1 
CELLULAR COMPONENT (CC ALL) 150 µg BPA/ L 0.5 µg MBP/ L 10 ng EE2/ L 
150 µg BPA/ L 
Repeat 
 P Value FDR P Value FDR P Value FDR P Value FDR 
protein complex     4.9E-2 9.4E-1   
Cell-cell junction       3.3E-3 1.8E-1 
cell junction       3.9E-3 1.1E-1 
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occluding junction       4.4E-3 8.5E-2 
tight junction       4.4E-3 8.5E-2 
apical junction complex       5.5E-3 7.9E-2 
apicolateral plasma membrane       5.5E-3 7.9E-2 
plasma membrane part       6.7E-3 7.7E-2 
plasma membrane       2.1E-3 1.9E-1 
keratin filament       2.7E-3 2.1E-1 
intermediate filament cytoskeleton       3.7E-2 2.5E-1 
intermediate filament       3.7E-2 2.5E-1 
KEGG PATHWAY 150 µg BPA/ L 0.5 µg MBP/ L 10 ng EE2/ L 
150 µg BPA/ L 
Repeat 
 P Value FDR P Value FDR P Value FDR P Value FDR 
Phenylalanine metabolism       8.5E-3 3.4E-1 
Drug metabolism       2.2E-2 4.2E-1 
Phenylalanine, tyrosine and tryptophan biosynthesis       4.2E-2 5.0E-1 
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Discussion 
BPA has been identified through epidemiological studies as a possible causative 
agent in increasing cardiovascular disorders (Melzer et al. 2010, Bae et al. 2012, 
Melzer et al. 2012, Shankar and Teppala 2012). A number of in vitro and in vivo 
studies in mammalian systems also appear to support this hypothesis (Yan et al. 
2011, Belcher et al. 2012, O'Reilly et al. 2012, Poidatz et al. 2012, Yan et al. 
2013, Posnack et al. 2014). However, experimental evidence is still lacking 
concerning the mechanisms by which this may occur. The zebrafish has emerged 
as a model organism useful for studying the vertebrate heart, with larval stages 
particularly useful for investigating developmental abnormalities that may arise. 
Several studies have also revealed that the core molecular mechanisms driving 
zebrafish cardiac valve formation are highly conserved with those found in 
mammalian hearts. (Beis et al. 2005). Using a transgenic zebrafish that responds 
to estrogenic stimulus with a fluorescent protein, we have previously 
demonstrated that exposure to BPA causes a fluorescent response in the heart 
valves of larval zebrafish, indicating an estrogenic related transcriptomic 
response. This resulted in an unstable atrial:ventricular beat ratio at 5dpf and a 
reduced beat rate in larvae at 14dpf. However, concentrations tested far 
exceeded those typically found in the environment (2500 µg/l). Here a 
transcriptomic approach utilising RNA-Seq was taken to determine if exposure to 
BPA, the potent BPA metabolite MBP and the classic steroidal estrogen EE2 
cause alterations in gene expression in hearts dissected from exposed larval 
zebrafish. Previous RNA-Seq studies on larval zebrafish have used whole larvae, 
making our approach particularly novel. 
Using the ERE-TG zebrafish,it was determined that at the exposure 
concentrations tested a similar fluorescent response was observed (Fig. 1), 
indicating a similar level of transcriptional activity based on GFP response. Using 
the bowtie2 aligner it was possible to determine the concentrations of GFP mRNA 
using FPKM values. FPKM value in control hearts was very low, representing low 
levels of GFP present as background, possibly due to the actions of endogenous 
estrogens (Fig. 3). FPKM values for GFP mRNA were significantly higher in fish 
exposed to BPA than those exposed to MBP and EE2, the reasons for this are 
unclear. This may result from the fact that the GFP protein is relatively stable 
compared to mRNA values, therefore fluorescence images indicate estrogen 
181 
 
activity over a longer period of time, which may differ from the smaller window 
indicated by mRNA. There was no significant difference between the GFP mRNA 
measured in MBP and EE2 exposed fish indicating a similar level of 
transcriptional response. Though it should be noted GFP production is not 
dependent on a particular estrogen receptor (ER) signalling pathway and these 
chemicals could be acting through different mechanisms. Though previous work 
in this thesis has indicated in the heart all three chemicals tested appear to 
mediate their effects via an esr1-dependent pathway (Chapter 3). 
Analysis of mRNA of the different ERs in these zebrafish hearts may help to 
further explain our previously determined results whereby morpholino (MO) 
knockdown of esr1 was sufficient to inhibit the fluorescence response in ERE-TG 
fish exposed to several different estrogens. In the first exposure study in this 
chapter there were no transcripts detected for esr2a across any treatment and 
only one replicate in each of the Control, BPA and EE2 treatments were found to 
have very low levels of esr2b transcripts (Fig. 3). In contrast transcripts for esr1 
were seen across all treatments, with FPKM values of 1.7 ± 0.3, 2.3 ± 0.9, 
4.9 ± 1.1 and 1.7 ± 1.0 for control, BPA, MBP and EE2 groups, respectively. 
Transcripts for both esr2a and esr2b however, were detected in the second BPA 
exposure study, possibly due to a larger depth of coverage generated by the 
sequencing run. FPKM values were several times lower than those seen for esr1. 
These results further indicate that during this early life stage estrogenic 
responses in the heart of zebrafish appear to be mediated via an esr1 dependent 
pathway as this is the dominant ER expressed. It could be argued therefore that 
chemicals more likely to preferentially target esr1 may be more likely to exert 
effects on heart development. 
Atrioventricular cardiac valve development in zebrafish (and other phyla) requires 
a multitude of specific processes, including initiation of endothelial-to-
mesenchymal transition (EMT), EMT migration and valve maturation (Beis et al. 
2005). The molecular cues that modulate these early processes in valvulogenesis 
have been studied extensively.  BMP modulates several important genes and 
pathways in atrioventricular valvulogenesis, such as Notch1 and TGF-β, which 
are known to play significant roles in endothelial-to-mesenchymal transition. 
Notch1 signalling in atrioventricular endothelial cells is also known to induce the 
expression of Snail, a transcription factor that promotes EMT. Specific cells and 
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tissue interactions are also expected to enlist a wide array of protease actions. In 
particular, the novel serine protease PRSS23 has been identified as essential for 
the Snail-dependent EMT during valvulogenesis (Chen et al. 2013). Interestingly 
PRSS23 has also been demonstrated to be regulated by ERα in human MCF-7 
cells, possibly suggesting a key role for ERα in valve development (Chan et al. 
2012). After EMT FGF signalling is important for the regulation of growth and 
development of cardiac cushions (Person et al. 2005). Cellular mechanisms 
involved in the formation of bulbus arteriosus are less well studied. However, 
BMP signalling has been identified as being evident in the proximal cells of the 
bulbus arteriosus during formation (Person et al. 2005, Hami et al. 2011). As we 
observed a GFP fluorescent signal in the atrioventricular valves and developing 
bulbus arteriosus in larval zebrafish we considered that BPA, MBP and EE2 may 
have some effect on development. However, in both the first and second (BPA 
only) studies we found no significant effect on the expression of any genes known 
to possess a role in formation of these tissues. This would suggest that at the 
concentrations tested at 96 hpf there is no measurable effect on valve formation, 
this may help to explain the results observed in Chapter 3 where there was no 
observable effect on cardiac parameters that may be affected by abnormalities in 
valve formation, namely, blood flow, blood speed and stroke volume. However, it 
should also be noted that many genes, particularly those involved in valve 
formation are temporal and window of response may have been missed. 
The number of differentially expressed genes observed was generally low. In the 
original study there were 26, 54 and 64 differentially expressed genes in groups 
exposed to 150 µg BPA/l, 0.50 µg MBP/l and 10 ng EE2/l respectively (Fig. 2). 
There was also little overlap in differentially expressed genes across treatments 
with only one gene slc4a1a significantly up-regulated by all treatments (Table 2). 
As many transcripts were found to not be present across all treatments it was 
considered possible that this library preparation may be less effective at detecting 
changes in transcript level in these tissues. However, RNA quality was sufficient 
as recommended by the preparation guidelines and the library preparation 
method has been optimised for experimental conditions such as these. We 
therefore ran the second exposure study to BPA comparing hearts from only 
Control and 150 µg BPA/l treated fish, to determine the library preparation 
effectiveness. This gave a greater read number, and therefore a greater depth of 
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coverage. Given this, transcript expression changes in these samples could be 
more confidently detected. Although more differentially expressed genes were 
detected in this second exposure, differentially expressed genes were still low, 
with 130 genes found to be differentially expressed out of the 14396 genes 
detected. It is therefore possible that the low number of differentially expressed 
genes in the initial study are partly due to the lower depth of coverage and partially 
due to the fact that estrogenic chemical effects on the heart at this stage may not 
have a profound effect on gene regulation. 
In the first study there were no significantly enriched GO terms for the 
differentially expressed genes observed in the BPA or MBP treated samples 
(Table 4). Indicating the differentially expressed transcripts do not group together 
in a way that disrupts specific processes. Though this is expected given the low 
numbers of differentially expressed genes, one commonly differentially 
expressed transcript between BPA and MBP treated fish was for the gene brd4 
where transcripts were up-regulated 1.6- and 2.0-fold respectively. BRD4 has 
been previously demonstrated as being a central regulator of ERα function in 
humans, where an increase has been observed in gene expression in ERα-
positive cells under estrogen treatment (Nagarajan et al. 2014, Nagarajan et al. 
2015). This may indicate that although there was no significant change in the 
expression of ERs under the treatment of these estrogenic chemicals, estrogen 
signalling is complex and alterations in the regulation of related genes could serve 
to alter the way ERs interact with EREs, changing expression of other related 
genes. Although brd4 expression was not significantly altered in EE2 treated fish 
a similar up-regulation (1.2-fold) was observed, possibly suggesting that 
upregulation of brd4 by these chemicals is estrogen dependent. 
Although EE2 treated hearts were observed to have the highest number of 
differentially regulated genes the number was still low and only one GO term was 
found to be significantly over-represented (protein complex). Several genes 
involved in proteolysis were found to be differentially regulated only in this 
treatment group, including sec11a, thop1, ubr5, cfd and wwp2. Ovariectomised 
rats have previously been found to have an increase in gene expression 
mediating proteolysis in cardiac tissue, an observation that could be corrected 
with E2 treatment, indicating estrogen does play a role in proteolysis in the heart 
(Hamilton et al. 2008). However, genes that were differentially expressed in 
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hearts exposed in this study did not show a consistent pattern of up or down 
regulation, despite all chemicals being primarily estrogenic in action, therefore 
confounding the ability to draw clear conclusions on possible health outcomes. 
There was only one common differentially expressed transcript in the first study; 
the solute carrier slc4a1a was significantly up-regulated compared to the control 
across all treatments. This may indicate that each chemical is targeting different 
pathways and that there is no conserved expression pathway for estrogenic 
chemicals in the heart. However, due to the fact that there was no expression for 
many genes across treatments, it could be that expression patterns are not seen 
due to poor coverage. This may have resulted due to the low levels of RNA as 
compared to traditional sequencing library preparations, or due to the 
methodology of the sequencing itself. 
In the second BPA exposure study a greater number of reads was generated 
from the sequencing run, possibly as a consequence a greater number of 
differentially expressed genes and GO terms were also observed (Table 4). Ion 
transport was a significantly enriched GO biological process following exposure 
to 150 µg BPA/l, corresponding with a decrease in the expression of a number of 
transcripts encoding membrane transport proteins. A number of transcripts 
encoding ion transport proteins in the solute carrier family (slc26a1, slc4a2a, 
slc4a4a, slc5a8, slc22a7b, slc4a4b, slc5a11l and slc13a3) were down regulated 
(by 1.8-4.5 fold). Of these, slc5a8l, slc5a11 and slc13a3 were further associated 
with the significantly enriched GO term for sodium ion transport along with the 
downregulated carbonic anhydrase II ca2 and upregulated slc13a2. The gene 
encoding for the potassium voltage-gated channel kcnj13 was also significantly 
down-regulated by1.8 fold. Previous studies have demonstrated the ability of 
BPA to act rapidly, binding to ion channels to affect heart function (O'Reilly et al. 
2012, Posnack et al. 2014). The mechanisms by which cardiac conduction may 
be impaired by BPA are complex, however reducing sodium and potassium ion 
transport have both been suggested as possible targets (Posnack et al. 2014). 
Both sodium and potassium are essential in maintaining cardiac contractions, 
therefore any downregulation in genes encoding for ion transport could potentially 
have effects on heart function such as arrhythmia as has been previously 
described for BPA (Gao and Wang 2014). 
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The majority of GO terms significantly enriched in the molecular function 
classification are also associated with transmembrane transport. Many of the 
same downregulated genes, in particular those belonging to the solute carrier 
family appear responsible for this enrichment. An additional significantly enriched 
molecular function GO term was structural molecule activity, consisting of 
transcripts largely encoding for claudin proteins, including cldn7b, cldnb, cldnh 
and cldni, all downregulated (by 2.5-3.0 fold). Claudin proteins are 
transmembrane proteins and the most important components of tight junctions, 
suggesting again that BPA may have some effects on cell transport. This is 
reflected in the cellular component classification where the majority of 
significantly enriched GO terms are again associated with cell junctions and 
membrane proteins. In addition to transcripts for claudin genes a significantly 
downregulated (2.8 fold) transcript was also identified for connexin 32.3 (cx32.3) 
another transmembrane gap junction protein. 
Gap junctions mediate the cell-to-cell movement of ions and in the heart play an 
important role in impulse conduction, allowing heart muscle cells to contract in 
unison. In knockout mice where a cardiac specific gap junction (cx40) was 
silenced various phenotypes were observed including slowed conduction, partial 
atrioventricular conduction block and arrhythmia (Kirchhoff et al. 1998, Simon et 
al. 1998). Therefore, downregulation in the genes encoding for gap junctions in 
the heart could potentially have physiological consequences. A small number of 
studies have investigated the effects of BPA on gap junction proteins previously 
and they appear to concur an inhibitory effect (Lee and Rhee 2007, Salian et al. 
2009, Li et al. 2010). However, mechanisms are less clear, it appears that BPA 
can act directly on connexin gap junctions. (Lee and Rhee 2007)determined that 
during exposure there was no effect on Cx43 mRNA level, suggesting that BPA 
(at concentrations as low as 91.3 µg/l) inhibits gap junction-mediated intercellular 
communication through modulation of the gap junction gating as opposed to 
through genomic modulation. However, in these studies exposure time was short, 
up to a maximum of 24 hrs. A long term study on male rats fed 400 µg BPA/kg 
BW during postnatal days 1-5 and sampled during adulthood did find a significant 
reduction in the expression of cx43 mRNA (Salian et al. 2009). 
The significantly enriched GO terms in the second BPA exposure study were not 
seen in the original study for BPA exposed fish, or for MBP and EE2. 
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Furthermore, there are actually very few similar differentially expressed genes. 
The reasons for this could possibly be due to the reduced coverage observed in 
the original study, resulting from the sequencing methodology. In addition, the 
TotalScript library preparation technique requires particularly high RNA integrity, 
due to the lower RNA concentrations than conventional library preparations and 
the fact that it is not rRNA depleted. In the first exposure study average RIN score 
across all samples was 8.1±0.25, whereas average RIN score in the repeat study 
was 9.2±0.08. This indicates that although the original study passed the minimum 
RIN score necessary for the use of TotalScript library preparation (RIN >7) the 
RNA quality was higher in the repeat study, which may have resulted in a more 
robust library for sequencing. 
Our findings demonstrate BPA has the ability to affect gene signalling in the heart 
of larval zebrafish, albeit only covering a relatively small number of functions. The 
main genes that appear to be affected are those associated with membrane 
transport, in particular ion transport and gap junction communication, where the 
majority of genes are downregulated. These functions play an integral part in 
cardiac function, in particular maintaining regular contraction. Despite the 
strongest fluorescent signal in our estrogen responsive transgenic fish being in 
the atrioventricular valves and bulbus arteriosus there was no significant effect 
on genes involved in the function or development of these tissues.  
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CHAPTER 5: General Discussion 
A wide range of screening and testing systems have been used to further 
elucidate both the effects and mechanisms of action for BPA, and other 
environmental estrogens, including both in vitro and in vivo systems. The different 
available systems have their different strengths and weaknesses. In vitro systems 
are high throughput, can be transfected with a range of receptors/reporter genes 
whilst being cheap and easy to maintain. However, in vitro systems have their 
limitations. Several factors may be overlooked including the ability of a test 
compound to bioconcentrate. Certain cells will also express different co factors 
and metabolism may alter between species or even between tissue types. 
Transgenic fish have emerged in recent years in the field of ecotoxicology and 
they provide integrative systems that allow for comprehensive effects 
assessment across multiple tissues in vivo (Lee et al. 2015). The aims of this 
thesis were to utilise the zebrafish as a model organism, including a novel ERE-
TG transgenic zebrafish line, to determine the tissue targets, health effects and 
estrogenic mechanisms of action of BPA, the BPA alternatives BPS, BPF and 
BPAF and the BPA metabolite, MBP. 
I shall now discuss the key findings from the research presented in the thesis 
chapters and what the collective contribution of these findings are, followed by a 
discussion on the limitations and challenges of the work and possible future 
research directions. Through my thesis work the following has been established: 
(1) The estrogen responsive target tissues for all bisphenolic chemicals tested 
appear to be the same, though concentration necessary to induce a response 
can vary (Chapter 2 and Chapter 3). In chapter 2 I demonstrated that BPA and 
its commercial alternatives BPF, BPS and BPAF all target the heart tissue, and 
this was confirmed in Chapter 3 to be the atrioventricular valves and bulbus 
arteriosus. In Chapter 3 I also demonstrated that the BPA metabolite MBP 
similarly targeted the heart valves. This would indicate that these bisphenolic 
chemicals have a similar mechanism of action, likely binding via ERs. However, 
the reason for the difference in potency is less clear, it is likely that substituents 
on the phenolic rings or the bridge between them affect interactions with the 
ER(s). In silico modelling of MBP suggests that the stronger response is due to 
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possessing a longer bridge between the phenolic rings (Baker and 
Chandsawangbhuwana 2012). 
 (2) In Chapter 2 I also showed that BPA, BPF, BPS and BPAF exerted 
teratogenic effects at concentrations higher than those needed to induce any 
estrogenic response. Although estrogenic response appears to possess similar 
targets and there were some similar teratogenic responses between the 
bisphenolic chemicals, namely cardiac edema and craniofacial abnormalities, 
there were many distinct phenotypes. This may suggest that the different 
chemicals can interact with different signalling pathways in addition to the ER(s). 
For example, it was suggested that the observed inhibition of pigment formation 
in fish exposed to BPF could be associated with ability to affect thyroid signalling. 
It has recently been shown that BPF does affect thyroid signalling in zebrafish 
from as low as 20 µg/l by altering concentrations of TSH, T3 and T4 (Huang et 
al. 2016). Characterising how different chemicals may affect different signalling 
pathways in vivo is a difficult task, further confounded by the fact that there may 
be cross talk between different cellular signalling pathways. However this is an 
important area of future research to fully understand the possible health effects 
of these compounds. 
(3) Although receptor binding is likely to cause the differences in response, the 
uptake experiments conducted through this thesis also indicate that bioavailability 
may play an important role in estrogenic potency in vivo. In Chapter 2 I 
demonstrated that some of the alternative bisphenols have different capacities 
for accumulating in body tissues, possessing different BCFs. Particularly 
interesting was BPS, where, at a dosing concentration 50-fold higher than for 
BPA, the measured internal concentrations were similar. This may suggest that 
once in cells BPS has a similar affinity to BPA, as seen in various in vitro studies, 
and it is the lower bioavailability that limits its effect. In Chapter 3 I also showed 
that MBP had a greater potential to bioconcentrate compared with BPA, by 
approximately 10-fold. However, the estrogenic potency as measured by GFP 
increase was, 400 to 1000- fold higher indicating receptor binding is the main 
reason for the observed differences in potency here. 
(4) Differences in the tissue targets (GFP expression) for the different chemicals 
in ERE-TG fish seen here in Chapter 3 and previously in (Lee et al. 2012) is likely 
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to relate to preferential binding to certain ERs that show tissue specific 
expression. Through morpholino knockdown I was able to illustrate that esr1 is 
essential for inducing a GFP signal in the heart. It has previously been observed 
using WISH (Gorelick et al. 2014), and I confirmed with RNA-Seq in Chapter 4 
that the dominant ER expressed in the heart is esr1. From this work, it would 
appear that bisphenolic chemicals have a stronger ability to bind to and activate 
esr1 in vivo. 
(5) Transgenic fish provide a powerful tool in combination with molecular 
manipulation techniques for determining signalling pathways. In Chapter 2 I 
illustrated that the bisphenolic chemicals induced responses through the classic 
ER signalling pathway. In Chapter 3 through combining chemical exposure and 
injection with morpholinos for specific ER(s) I was able to illustrate the specific 
ER(s) responsible for signalling in the different tissues. Specifically, esr1 was 
found to be essential in heart signalling, esr2a and esr2b essential for signalling 
in tail myotubes and all ERs play a role in liver signalling. 
(6) BPA may have health effects in the heart. Work in Chapter 3 and Chapter 4 
indicates BPA can exert a measurable effect on heart function and gene 
expression. In Chapter 3 live imaging of exposed zebrafish larvae indicated that 
exposure to BPA affected the ability of the heart to contract effectively (5 dpf and 
14 dpf). Specifically at 5 dpf the A:V beat ratio was disrupted and at 14 dpf heart 
rate was lowered. It should be noted however, that these effects were only 
observed at a concentration of 2 500 µg/l, far exceeding even the highest 
environmental dose by 100-fold. Testing at a much lower concentration of 
150 µg/l (that still exceeds environmental concentrations by at least 7-fold), I later 
showed (in Chapter 4 through RNA-seq analysis) that several genes involved in 
ion transport and cell-to-cell signalling were downregulated. These processes are 
essential for maintaining regular and consistent contraction. It is therefore 
feasible that downregulation of these genes may be having a more subtle effect 
on heart function not detected in my work. Much longer (including lifelong) 
exposure should be explored to assess for the possibility of more subtle health 
effects and thus provide greater re-assurance for a lack of health effects of BPA 
on heart function. 
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5.1 Collective contribution of this thesis 
This thesis has presented a range of novel findings as stated above, which make 
a valuable contribution to the current understanding in this field. For example, 
despite the increasingly frequent use of alternative bisphenols in BPA-free 
plastics prior to my thesis there was very little research on in vivo health effects 
of these alternatives. Several in vitro studies have shown conflicting evidence as 
to the potency of the most commonly used alternative BPS (Masuno et al. 2005, 
Grignard et al. 2012). The data in this thesis does demonstrate that in vivo BPS 
does appear to be up to 50-fold weaker as an estrogen than BPA, making it more 
suitable as a replacement. However, we also show for the first time that it does 
display similarities in tissue targets, that would also suggest there are still 
concerns for both aquatic species and human health. The fact our research also 
determined that BPF and BPAF were found to be as potent and 10-fold more 
potent in vivo than BPA respectively should be cause for increased concern. 
These compounds are currently used in replacement plastics and resins without 
the scrutiny BPA receives and are found in environmental and human samples 
(Liao et al. 2012, Liao and Kannan 2013, Yang et al. 2014). This data presents 
the first findings comparing in vivo estrogenic potency and tissue targets of these 
bisphenols in an aquatic vertebrate. The data in this thesis, therefore contributes 
valuably to the current knowledge on the health effects of bisphenolic chemicals 
and as such may be used to aid policy and decision makers on the improvement 
of both environmental quality standards and human health protection. 
Although water chemistry measurements are now common in toxicity testing (as 
advised in OECD guidelines Test, 236), measurements of chemical uptake and 
bioconcentration are much rarer in routine dose response studies (Yamaguchi et 
al. 2005, Rochester and Bolden 2015, Tisler et al. 2016). The data presented in 
this thesis demonstrates the importance of taking such measurements. This is 
the first study that has compared the uptake of various bisphenolic chemicals to 
their in vivo estrogenic activity. Previous data has relied on receptor affinity to 
determine possible health effects (Rosenmai et al. 2014, Rochester and Bolden 
2015). Uptake data is important as it indicates that bioavailability in combination 
with receptor affinity plays an important role in the activity of a chemical. This 
further emphasises the relevance of in vivo studies to gain a greater 
understanding of the mechanisms of effect for any given chemical. 
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Although there are now several transgenic fish lines developed for use in 
ecotoxicity testing, few have progressed to the stage where they are commonly 
employed in empirical research, instead being reported in papers where their 
generation is the focus (reviewed in Lee it al. 2015). This thesis provides evidence 
that the ERE-TG zebrafish line can be employed to ask relevant research 
questions which is essential if these models are to ever gain a place in regulatory 
testing. We have shown that they can be used to compare in vivo estrogenic 
potency across a family of chemicals and in combination with receptor 
knockdown to determine tissue specific effect mechanism. Previously specific 
ligand receptor interactions were determined by in vitro binding assays or by 
changes in receptor expression both of which have limitations (Kitamura et al. 
2005, Li et al. 2013, Delfosse et al. 2014 Rochester and Bolden 2015). This is 
the first study that has utilised receptor knockdown with an estrogen responsive 
transgenic fish to determine specific receptor signalling pathways, proving that it 
is a viable method useful to the field of ecotoxicology research.  
In chapter 3 we determined that the heart valves were a key target for bisphenolic 
compounds. This finding demonstrates the importance of transgenic fish models 
that do not have markers reliant on individual tissues, such as a vtg or cyp19a1b 
promotor that only express in the liver and brain respectively (Bogers et al. 2006, 
Peterson et al. 2013). Despite the observed signal, BPA did not appear to have 
any specific functional health effects relating to these structures, that we were 
able to identify. Therefore, although this thesis presents some of the first data 
using transgenic fish in novel ecotoxicology research, it also demonstrates the 
need for caution in interpreting results. It must be emphasised that although 
extremely useful in identifying specific tissue targets and determining signalling 
pathways, a fluorescent response cannot be assumed to result in health effects 
in these tissues. Moving forward with these models, with this in view, they should 
form a basis for further experimental work investigating the potential health 
effects in larvae, but also other life stages. 
This thesis provides new evidence on the practical uses of RNA-seq for 
determining global transcriptome changes in specific larval tissues following 
chemical exposure. In previous studies when assessing alterations to gene 
transcription in larvae DNA has been extracted from whole larvae, likely due to 
the difficulties with isolating individual organs (of 33 studies reviewed by Schuttler 
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et al. 2017). However, the need to understand gene changes in specific organs 
is vital, particularly at this early stage as organogenesis is in progress (Martin and 
Bartman 2009, Staudt and Stainier 2012). The data presented in Chapter 4 
demonstrates, again for the first time, that it is possible to extract high quality 
RNA from specific larval tissues and generate libraries suitable for sequencing. 
This information is valuable to those planning RNA-seq experiments in larval 
stages and moving forward investigators should look to examine the specific gene 
responses across organs in larvae as is frequently done in adult exposures. 
5.2 Challenges and Limitations Encountered  
Transgenic fish line 
The use of the transgenic ERE-TG zebrafish line was an integral part of this 
thesis, consistently used throughout each research chapter. However, 
maintenance of the line proved to be time consuming. In particular, screening to 
ensure homozygosity of both transgenes (ERE:Gal4ff)/(UAS:GFP) that needed 
to be undertaken on several occasions. A further limitation in the line I used was 
that zebrafish natural pigmentation formation occluded the fluorescence signal at 
later life stages. This was a major driver for conducting all work in larval stages. 
Larval stages however were especially useful for much of this work, including for 
the application of morpholino knockdown to establish chemical effect 
mechanisms. Larval stages are practically easier also for conducting exposures 
and considering space and resources generally. However, embryonic and early 
life stage responses may not always be representative of those seen in later life 
and may only be used to infer possible health outcomes for older life stages. The 
issue with pigmentation has been addressed during the course of this PhD and a 
further line has been developed in the pigment free casper zebrafish line (Green 
et al. 2016). However, even in this line thickness of skin and depth of internal 
organs only allows for practical quantitation of fluorescence up to approximately 
30 dpf. A further possible limitation of using a transgenic line is that there has 
currently been very little research into the comparable responses between 
transgenic and wildtype animals. Also as to how the nature of the promoter differs 
from natural promoters. In the ERE-TG fish used in this study a 3x repeat 
synthetic ERE promoter was used as this was determined to produce the 
strongest response and bind all ER-subtypes, capturing responses via all ER 
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mediated pathways. However natural EREs are likely to interact with differing 
efficiencies - an area where future research would be beneficial. 
Timing of exposure and sampling 
Calculating the timing of sampling frequently presented a challenge in several 
chapters. In Chapter 3 I exposed morpholino injected larvae. Morpholinos are 
known to be time sensitive, with effectiveness only lasting into the first few days 
post injection. A preliminary study indicated that at 96 hpf GFP could be induced 
in the heart of morpholino injected fish (against all ERs) by BPA, whereas at 
72 hpf no induction was observed. Therefore, fish were sampled for microscopic 
imaging at 72 hpf to ensure we were observing effective knockdown by the 
morpholino. This was an earlier time point than for other studies in this thesis 
(largely 96-120 hpf). However, the fact that esr1 was the dominant ER expressed 
in the heart at 96 hpf in Chapter 4 would suggest we can be confident in the 
results obtained by morpholino injection that indicated estrogen signalling in the 
heart is dependent on esr1. 
Timing of sampling also had to be decided for RNA-seq in Chapter 4. As valve 
formation has been reported to occur between 72 hpf and 120 hpf, I chose the 
midpoint of 96 hpf, in an attempt to capture specific gene pathways involved in 
this process. Preliminary work also indicated that 96 hpf was the most appropriate 
age to optimise the heart extraction technique, which was necessary to obtain 
sufficient RNA (discussed below). 
In both sequencing experiments I did not detect any alterations in genes involved 
in valve/bulbus arteriosus formation. It may be the case that despite responding 
to estrogen (producing a fluorescent signal in these tissues) there is no direct 
effect on development of these structures. The GFP protein is relatively stable 
and without UV exposure may remain stable for several days, with a half-life of 
approximately 26 h in one system (Corish and Tyler-Smith 1999). GFP may 
therefore only indicate where there has recently been transcription. Further work 
should seek to investigate whether there is a time-related response to genes 
involved in valve formation on exposure to these chemicals. 
RNA-seq RNA concentration and methodology 
203 
 
Although RNA-seq offered many advantages I encountered significant 
challenges in obtaining enough mRNA to perform RNA-seq. Larval zebrafish 
hearts contain a very low concentration of RNA, I calculated an average heart to 
have RNA present at approximately 36pg/µl. A significant period of time was 
therefore spent optimising the heart extraction and isolation technique and 
comparing the different methods of RNA extraction, namely using Trizol or 
Qiagen column methods. Qiagen columns were found to be most effective. As 
total RNA concentrations were still low (ranging from 1 497 to 3 279 pg/µl), even 
when pooling hearts of approximately 50 larvae it was necessary to investigate 
library preparation techniques that were optimized for this. The TruSeq library 
preparation method used frequently by Exeter Sequencing Service request a 
minimum of 200ng total RNA, TotalScript was therefore selected which is 
optimised to work with concentrations as low as 5ng total RNA. Further issues 
encountered with sequencing were discussed in Chapter 3, particularly with 
regards to the first sequencing experiment. It is believed these issues were 
possibly related to the sequencing run as the libraries for this experiment were 
multiplexed on a sequencing lane with a separate experiment. This resulted in a 
smaller number of reads per sample and could have affected downstream 
analysis. Another reason suggested was the lower quality of RNA in the first 
experiment. Unfortunately, due to the low levels of RNA it was not possible to 
perform a second sequencing run on the previous samples and a second 
experiment was instead performed. 
Use of microscopy to quantify fluorescence 
Another common theme throughout this thesis is the use of fluorescence 
microscopy and subsequent image analysis to measure GFP intensity, to infer 
differences in potency and target tissues between chemicals. There are some 
inherent limitations with carrying out this process. Firstly ,the number of 
observable fish per treatment is limited by workload constraints. Although 
microscope parameters (exposure length, light intensity, microscope aperture 
etc.) were maintained throughout an experiment it is necessary to orientate the 
larvae in an identical manner for every photograph. This can be difficult to judge 
by eye. Some of the problems with the nature of this work can be overcome with 
the use of automated systems, recently applied to rapidly scan and analyse 
responses in transgenic fish (Green et al. 2016). However, sensitivity is lost in 
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automated systems currently available, for example the lowest observed effect 
concentration for BPA was reported to be 1000 µg/l as opposed to 100 µg/l as 
observed using conventional microscopy. Also the inability to manually orientate 
larvae increases the difficulty of identifying specific tissue targets. It is likely 
therefore that although these high-throughput methods may be very useful in 
identifying chemicals of interest for future research they will be used in 
combination with more traditional microscopy techniques. Though it should be 
noted that the increased use of transgenic fish and the need for higher throughput 
screening, particularly necessary if intended as a tool for regulatory testing, is 
likely to drive rapid improvements in the field of automated detection. These 
improvements, for example use of automated insertion of larvae into a capillary 
tube allowing orientation to be manipulated, should overcome these issues. 
Test Concentrations of Bisphenolic chemicals 
Test concentrations for bisphenolic compounds were generally high and well 
above those found in the natural environment. This needs to be considered 
against the biological target and effects seen. The work presented nevertheless 
provides important information in establishing effect mechanisms of action and 
target tissues for potential health effects for these compounds. As MBP has never 
been detected in environmental samples, which may be because it has not been 
screened for, it was not possible to establish what an environmentally relevant 
dose was for the exposure studies.  However it is likely that concentrations tested 
in Chapter 3 are unlikely to be found in water samples, due to the fact that 
production of MBP is not a major metabolic pathway in mammals (details on MBP 
production in other taxa are currently unknown). This work still allowed us to 
demonstrate that a known metabolite of BPA (in mammals) is more potent as an 
estrogen in vivo than BPA itself. More work is necessary to determine the 
potential in fish to produce similar metabolites, whether these metabolites 
circulate freely and whether they are present at concentrations likely to cause 
health effects. I did detect an estrogenic response in the heart valves at 100 µg 
BPA/l and changes in gene transcription at 150 µg/l, these concentrations are 
much closer to the highest environmental samples, but still 5 to 7-fold higher. 
Further work should aim to establish if similar genetic targets are affected at more 
environmentally relevant concentrations. 
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5.3 Future Considerations 
Transgenic fish models 
This thesis has demonstrated that transgenic fish may be employed to determine 
target tissues and effect mechanisms of bisphenolic chemicals. These data can 
then be used to further investigate possible health outcomes. As previously 
discussed this can be taken forward with high-throughput screening to rapidly 
screen and easily identify chemicals of interest (Green et al. 2016). However one 
of the most effective uses for transgenic fish is that receptor subtype effect 
pathways may be investigated relatively easily using silencing methods. In this 
thesis we used a generic drug targeted inhibition (Chapter 2) and a targeted 
morpholino knockdown approach (Chapter 3) to determine ER pathways specific 
to subtype. However new methods in gene silencing have been developed in 
recent years that may also prove effective. Future studies could utilise CRISPR 
technology, as one such method, that may prove useful in combination with 
transgenic fish species. This allows for simple and efficient targeting of the 
genome itself, as opposed to morpholinos that target mRNA (Wei et al. 2013). 
Advantages suggested in using CRISPR models are that possible side effects 
sometime apparent with morpholinos are reduced. Also changes are longer 
lasting, essentially creating a mutant organism, which would allow for 
observations at later life stages than with morpholinos.  
A further method by which the use of ERE-TG fish could be improved in the future 
includes the use of different reporters and promoters. For example, currently in 
development is an ERE-TG fish where the reporter instead uses the kaede 
protein, which converts from green to red fluorescence after UV treatment (Lee 
et al. 2015). This offers opportunities to identify responses for sequential 
exposures, for either the same or different chemicals. Combining different 
reporters in one animal such as the ERE and cyp19a1b gene promoters (with 
separate fluorescent reporters) could also help to better understand the roles of 
estrogenic chemicals in fish. 
Bisphenolic chemicals in plastics 
During the course of my PhD there has been increased regulation on the use of 
BPA, with several regulatory bodies banning the use of the chemical, particularly 
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in baby bottles (Barraza 2013). This is a step forward, indicating that sound 
scientific evidence in combination with public pressure (itself brought about by 
increasing the public awareness of scientific research and its implications for 
environmental and human health) can have a positive effect on changing 
legislation. It is essential that research, industry and policy makers work in 
collaboration to thoroughly progress the understanding of these chemicals. 
However, there is now growing evidence, which this thesis contributes to, on the 
comparative toxicities of all bisphenolic chemicals. As yet, however, there do not 
appear to be any moves to reduce the use of alternative bisphenols. Research 
such as this is therefore important to highlight the potentially similar activity of 
these commonly used alternatives to better inform policy makers. Although 
currently chemicals have to undergo safety testing this largely relates to toxicity. 
Transgenic fish, such as the ERE-TG zebrafish used throughout this thesis could 
form an extremely useful addition to standardised toxicity testing, to determine 
sub-lethal negative health effects, though they have yet to achieve regulatory 
acceptance. 
In addition to the estrogenic effects of these alternatives, my research has 
demonstrated that additional effects may also occur through different pathways. 
To fully understand the mechanisms of action of these bisphenol chemicals 
further research is necessary to determine their effects on other pathways such 
as androgen and thyroid signalling. Certain bisphenol analogues, TBBPA, for 
example, have been well documented as having a stronger effect on thyroid 
signalling than estrogen (Kitamura et al. 2005). BPF has also recently been 
demonstrated to disrupt thyroid hormone concentration in fish (Huang et al. 
2016), which may indicate a possible reason for some of the effects we observed 
in Chapter 2. 
Possible health effects of long-term exposure 
Most of the experimental work in this thesis was carried out on larval zebrafish 
<120 hpf, with functional effects measured up to 14 dpf only. Though these 
studies have merit as this is an important stage for organ development and any 
effects may have lifelong health consequences. This may also be seen as a 
limitation, as levels of estrogens differ during different life stages and there may 
be life stage specific effects for bisphenol exposures. Most epidemiological 
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studies that link BPA exposure in human populations to cardiovascular risk 
factors are likely to have resulted from a lifelong exposure of BPA. The small 
numbers of mammalian in vivo studies that have investigated the effects of BPA 
on the heart have also investigated chronic exposure (Patel et al. 2013, 
Chapalamadugu et al. 2014, Kim et al. 2014). In the future it would be beneficial 
to determine the effects of life long BPA exposure on these fish to better link the 
health effects we observed in this thesis to those seen in humans. Further work 
should seek to investigate the effect of lifelong exposure on valve 
formation/function, but also general cardiovascular health. It would be interesting 
to compare this to early life exposure with a subsequent depuration until maturity 
to assess if being exposed at this early stage, when the heart is first developing, 
can have effects in maturity. 
Metabolic activation 
Metabolism of BPA and its alternative replacements could be a key area for future 
research to focus on. As we have demonstrated a metabolite of BPA – MPB - is 
much more potent than BPA as an estrogen in vivo. However, there is very little 
known about the comparative metabolism of the alternative bisphenols discussed 
in this thesis. The group that originally identified MBP as an active metabolite of 
BPA in mammalian S9 liver fractions also identified a similarly structured and 
potent metabolite of BPB, a bisphenol not tested in this thesis (Yoshihara et al. 
2004). However, although metabolite structures were not identified, incubation of 
BPF with S9 liver fraction did not increase estrogenicity as observed with BPA 
and BPB (Okuda et al. 2011). Preliminary investigations carried out on uptake in 
Chapter 2 also appeared to identify that BPS metabolism in our fish differ 
distinctly from that seen for BPA. I would suggest that there should be a focus in 
future research on mapping the metabolic pathways of these chemicals to 
determine if metabolic activation is a likely mechanism of action. As with BPA it 
is then necessary to determine if any potentially potent metabolites are produced 
in vivo at concentrations likely to induce health effects. A further focus on 
metabolic activation could investigate the ability of different life stages to 
metabolise BPA, as it has been suggested foetal and adult livers may possess 
distinct mechanisms (Takahashi and Oishi 2000). 
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5.4 Concluding remarks 
The research conducted in this thesis has provided knowledge on BPA and its 
most commonly used alternatives, BPF, BPS and BPAF in terms of their 
biological effects on zebrafish during early life stages. It provides the first 
evidence that differences in estrogenic activity likely relate not only to how these 
chemicals interact with ERs but also to the uptake and bioavailability of the 
relevant compound. This thesis established the target tissues for the various 
bisphenols as well as determining pathways by which these effects may be 
mediated. Metabolic activation was suggested as a way that BPA may exert some 
of its effects in vivo. This may hopefully initiate the further exploration of the 
different metabolic pathways of BPA alternatives, to further understand the 
differences observed in toxicity. As these chemicals may possess hormonal 
activities similar to or even beyond that of BPA, this demonstrates the need for 
rigorous safety evaluation. It may even be prudent to suggest that safety 
evaluations of compounds for consumer use should consider entire classes 
instead of individual compounds. 
Through establishing the heart as a key tissue target of BPA, further 
investigations found health effects associated with contractility and genes related 
to ion transport. This data is of concern to aquatic species as BPA concentrations 
have been measured consistently in environmental water samples and also to 
humans where BPA exposure is known to occur consistently. 
Plastics and resins are extremely useful materials, with a wide range of 
applications, it may even be suggested they are essential for modern living. 
However, as demonstrated throughout this thesis and related research there 
does not appear to be any suitable bisphenolic chemicals to use as monomers in 
production of these materials, due to reported health effects. Future research 
would therefore be best focused on the design of chemical substitutes that do not 
possess biological or hormonal activity similar to those of BPA. This would require 
an integrative multi-disciplinary approach in collaboration with industrial partners, 
where efficient screening methods are employed prior to mass manufacture. 
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